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Introduction 
 
During the last decades, the use of antimicrobial drugs, growth promoting agents and 
food additives in animal husbandry has increased considerably. As a result, residues of these 
drugs occur in food products derived from treated animals or reach soil and ground water 
after excretion via faeces and urine (Dupont and Steele, 1987; Franco et al., 1990).  
 
These residues can be harmful for human and animal health (Milhaud and Person, 
1981; Dupont and Steele, 1987), due to direct toxicity when high concentrations are present 
(Schmid Von, 1983), the development of antibiotic resistant pathogenic bacteria (Al-Sam et 
al., 1993; Anonymous, 1997b; Schwarz and Chaslus-Dancla, 2001), the disturbance of the 
intestinal flora (Okerman, 1995), and finally, the potential of some residues to induce 
hypersensitivity reactions (Burgat-Sacaze, 1981; Allison, 1985; Dewdney et al., 1991).  
 
The presence of residues in food producing animals induces financial losses. Carcasses 
and products containing violating levels of residues are confiscated and the farm owner is 
sanctioned with extra controls (Anonymous, 1997a). Residues in milk and meat affect the 
fermentation process of yoghurt, cheese and sausage preparation (Mourot and Loussouarn, 
1981; Allison, 1985; Koenen-Dierick and Van Hoof, 1988; Grunwald and Petz, 2003). 
 
To protect consumers from risks related to drug residues, maximum residue levels 
(MRL) and withdrawal times were determined for drugs in food (Anonymous, 1990), and the 
inspection of food derived from treated animals was regulated (Anonymous, 1996a). Food is 
considered safe for consumption when no drug residue is present above the MRL. Each 
member of the European Union has a monitoring program to test for the presence of legal and 
illegal veterinary drugs in edible tissues.  
 
During the monitoring for the presence of drug residues, a large number of samples 
are screened using receptor assays, immunological or microbiological methods (Allison, 
1985; Charm and Chi, 1988; Kavanagh, 1989; Moats, 1990). Because a large number of 
samples is analysed, the ideal screening test is cheap, fast, requires no or little sample 
preparation and has a high sensitivity. The screening of samples will provide a majority of 
negative results, indicating that the samples are “compliant” with the legislation. Compliant 
samples require no further analysis. A minority of samples will be tested positive during 
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screening, indicating that the samples are suspected to be non-compliant with the legislation. 
In the case of a suspected non-compliant sample, this result must be confirmed by a 
confirmatory method (liquid or gas chromatography combined with spectrometric detection; 
Anonymous, 2002). The results of such analysis are considered to be exact and very reliable. 
The drawback of the method is the intensive sample preparation and the expensive price. It is 
therefore important to use screening assays with high specificity to avoid the superfluous 
analysis of false non-compliant samples with the expensive and laborious confirmation 
methods.  
 
Actually, the Belgian residue control program for meat and meat products is currently 
operating in three steps. First, the kidney and sometimes muscle tissues collected at 
slaughterhouse are analysed in the New Belgian Kidney Test (NBKT; Anonymous, 1995) for 
the presence of antibiotics and other anti-microbiological substances (pre-screening). The 
NBKT is a microbiological assay based on the growth inhibition of bacteria on an agar plate 
in presence of a meat sample (Okerman, 1995; Okerman et al., 1999). The assay only 
indicates the presence of an anti-microbiological agent and does not discriminate between 
different families of agents. Therefore, suspected non-compliant samples are further screened 
using other microbiological assays or using immunoassays to identify the inhibitory substance 
or the group to which it belongs (screening). Finally, the analyte present is identified and 
quantified using a confirmatory method (confirmation). 
 
Penicillins and sulfonamides are widely used in veterinary medicine. The NBKT used 
in the pre-screening step, can also be applied to screen samples for the presence of penicillins 
(Okerman, 1995). Therefore, the samples are incubated with and without penicillinase. The 
inhibitory activity of penicillin on the bacterial growth of the test will be abolished by 
penicillinase. Other assays used for screening purposes are the Penzyme Test (Everest et al., 
1993) and the microbiological receptor test Charm II (Charm and Chi, 1988). These three 
methods detect only the microbiological active form of penicillin and not the allergenic 
metabolites. Penicillins are easily broken down during storage or sample preparation (Boison, 
1995). As a result, an underestimation of the real penicillin concentration will occur. The 
screening for sulfonamides is also a problem. The NBKT is not sensitive enough (Okerman, 
1995). A lot of ELISAs are commercially available, each of them highly specific for one or 
two sulfonamides. Thus, screening with these ELISAs would be very expensive. The Charm 
II Test is sensitive enough to detect the sulfonamides at the MRL, but the assay is based on 
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radioactivity. The penicillins as well as the sulfonamides can be identified and quantified at 
concentrations below the MRL using liquid chromatography coupled to spectrometry 
(Boison, 1995; Ito et al., 2000; Van Eeckhout et al., 2000).  But these techniques can only be 
applied for confirmation because they are too expensive and labour-intensive for screening.  
 
There is a need for adequate, sensitive screening tests for penicilllins and sulfonamides 
enabling the group-specific detection of both families. Immunochemical methods like 
Enzyme-Linked Immunosorbent assays (ELISA) and optical immunobiosensors are therefore 
interestingly because they can be designed to be specific for one group of antibiotics or 
chemotherapeutics, allowing the group-specific identification during the screening step of the 
residue control program. ELISAs are quick, sensitive and have the additional advantage of 
analysing several samples simultaneously (Paraf and Peltré, 1991). Optical biosensors like the 
Biacore™ biosensor, based on the antigen-antibody interaction can provide fast, automated, 
reliable and sensitive analysis (Elliot, 2001). A test kit for the group-specific detection of all 
sulfonamides in porcine tissues using the Biacore biosensor is nowadays available (McGrath 
et al, 2004). 
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Chapter 1: Principles of immunoassays 
 
1.1. Antibody and antigen 
 
Immunochemical methods are based on the extraordinary discriminatory power of 
antibodies, based on the ability of the immune system of vertebrates to produce an unlimited 
variety of proteins (antibodies), each with an affinity for a specific foreign compound (antigen 
or hapten). An understanding of the physicochemical and mathematical background of the 
interaction between antigen and antibody, and the way it is influenced by external factors is of 
crucial importance for the quality of the immunoassays. 
 
1.1.1. The antibody – antigen interaction   
 
The binding between an antibody and an antigen is non-covalent and reversible. The 
interaction is the result of a combination of attractive and repulsive forces (reviewed by Van 
Oss, 1994). Four types of forces promote the binding: the electrostatic interaction, dispersion 
forces, hydrogen bonds and hydrophobic interactions. A lack of complementarity (steric 
factor) between the antigen and the antibody binding sites is important among the repulsive 
forces and prevents a close approach of the two molecules necessary for the weak, attractive 
forces to be effective. The major driving forces for the antigen-antibody reaction are the 
hydrophobic interactions. They are based on the repulsion of water by non-polar groups rather 
than on attraction of molecules (Tanford, 1978). The water molecules are squeezed from the 
binding sites, enhancing the tightness of electrostatic or ionic binding, since water molecules 
no longer compete with the latter. The dispersion or van der Waals forces are responsible for 
the attractive interaction between non-polar residues of the antigen and the antibody. They act 
over small distances only (the forces decrease with the inverse 7th power of the intermolecular 
distance until a certain minimum distance) and are characterized by their additivity; the force 
between two large sites equals the sum of all interactions (Tijssen, 1985). The electrostatic 
interactions are usually not dominant in the antibody-antigen complexes. These forces are 
inversely proportional to the second power of the intermolecular distance and to the dielectric 
constant, which decreases drastically when water molecules are squeezed out. Therefore, 
complementarity around the bond, which determines the degree of water elimination, is 
directly related to energy gain. The level of ionisation depends on the pH of the immediate 
environment (Tijssen, 1985). Hydrogen bonding is primarily exothermic and increases in 
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strength by reduced temperature. Consequently, antigen-antibody interactions for which 
hydrogen bonding is important are more stable at lower temperature (“cold antibodies”, 
Tijssen, 1985) (Van Oss, 1994). 
 
The equilibrium reaction between antibody (Ab) and antigen (Ag) may be expressed 
as: 
Ab + Ag               Ab-Ag 
 
Where ka and kd represent the association and dissociation rate constant. The 
equilibrium (affinity) constant K may be established according to the law of mass: 
 
ka[Ab][Ag] = kd[Ab-Ag] and K = ka/kd = [ Ab-Ag]/ [Ab][Ag] 
 
with [Ab], [Ag] and [Ab-Ag] the equilibrium concentration of the free antibody, free 
antigen and the antibody-antigen complex, respectively (Van Regenmortel and Azimzadeh, 
1994). K is the equilibrium or affinity constant (M-1) and is a parameter for the closeness of fit 
between antigen and antibody or the complementarity between the binding site of antigen and 
antibody. The association rate constants ka are very similar for various antibody-antigen 
systems, i.e., for many haptens around 107-108, which are only slightly below the diffusion 
rate and depend directly on, but cannot be faster than, the diffusion controlled encounter of an 
antigen with its antibody. The initial rate for protein antigens can be about 100 times lower, 
due to their slower diffusion. In contrast, kd can vary from 10-4 for high affinity antibodies to 
103 for low affinity antibodies, depending on the closeness of fit (Tijssen, 1985). An antibody 
of extremely good fit can have an affinity around 1011 M-1, K-values around 109 M-1 are fairly 
normal, while low affinity antibodies will display values below 106 M-1 (Van Regenmortel 
and Azimzadeh, 1994). 
 
1.1.2. The antibody 
 
Antibodies or immunoglobulins are proteins synthesized by B-lymphocytes of an 
animal or human in response tot the presence of a foreign substance. The basic structure of an 
intact immunoglobulin is a Y-shaped molecule composed of two heavy (H) and two light (L) 
chains. The H-chain (50-70 kDa) is built out of one variable domain VH and three constant C 
domains CH1, CH2 and CH3. The L-chain (about 25 kDa) consists of a VL and a CL domain. All 
ka 
kd 
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these domains consist of about 100 amino acid residues, are homologous in their primary 
structure, and are independent, stable structural units (Stryer, 1988). The polypeptide chains 
between the domains are susceptible to protease cleavage. The immunoglobulin molecule is 
cleaved by pepsin in the hinge region, linking the two arms to the base of the molecule. The 
two arms form together the (Fab)2 fragment, while the base of the molecule is called the Fc 
fragment. After cleavage of the bivalent Fab fragment by papain, the two arms are released 
from each other and are known as Fab fragments (Tijssen, 1985).  
 
Antibodies have two functions: recognition of the antigen and activation of the 
immune system. The first function is mediated by the antigen-binding sites, situated between 
the VL and VH domain, at the top of the Fab fragments and known as complementarity 
determining regions (CDR). The activation of the protective system depends on the different 
heavy chains. Immunoglobulins are therefore classified according to the structure of the 
heavy chain into IgG, IgM, IgA, IgE and IgD. According to the animal species, some classes 
are subdivided into subclasses, designated by addition of a number (IgG1, IgG2,…). Table 1.1 
shows some characteristics of the human immunoglobulins. IgG is involved in secondary 
responses, placental transfer and complement fixation; IgA is the major class of antibodies in 
external secretions (saliva, tears, bronchial and intestinal mucus). IgM is produced in primary 
responses and in response to T-cel independent antigens. IgM is also a powerful agglutinin 
and is important for complement fixation. IgD is an early receptor on lymphocytes and IgE 
plays a role in allergic reactions (Tijssen, 1985; Stryer, 1988). 
 
Antibodies are synthesized against all antigenic conformations the immune system 
could possibly encounter (Creighton, 1993). Each antibody-producing cell produces a single 
antibody molecule, expressed as membrane protein (B-cell receptor). When such a cell 
encounters an antigen that is recognized by its receptor, the cell is stimulated to undergo cell 
division, to proliferate and to produce large quantities of antibodies. This means that an 
enormous number of antibodies with different antigen specificity are produced. This diversity 
is generated by a special mechanism during the biosynthesis of the antibodies. The variable 
domains are encoded by separated gene segments: variable (VH), diversity (D) and joining (J) 
for the heavy chain; VL and JL for the light chain. Different antibodies are generated by 
joining these segments in different combination. Further genetic variation is introduced at the 
sites where the segments are joined together by the genetic fusion mechanism. Most of the 
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variations occur in the residues comprising the three CDR regions of each polypeptide chain 
(Creighton, 1993). 
 
Table 1.1.: Characteristics of the human immunoglobulins (from Tijssen, 1985). 
 IgG IgA IgM IgD IgE 
Heavy Chain γ α µ δ ε 
Mass H chain 
(kDa) 50 65 70 70 72.5 
Light chain κ or λ κ or λ κ or λ κ or λ κ or λ 
Mass L chain 
(kDa) 25 25 25 25 25 
Secretory 
component No yes no no no 
Polymer monomer dimer pentamer monomer monomer 
Valence for Ag 
binding 2 2 or 4 10 2 2 
Approximate 
concentration 
in serum (g/l) 
10 2 1 0.05 10-4 
Mass (kDa) 150 160-400 900 185 200 
 
 The lymphocyte precursor cell will first express IgM on its surface, followed by IgD. 
After stimulation by contact with an antigen, the cell will differentiate into memory cells and 
antibody producing plasma cells. During the primary response, IgM is produced. After a 
second contact with the antigen, mostly antibodies of the IgG class, but also some IgE and 
IgA are then formed (Tijssen, 1985). During this process of repeated contact with the antigen, 
the genetic segments coding for the variable region of the antibody molecule undergo 
mutations at a rate much higher than normal. Cells producing antibodies with higher affinity 
are then selected. Consequently, the immune response to an antigen changes in time. Initially, 
low affinity antibodies are produced (Kd = 10-5- 10-7), but with time antibodies of increasing 
affinity are produced (Creighton, 1993). 
 
1.1.3. The nature of immunogens, antigens and haptens 
 
 Two fundamental requirements must be fulfilled by a molecule to be immunogenic: 1) 
it should be foreign to activate the immune system, and 2) it must be of a certain complexity 
to react with the different compounds of the immune system. Immunogenicity is thus the 
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ability to stimulate a specific response, here the production of specific antibodies. Only 
restricted portions of a macromolecule are involved in the antigen-antibody interaction. These 
regions are called epitopes and are rather small (5-7 amino acids). Epitopes have to fit in the 
antigen binding sites (paratopes) on antibodies. Macromolecules may contain many epitopes 
on one molecule. Antigens carry a number of epitopes. Immunogens carry in addition to these 
epitopes, T-cell epitopes that play a role in the immune response. For the induction of 
antibody production, both a B-cell and a T-cell immune response are required. The precursor 
of each antibody-producing lymphocyte makes Ig of only one specificity, which is expressed 
as membrane protein. When a specific immunogen (peptide) binds to this surface antibody, 
the cell will proliferate and differentiate into specific-antibody secreting cells and into a clone 
of memory cells (responsible for the faster and stronger secondary response). This 
proliferation however, will only occur with some help from T-cells triggered by the 
immunogen. Foreign proteins are phagocytized and degraded into peptides by antigen 
presenting cells (macrophages, monocytes, dendritic cells, B-cells). The peptides are 
presented at the surface of the antigen presenting cells and can now be recognized by T-cell 
receptors. Once recognized, the T-cell will proliferate and differentiate into T-helper cells and 
produce cytokines necessary for the B-cell to proliferate and differentiate (Stryer, 1988; 
Jemmerson, 1995).  
 
Haptens are antigens but not immunogens because they lack the carrier determinant or 
T-cell epitope. Haptens can be rendered immunogenic after covalent attachment to a suitable 
immunogenic carrier protein (Van Regenmortel et al., 1988). Most of the time haptens are 
small molecules, for example antibiotics or toxins, but immunogenicity and not size is the 
criterium. Large non-immunogenic molecules can also act as haptens and rendered 
immunogenic after conjugation to a suitable carrier. An antigen must also be degradable to be 
immunogenic. For example, the weak immunogenicity of D-amino-acids polymers could 
possibly be due to the lack of processing by macrophages (Tijssen, 1985). Haptens are not 
only coupled to carrier proteins for immunogenic purposes. Conjugates are also useful as 
reagents for the detection of antigen by immunoassays (Van Regenmortel et al., 1988). 
 
A variety of methods for covalent coupling exist. These methods may employ a 
functional group on a terminal residue or on internal residues as sites of attachment. The 
reactive groups on haptens are also frequently their specific immunodeterminant, which 
distinguishes the hapten from related molecules. The use of these groups can thus decrease 
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the specificity of the generated antibodies (Murphy, 1980; Tijssen, 1985). Although in some 
situations the recognition of a wider range of haptens is desirable (for example the group-
specific detection of penicillins), specificity is often required. Superior specificity can be 
obtained by choosing a group common to related molecules as the site of linkage (Cook et al, 
1976). For example, antibodies induced with sulfonamides linked at the aromatic amino group 
to carrier proteins were highly specific for that linked sulfonamide and showed no or very 
little cross-reactivity for other sulfonamides (Fleeker and Lovett, 1985; Dixon-Holland and 
Katz, 1988; Sheth and Sporns, 1990; Muldoon et al., 2000; Lee et al., 2001; Spinks et al., 
2001). The linker molecule can be homobifunctional, with the same reactive group at each 
end, or heterobifunctional, with two different reactive groups. The length of the linker 
molecule can be long or short, with an aliphatic or aromatic character (Kirkley et al, 2001). 
Several studies analysing the influence of the linker molecule on the immunogenicity of a 
hapten-carrier conjugate or specificity of the immunoassay using a conjugate suggest that the 
selection of the linker molecule depends on the hapten and should be evaluated on a case-by-
case basis (Kirkley et al., 2001). The choice of the carrier is also important. The most 
common carriers are serum albumin of various species, keyhole limpet hemocyanin, 
thyroglobulin or fibrinogen (Tijssen, 1985). The coupling rate depends on the linker molecule 
and the reagents ratio. For immunization, a certain number of 8 to 25 haptens per carrier 
molecule is optimal, but that may be quite different for immunoassay application (Tijssen, 
1985; Van Regenmortel et al., 1988). Too many hapten molecules per carrier can lead to 
tolerance whereas a lack of immune response may be observed using conjugates with a low 
hapten load. Landsteiner (1945) observed that the antibody response is mostly directed 
against the group of the hapten the farthest away from the linkage. Otherwise, antibodies 
against the linker molecule are often generated (Eisen and Siskind, 1964). It is therefore 
important to use different linker molecules in conjugates used in the immunizations than in 
immunoassays (Van Weemen and Schuurs, 1975).   
 
1.1.4. Production of polyclonal antibodies 
 
 Polyclonal antibodies are obtained by immunizing animals and collecting the serum. 
The immunization efficiency may be influenced by many factors related to the immunogen, 
the animal and the immune response. As mentioned before, an antigen will only stimulate 
antibody production if it is immunogenic: it must be a foreign, degradable molecule with a 
certain complexity. Moreover, the purity of the immunogen is important for polyclonal 
  Chapter 1: Principles of immunoassays  
 13
antibody production since traces of very immunogenic impurities can overwhelm the 
principle antigen response (Booman, 1988).  
 
The response to weak immunogens can be enhanced using an adjuvant. Adjuvants are 
immunopotentiators that enhance the activation of the immune system resulting in an 
increased immune response (Boersma and Claassen, 1995). Adjuvants like aluminum salts or 
mineral oils, change the physical state of water-soluble immunogens by forming depots so 
lowering the rate of elimination (Nicklas, 1992). This prolonged persistence of the 
immunogen in tissues results in a continuous stimulation of the immune system. Some 
adjuvants (endotoxin) increase protein synthesis. Other adjuvants stimulate different cellular 
parts of the immune system: mycobacteria expand the T-cell population, endotoxin and 
Bordetella pertussis stimulate B-cells, and many adjuvants of bacterial origin mobilize 
macrophages. Complete Freund’s adjuvant causes local formation of granulomas that are rich 
in macrophages and immunocompetent cells. Freund’s incomplete adjuvant is a mineral oil 
with a stabilizer; complete Freund’s adjuvant contains in addition heat-killed Mycobacterium 
tuberculosis. Freund’s adjuvant has been used for many years and is considered to be one of 
the most effective adjuvants (Boersma and Claassen, 1995). 
  
Another important factor for the induction of an immune response is the way the 
immunogen is administered: intramuscular, intravenous, intradermal, intraperitoneal or 
subcutaneous. Intramuscular, intraperitoneal and subcutaneous injections are most commonly 
used because they give sustained stimulation of the immune system. Intradermal inoculation 
is ideal for injection of small volumes and a prolonged release. Intravenous immunization is 
preferred for a final booster immunization since the immunogen will be mainly captured in 
the spleen and since no adjuvants can be used (Harlow and Lane, 1988).    
  
The choice of animal is mostly one of convenience rather than necessity. Generally, 
rabbits, sheep and goats are used for polyclonal antisera production and mice and rats for 
monoclonal antibody production. 
  
One important restriction of polyclonal antibodies is the lack of reproducibility. 
Antisera of different animals against the same immunogen and even antisera taken at different 
times from the same animal can vary drastically in characteristics (specificity, avidity). This 
problem may be overcome by the production of monoclonal antibodies or the ability of 
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selecting and cloning one individual antibody-producing cell. Furthermore, the methods of 
protein engineering make it possible to manipulate the genes encoding antibody synthesis, to 
express them in micro-organism and to select antibodies with the desired specificity (Kramer, 
2002). 
 
1.1.5. Production of monoclonal antibodies 
 
Lymphocytes do not have the ability to grow in vitro. This problem can be overcome 
by transformation of the B-cells in vitro using oncogenic viruses or by fusion of the antibody 
producing cells with myeloma cells. 
  
The discovery of transformation of human B-lymphocytes with Epstein Barr virus was 
very promising since high percentages of the transformed cells were obtained. Rabbit cells 
could also successfully be transformed using SV40, but the method was not found suitable for 
murine cells (Zurawski et al., 1978; Steinitz et al., 1980).  
 
In 1975, Cesar Milstein and Georges Köhler discovered that monoclonal antibodies 
can be obtained by fusion of an antibody producing cell with a myeloma cell. Myelomas are 
uncontrolled dividing B-lymphocytes. Tijssen (1985) reviewed different strategies to produce 
monoclonal antibodies. A mouse is immunized with a given antigen, and its spleen is 
removed after several days. The lymphocytes are fused with myeloma cells by exposing them 
to polyethylene glycol, a polymer that induces cell fusion (Harlow and Lane, 1988). The 
fusion can also be stimulated using electric pulses (Karsten et al., 1988; Van Duijn et al., 
1989). The myeloma cell line lacking hypoxanthine-guanosine phosphoribosyl transferase 
(HGPRT) is used to enable the selection of hybrids. The enzyme HGPRT catalyzes the 
synthesis of inosinate (a precursor of AMP and GMP) in the salvage pathway of nucleotide 
synthesis. The cells are grown in a medium containing hypoxanthine, aminopterin and 
thymine (called HAT medium) to kill unfused myeloma cells. The role of aminopterin in this 
medium is to block the de novo synthesis of nucleotides. Unfused myeloma cells cannot use 
hypoxanthine because they lack HGPRT. Spleen cells contain HGPRT, but they die in cell 
culture because they are not able to proliferate in vitro. Hybrid cells, called hybridoma cells, 
survive in vitro because they obtained the ability to proliferate from their myeloma cell parent 
and the HGPRT gene from the lymphocyte cell parent (Tijssen, 1985; Stryer, 1988). 
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Hybridoma cells are grown in wells in tissue-culture plates. The supernatants from 
these wells are screened for the presence of specific antibodies. The cells of positive wells are 
cloned and screened to obtain hybridomas of a single kind. The hybridomas can be frozen and 
stored for long periods (Harlow and Lane, 1988). 
 
1.1.6. Monoclonal vs polyclonal in immunoassays 
 
Antisera taken at different points of time from the same animal can vary in their 
properties. In contrast, monoclonal antibodies are produced by a single clone of B cells and, 
consequently, have the same specificity and sensitivity. The most important advantage of 
monoclonal antibodies is therefore the possibility to standardize assay methods. Other 
advantages are that they can be produced in unlimited quantities (Booman, 1988) and that 
pure immunogen is not required for the immunization due to cloning and selection during the 
production. On the other hand, monoclonal antibody production is laborious and time 
consuming. The number of species that can be used to produce monoclonals is limited. 
Mostly mice are used. Fusion of myeloma cells with cells of other species leads to rapid 
segregation of chromosomes (Yarmush et al., 1980). Each monoclonal antibody may have 
very specific properties, in contrast to the average of polyclonal Ig. Monoclonal antibodies 
may have biological functions different from the corresponding polyclonal antisera and may 
be much more sensitive to inactivation by freezing and thawing, changes in pH or other 
physical properties (Mosmann et al., 1980) important for their purification (Tijssen, 1985).  
 
The strategy of the immune system to produce polyclonal antibodies results in two 
important bonus effects: the affinity bonus and the specificity bonus. Both are eliminated by 
cloning. Most monoclonal antibodies have affinities far below the corresponding conventional 
antisera (Booman, 1988; Van Oss, 1994). The specificity of a monoclonal is also sometimes 
lower than expected. Some may cross-react. In contrast to polyclonal antibodies, this cross-
reaction cannot be removed with immunosorbents. A monoclonal cannot distinguish between 
different antigens if these antigens have the same epitope (Tijssen, 1985). This characteristic 
however, makes the application of monoclonal antibodies in immunoassay for the group-
specific detection of antibiotics interesting.  
 
The affinity is a thermodynamic measurement of the strength of the non-covalent 
interactions between one site of the antibody and of the antigen. In contrast, the avidity is an 
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operational term expressing the ability of an antiserum to bind antigens and therefore depends 
not only on affinity but also on multivalency of the antibody and other non-specific factors. 
The interaction between antibody and antigen is a continuous process of association and 
dissociation during which the two molecules may become separated. In the case of 
multivalency, the multiple bounds do not separate at the same moment, making it less likely 
that the complex becomes separated. For example, the avidity of the multivalent IgM is 102-
104 times higher than the affinity of the individual Fab fragments (Van Oss, 1994). 
 
Avidity is thus an important characteristic of polyclonal antisera, since they generally 
contain antibodies against all determinants of an antigen, in contrast to monoclonal 
antibodies.   
 
1.2. Immunochemical methods 
 
1.2.1. The Enzyme-Linked Immunosorbent Assay (ELISA) 
 
 Enzyme immunoassays (EIA) were developed in the mid-sixties for the identification 
and localization of antigens in histological preparations and for the identification of antigens 
precipitated in immunodiffusion and –electrophoresis experiments (Nakane and Pierce, 1966; 
Avrameas and Uriel, 1966). These enzyme immunohistochemistry methods were found very 
useful in other fields. The observation that antigens or antibodies can be immobilized (coated) 
on solid phases and the labelling of the immunoreactants with an enzyme (Rubenstein et al., 
1972) made it possible to apply similar methods for the quantification of immunoreactants in 
test tubes. The development of methods to produce monoclonal antibodies (Kohler and 
Milstein, 1975) enhanced the possibility of standardization of EIA with higher specificity and 
sensitivity, and contributed to new assay designs. Solid phase enzyme immunoassays are still 
one of the most applied test systems. The great advantage of these assays is the simplicity, 
their sensitivity and specificity, and the ability of analysing a lot of samples simultaneously 
(Paraf and Peltré, 1991). Immunoassays are widely used in human and veterinary medicine 
diagnostics, environmental and forensic investigations, and food monitoring (Paraf and Peltré, 
1991). 
  
Immunoassays can be divided into homogeneous and heterogeneous, competitive and 
non-competitive, direct and indirect assays.  
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In the non-competitive homogeneous enzyme immunoassays, all reactants remain in 
solution during the test. There is no separation of labelled and free reactant before signal 
generation. The distinction between bound and free conjugate is achieved by labelling two 
monoclonal antibodies, each specific for a different epitope of the antigen, with two different 
enzymes selected so that one produces the substrate for the other (e.g. glucose oxidase and 
peroxidase). The enzyme activity is only detected when the two labelled antibodies react with 
the antigen, bringing their labels close to each other (Tijssen, 1985).  
 
An example of a competitive homogeneous enzyme immunoassay is the enzyme 
multiplied immunoassay technique (EMIT). In this assay, the hapten is detected using an 
enzyme-hapten conjugate. The activity of the conjugated enzyme is modulated by the reaction 
of an anti-hapten antibody with the haptenated enzyme, either by steric hindrance or by 
changes in configuration of the enzyme. Competing free hapten will decrease this modulation, 
so increasing the signal (Tijssen, 1985). 
 
In the heterogeneous assays, the reacted and unreacted components are separated 
before signal generation. Therefore, one of the reactants is immobilized on a solid phase 
(plastic, membrane, latex,…), the sample is added, the unreacted components are removed by 
washing, and finally the antibody-antigen complexes are visualized using an enzyme induced 
signal generation. In the direct assay, the antibody or antigen is directly labelled with an 
enzyme. In the indirect assay, a labelled anti-Ig antibody is used to detect the bound antibody 
(Tijssen, 1985). An important advantage of a solid phase assay compared to the homogeneous 
one, is the removal of interfering components during washing steps. Furthermore, solid phase 
assays are far more sensitive than the homogeneous assays (Delagneau and Masseyeff, 1990; 
Van Peteghem and Daeseleire, 2003).  
 
Heterogeneous solid phase enzyme immunoassays are also called enzyme-linked 
immunosorbent assays (ELISA). Three kinds of ELISAs are currently applied for the 
detection of food contaminants: the sandwich ELISA, the antigen competitive ELISA and the 
antibody competitive ELISA. 
 
The sandwich ELISA is a non-competitive immunoassay. The antigen in the sample is 
captured between an antibody immobilized on the solid phase and another antibody free in 
solution. Both antibodies are specific for a different epitope of the antigen. If the indirect 
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method is used to detect the captured antigen, the free antibody should be from a different 
species than the coated antibody, to prevent binding of the species-specific labelled anti-Ig 
antibody with the coated antibody. 
 
The competitive ELISA (cELISA) or competitive inhibition (ci)ELISA is the most 
appropriated immunoassay for the detection of low molecular weight analytes in solution, like 
residues in meat extracts or milk (Tijssen, 1985). Because this type of ELISA will be used in 
the experimental part of this thesis, the ELISA is discussed in more detail.  
 
Two kinds of ciELISA can be distinguished: the antigen ciELISA and the antibody 
ciELISA (Figure 1.1 and 1.2). 
 
In the antigen ciELISA, the antigen is immobilized on the surface of the ELISA plate 
(Figure 1.1). Low molecular weight analytes or haptens are too small to be immobilized. In 
that case hapten-protein conjugates can be used. After incubation, the unbound molecules are 
washed away. The wash step occurs after each incubation step, except after adding the colour 
reagent. After coating, free space is blocked with an irrelevant molecule, like glycine, bovine 
serum albumin or casein. The blocking step is crucial to avoid non-specific bindings during 
the assay performance. Subsequently, the sample containing the antigen to be detected is 
added to the plate, together with an antigen-specific antibody. During the incubation, there 
will be competition between the antigen in solution and the antigen on the plate for binding to 
the specific antibody. After washing, only the antibodies bound to the coated antigen will 
remain. In the indirect ciELISA, these antibody-antigen complexes are detected using labelled 
species-specific anti-Ig polyclonal antibodies. The horseradish peroxidase (HRP) enzyme is 
often used as the label, but other enzymes can be used (Alkaline phosphatase, β-
glucuronidase). The colour development after adding a substrate for the enzyme (together 
with a chromogen in case of HRP) is measured using a spectrophotometer. The intensity of 
the colour development is inversely related to the amount of free antigen in the sample. 
Maximum signal is obtained when there is no free antigen in the sample. 
  
In the antibody ciELISA, the antigen-specific antibodies are coated on the surface of 
the ELISA plate (Figure 1.2). After blocking, the sample containing the free antigen, is added 
together with labelled antigen. Competition will occur between the unlabelled antigen in the 
sample and the labelled antigen for binding to the coated antibodies. Here again, the intensity 
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of the colour development will be inversely related to the amount of unlabelled antigen in the 
sample. 
 
Figure 1.1: The antigen ciELISA 
 
 
Figure 1.2.: The antibody ciELISA 
 
 Immunoassays are not only characterized by their design, but also by the label used to 
visualize the antigen-antibody interaction. A lot of labels exists: enzymes, radioactive, 
chemiluminiscent and fluorescent labels, stable free radicals, latex particles and 
bacteriophages (Tijssen, 1985).  
 
Before the introduction of enzymes in immunoassays, radioimmunoassays (RIA) were 
mostly applied for diagnostic purposes and basic research. However, the use of radioactive 
agents implies important inconveniences: special expensive equipment required for the 
measurement of radioactivity, radioactive waste, potential health hazard, etc. Enzyme 
immunoassays offer the same specificities as RIA and sometimes even higher detectabilities, 
without the disadvantages of radioactivity (Tijssen, 1985).  
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Alkaline phosphatase (AP), β-galactosidase (β-GAL), and most of all horseradisch 
peroxidase (HRP), are commonly used labels in ELISA. A colour development will be 
obtained when adding the substrate for the enzyme. In case of HRP, the substrate (peroxide) 
is added together with a chromogen. The enzyme HRP catalyses the reaction of peroxide 
(H2O2) into H2O and O2, causing the oxidation of the chromogen, what finally results in a 
colour development. Frequently used chromogens for HRP applied in ELISA are 3,3’,5,5’-
tetramethylbenzidin (TMB) and 2,2’-azino-di-[3-ethylbenzthiazoline sulfonate] (ABTS) 
(Tijssen, 1985). 
 
 Another detection system is based on the strong interaction between biotin, a B-
vitamin and streptavidin, a protein isolated from Streptomyces avidinii (Chaiet and Wolf, 
1964). Biotin is labelled to the antibody or antigen, streptavidin is coupled to an enzyme. The 
high affinity of biotin for streptavidin enables sensitive detection and low background levels. 
Amplification of the signal is achieved by using biotin as label for the immunoreactant and 
unlabelled streptavidin. Streptavidin has four binding sites for biotin. After reaction of 
streptavidin with the biotin coupled to the immunoreactant, there are still three binding sites 
available. These can be used for the binding of enzyme-labelled biotin. This allows the 
enzymatic activity of three enzyme molecules instead of one when enzyme-labelled 
streptavidin is used, and will enhance the colour development (Tijssen, 1985). 
 
1.2.2. The BIAcore™ optical biosensor 
 
Optical biosensors, such as BIAcore are becoming widely considered for food quality 
and safety control. The BIAcore technology provides fast, automated, reliable, robust and 
high capacity multi-residue analysis. Analysis of one sample is completed within minutes. 
Immunobiosensor assays for the detection of sulfonamide residues in milk, chicken sera, 
porcine bile and muscle tissues have been described (Sternesjo et al., 1995; Crooks et al., 
1998; Elliott et al., 1999; Bjurling et al., 2000; Haasnoot et al., 2003). Test kits for 
clenbuterol, streptomycine, sulfadiazine, sulfamethazine, and for the group-specific detection 
of all sulfonamides are already commercially available.  
 
 A biosensor can be described as a device combining a biological detection system with 
a signal transducer. The transducer generates a measurable signal as a result of a change in 
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concentration of a given molecule at the detection surface. Dependent on the transducer, 
different biosensors were developed: optical, membrane and electrode directed amperiometric 
or potentiometric biosensors (Robinson, 1993).   
 
The Biacore™ optical biosensor is based on the surface plasmon resonance (SPR) 
phenomenon, which allows the measurement of interactions between molecules in real time 
(Figure 1.3; Jonsson et al., 1991; Panayotou, 1998).  
 
SPR detection is based on the changes of refractive index of the medium close to a 
thin metal layer. When plane polarized light coming from a medium with higher refractive 
index (prism; glass) reaches the interface with a medium with lower refractive index (in the 
flow channel; water), it is totally internally reflected at a certain angle of incidence. A specific 
component of the incident light, the evanescent wave will penetrate into the medium with 
lower refractive index. If the interface between the two media is coated with a thin metal film 
(gold in the case of Biacore™ biosensor), the evanescent wave will interact with free 
oscillating electrons, called plasmons, in the metal film. This phenomenon is observed as a 
decrease in intensity of the reflected light and occurs thus at a certain angle of incident light, 
called the resonance angle. In the Biacore™ biosensor, one reactant is immobilized on the 
sensor surface and the other is injected over the surface using a constant flow rate. Binding or 
dissociation at the close vicinity of the sensor surface causes changes in refractive index and 
thus a shift in the resonance angle, which is measured by the detection system of the 
biosensor. The response is expressed in resonance units (RU) and 1 RU corresponds to a shift 
in angle of 0.0001°, or a change in mass concentration of 1 pg/mm2 on the sensor surface 
(Jonsson et al., 1991). By plotting the measured angular shift against time, a sensorgram is 
obtained illustrating the progress of the interaction at the sensor surface in real time (Figure 
1.3). 
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Figure 1.3: The Biacore optical biosensor detection system based on surface plasmon resonance 
(SPR). Binding or dissociation of molecules to the sensor surface causes changes in refractive index 
near the surface, resulting in a shift in the SPR angle (from I to II). 
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Chapter 2. Penicillins 
  
2.1 Introduction: use of penicillins in veterinary husbandry 
 
 In 1929, the bacteriologist A. Fleming observed that the growth of Staphylococcus 
aureus colonies was inhibited by the presence of contaminating Penicillium notatum colonies. 
This observation resulted in the discovery of one of the most remarkable therapeutic 
molecules, penicillins. Benzylpenicillin was first used successfully to treat infections in 1941. 
Benzylpenicillin is active against most Gram+ organisms and some Gram- organisms (e.g. 
Actinomyces species). Because of its instability in acidic conditions, the use of 
benzylpenicillin is restricted to parenteral administration. Penicillin V, another natural 
occurring penicillin with the same spectrum but lower activity as benzylpenicillin, is stable 
under acidic conditions and can therefore be orally administrated (Butaye, 2001).  
 
Increased bacterial resistance to these natural penicillins has led to the development of 
more semisynthetic penicillins (Oshiro, 1999). Addition of an amino-group to the 
benzylpenicillin molecule resulted in the aminopenicillins, ampicillin and amoxicillin, both 
with broader spectrum of activity. They are both active against most aerobic Gram+ cocci and 
some Gram- organisms like Salmonella, Shigella, E. coli. Because these penicillins can be 
inhibited by β-lactamase activity, they are often combined with β-lactamase inhibitors (e.g. 
clavulanic acid). The β-lactamase resistant penicillins (oxacillin, cloxacillin, dicloxacillin) are 
moderately effective against pneumococci and streptococci and highly active against most 
staphylococci. They are frequently used in bovines for treatment and prevention of mastitis 
(Butaye, 2001). Another evolution in the development of new penicillins is the synthesis of 
molecules with activity against Pseudomonas aeruginosa such as ureidopenicillins (e.g. 
piperacillin, mezlocillin) and carboxypenicillins (e.g. carbenicillin, ticarcillin). However, 
these penicillins are not registered for veterinary applications. They should only be used in 
human medicine for the treatment of serious infections, in particular in hospitals (Butaye, 
2001). 
 
Beta-lactams are used in veterinary medicine at therapeutic levels to treat infectious 
diseases and sometimes also to prevent infections. They were used at sub-therapeutic levels as 
feed additive, to increase feed efficiency, promote growth and prevent infections (Boison, 
1995). The penicillins authorised for use in veterinary medicine are shown in table 2.1 and 
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figure 2.1. The penicillins authorized in feed for animals are amoxicillin (300-400 mg/kg feed 
for pigs; 2000-16000 mg/kg feed for fish), benzylpenicillin (83 mg/kg feed for pigs) and 
penicillin V (200 mg/kg feed for pigs) (Anonymous, 1992; Anonymous, 2000). 
 
The MRL-value for ampicillin, benzylpenicillin and amoxicillin is 50 ppb (µg/kg, 
ng/ml) in meat products and 4 ppb in milk for all food producing species, for penicillin V 25 
ppb in porcine muscle, liver and kidney tissues, and for oxacillin, cloxacillin and dicloxacillin 
300 ppb in meat and 30 ppb in milk for all food producing species (Anonymous, 1990). 
 
Table 2.1.: Penicillins authorized for use in veterinary medicine. 
Group of Antibioticum Penicillin 
Gram+ spectrum Benzylpenicillin (pen G), Phenoxymethyl penicillin (pen V) 
Broad spectrum Ampicillin, Amoxicillin 
β-lactamase resistant penicillin               
Gram+ spectrum Oxacillin, Cloxacillin, Dicloxacillin 
Combination with β-lactamase 
inhibitor- broad spectrum Amoxicillin + Clavulanic acid 
 
 
2.2 Physicochemical and biological properties 
 
 Penicillins belong to the group of β-lactam antibiotics, together with β-lactamase 
inhibitors and cephalosporins (Boison, 1995). The basic structure of penicillins, the 6-
aminopenicillanic acid, consists of three components: a thiazolidin ring, a β-lactam ring and a 
side chain (Figure 2.1). 
  
Bacterial β-lactamase hydrolyzes the β-lactam ring, resulting in the production of 
inactive penicilloic acid (Bush et al, 1995; Boison, 1995). Penicillins are also relatively 
unstable in aqueous solution. Their degradation is catalyzed both by acids and bases (Hou and 
Poole, 1971). The aqueous instability of β-lactams has important consequences in sample 
analysis, storage of a stock solution and storage of incurred tissues. It has been demonstrated 
that benzylpenicillin is fairly stable in solution between pH 5 and 9 (Wiese and Martin, 
1989a), and in animal tissues, milk and plasma when stored at –76°C (Wiese and Martin, 
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1989b; Boison et al., 1992; Boison et al., 1994). Methanol rapidly degrades penicillins into 
their penicilloic acid esters, while 25% acetonitril or ethanol in water results in the least 
degradation (Boison, 1995). 
 
Figure 2.1: Chemical structure of 6-aminopenicillanic acid, of the common structure of penicillins 
and of the side chain residues of the tested penicillins. 
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The bactericidal action of penicillins includes the inhibition of cell wall synthesis and 
activation of endogenous autolytic mechanisms, causing cell lysis and death. The drug will 
first penetrate into the cell wall, which contains cross-linked peptidoglycans that maintain the 
structural stability of the wall. The cross-linking reaction is catalyzed by enzymes located at 
the inner surface of the wall. These enzymes contain penicillin-binding proteins (PBPs). 
Binding of penicillin on the PBPs causes termination of the peptide chain linkage and inhibits 
the formation of a normal peptidoglycan structure. Binding of penicillins to the PBPs also 
switches off endogenous inhibitors of bacterial autolysins and subsequently causes cell lysis. 
PBPs are species specific, and have a different affinity for different β-lactam antibiotics 
(Blumberg and Strominger, 1974; Spratt, 1983).   
 
2.3. Metabolization of penicillin 
 
 Penicillins are distributed rapidly in most extracellular fluids. The concentration in the 
extracellular fluids is 50 to 100 % of the highest plasma concentration. Low distribution 
occurs in spinal fluid (Divers, 1996). Approximately 50 % of the penicillin will be bound to 
plasma proteins.  
 
Penicillins undergo little metabolization and are excreted largely unchanged into the 
urine. Thirty to 60 % of the penicillin becomes conversed to inactive metabolites, some of 
them being potential allergens. Excretion of penicillins or their metabolites occurs mainly in 
urine and in lesser extent in bile, while very low amounts are found in milk, saliva and sweat. 
For benzylpenicillin, renal excretion (80 % tubular secretion, 20 % glomerular filtration) 
contains 40 to 70% of the active molecule and 30 to 60 % metabolites (Divers, 1996). 
 
The β-lactam ring of penicillin spontaneously opens under physiological conditions, 
forming the penicilloyl group. Approximately 95 % of the penicillin molecules that 
irreversibly bind to proteins form penicilloyl moieties and therefore this metabolite is 
designated as the major determinant. Penicillin is also degraded by other metabolic pathways 
forming other antigenic determinants in smaller quantities. Penicilloic acid, penicillenyl, 
penicillenic acid and penicillamine are such minor determinants. (Dewdney et al, 1991; 
Chowdhury and Lieberman, 1999). The haptens derived from penicillin are shown in figure 
2.2. 
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Figure 2.2: Haptens derived from penicillin. 
 
2.4. Implication of penicillin residues 
 
 The use of penicillins in veterinary medicine can lead to penicillin residues in edible 
tissues and milk of food producing animals, to an increased bacterial resistance against these 
antibiotics, to the transfer of these resistant bacteria from animals to humans, and to adverse 
reactions in some individuals after consumption of food of animal origin with low levels of 
antibiotic (Boison, 1995; Anonymous, 1997b). 
 
2.4.1. Bacterial resistance to penicillins 
 
 The use of antimicrobials leads to the selection of resistant bacteria. The development 
of resistance is influenced by drug concentration, long-term exposure, organism type, 
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antimicrobial type and host immune status. Low-level, long-term exposure to antimicrobials 
(feed additives) may have a greater selectivity than short-term, full-dose therapeutic use. It is 
suggested that levels of antimicrobials exceeding the MRL in food of animal origin represent 
low risks for the generation of resistance in humans. However, the presence of antimicrobials 
at concentrations above the MRL indicates inappropriate use of antimicrobials by the 
producer (Anonymous, 1997b).  
 
Resistance to penicillins is mainly mediated by a large number of β-lactamases. Other 
resistance mechanisms include the acquisition of penicillin binding proteins (PBPs) with 
reduced affinity for β-lactams, mutations in the PBPs, and also reduced β-lactam uptake due 
to alterations in the outer membrane of Gram- bacteria or export by multidrug transporters 
(Schwarz and Chaslus-Dancla, 2001; Butaye et al, 2001). 
 
2.4.2. Adverse reactions to penicillins 
  
Despite their low toxicity, residues of penicillins in food can be harmful for the 
consumer (Milhaud and Person, 1981), by eliciting allergic responses. Penicillins are able to 
induce the four types of hypersensitivity: immediate hypersensitivity reactions including 
anaphylaxis (Type I), antibody-dependent complement-mediated cell lysis (Type II), immune 
complex reactions (Type III) and delayed hypersensitivity (Type IV). However, the Type I or 
IgE-mediated reactions are most significant. The immuno-allergic properties of the β-lactams 
are related to the reactive structure of the parent drug and some major metabolites. As hapten, 
they can covalently bind macromolecules. The major determinant is the penicilloyl conjugate 
formed between the carboxyl group of the open β-lactam ring and the amino group of the 
macromolecule (Dewdney et al, 1991).  
 
It is considered unlikely that a person will develop allergic reactions after intake of 
penicillin contaminated food since allergic reactions are least likely to occur when the drug is 
administered orally  (Dewdney et al, 1991). Moreover, it is assumed that no toxic or allergic 
reactions will occur if the MRL is not exceeded (Okerman, 1995). However, the risk in case 
of already sensitised individuals may not be underestimated (Dewdney et al, 1991). Indeed, 
penicillin is the most common cause of allergic drug reactions; it is estimated that penicillin 
allergy occurs in 3 to 10 % of the general population (Raynor, 1997). 
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2.4.3. Technological implications 
  
Starter cultures (e.g. lactic acid bacteria) used in fermentation processes are sensitive 
to antibiotics. Several studies report the influence of penicillin antibiotics on the fermentation 
process of yoghurt, cheese and sausage preparation (Mourot and Loussouarn, 1981; Allison, 
1985; Koenen-Dierick and Van Hoof, 1988; Grunwald and Petz, 2003). However, the MRL is 
lower than the levels required to inhibit the growth of starter culture (Bergstrom, 1996), so 
that in case of correct use such problems should not be expected. 
 
2.4.4. Environmental risks of penicillins  
  
Until now, only one study is published about β-lactam contamination of feed for 
animals giving rise to too high levels of residues in edible tissues and milk of the animals 
after intake of the contaminated feed (McEvoy, 2002). McEvoy (2002) described the 
occurrence of penicillin V in milk tank samples from two farms in the UK, while penicillin V 
has no MRL for milk and is only authorized as feed additive for pigs. It was concluded that 
the presence of the residues could only have been caused by feeding penicillin V 
contaminated feed to dairy cows. 
 
2.5. Current state on detection methods 
 
A lot of screening tests are available for the detection of penicillins. However, most of 
them were developed for the analysis of milk and are not suitable for the detection of 
penicillin in animal tissues. Moreover, microbiological inhibition tests, receptor tests and 
enzymatic assays only detect the microbiological active form of penicillins and not the 
degradation products. Penicillins are easily broken down (open beta-lactam ring), especially 
during sample storage and preparation (Boison, 1995). As a result, an underestimation of the 
real penicillin concentration in the carcass will occur. Another drawback of the 
microbiological inhibition tests and some of the receptor tests is that they do not discriminate 
between different antimicrobial families. These assays are thus suitable for pre-screening 
purposes.  
 
Assays using antibodies specific for an epitope of the common penicillin structure, but 
different from the beta-lactam ring could circumvent these problems. Such antibodies should 
  Chapter 2: Penicillins 
 32
allow the detection of both the native penicillin molecule and the degradation products. 
Several studies have been published about the development of penicillin-specific antibodies 
(de Haan et al., 1985; De Leuw et al., 1997; Dietrich et al., 1998; Usleber et al., 2000), but 
only some of them gave rise to the development of a group-specific penicillin assay, like the 
LacTek™ ELISA (Mitchell et al., 1999; not available anymore) and the Parallux™ assay 
(Huth et al., 2002).  
 
Optical biosensors, such as BIAcore™ are becoming widely considered for food 
quality and safety control. The BIAcore™ technology provides fast, automated, reliable, 
robust and high capacity multi-residue analysis. Analysis of one sample is completed within 
minutes. At the moment, no test kits for penicillins are commercially available. 
  
Among all kind of physico-chemical techniques, liquid chromatography coupled to 
spectrometry is very efficient for the detection of all penicillins at the MRL in animal tissues 
(Boison, 1995). This technique, like most of the physico-chemical methods, is also very 
expensive and laborious and can therefore only be applied for confirmation purposes.  
 
Some of the currently used pre-screening (detection of an antimicrobial agent) and 
screening assays (group identification) are mentioned below. The confirmation methods will 
not be discussed in this review. 
 
2.5.1. Microbiological inhibition assays 
 
Penicillins are detected below the MRL in kidney and muscle tissues using the New 
Belgian Kidney Test (NBKT) and the European Four Plate Test or a variant (Okerman, 1995, 
Okerman, 1998b). These microbiological inhibition assays do not discriminate between 
different families of antimicrobial agents. However, repeating the assays in the presence of 
Penicillinase I allows to identify penicillins. Indeed, the enzyme will abolish the antimicrobial 
activity of a penicillin present in the suspected samples.  
 
Other broad-spectrum screening tests based on the inhibition of bacterial growth are 
the Delvo®test SP and the Premi®test (DSM-Gist, Delft, Netherlands). Both assays contain 
spores of Bacillus stearothermophilus in agar together with a pH-indicator. The colour change 
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of the agar medium caused by the acid production is interpreted visually. In Belgium, the 
Delvo®test SP is used as confirmatory method for the detection of penicillins in milk 
(Reybroeck and Ooghe, 2003). No studies or data are available for the application of the 
Delvo®test on meat samples. The Premi®test is specially designed for meat and meat 
products. Penicillins are detected in spiked meat fluids from pig, chicken and cattle at levels 
ten times below the MRL (Arts et al, 2000). The drawback of the Premi®test is the visual 
interpretation of the colour development. However, the use of scanner measurements to 
determine the test end-point was recently reported, improving the assessment of the analytical 
data by eliminating the subjectivity of the previous visual approach (Stead et al., 2004). This 
assay seems very promising for pre-screening purposes. 
 
2.5.2. Receptor assays 
 
Three receptor assays are commercially available.  
 
The Beta-STAR (UCB Bioproducts) uses a penicillin-specific receptor and an 
immuno-chromatographic support, and is designed for the detection of penicillins in milk. An 
extraction procedure was proposed for the analysis of porcine tissues, enabling the detection 
of penicillins at the MRL. The detection was however close to the limit of detection of the 
assay (Janosi et al., 2000).   
 
The Charm II test is based on the competition between analyte in the test sample and 
radioactive labelled analyte for the binding on an analyte-specific receptor (Charm and Chi, 
1988). The assay was initially developed for milk, but has since been modified to include 
tissues (Lynas et al, 2000). Penicillins, but also cephalosporins are detected below the MRL. 
The drawback of the method is the use of radioactive labelled analytes. 
 
The Penzyme test is based on the inactivation of the enzyme carboxypeptidase by 
binding of beta-lactams. The assay was also initially developed for analysis of milk. Everest 
and coworkers (1993) described a modification of the method for the analyses of kidney 
tissues. Nevertheless, until now the application of the assay for screening purposes of animal 
tissues has not been reported. 
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2.5.3. Immunoassays 
 
The Parallux™ assay is a solid-phase fluorescence immunoassay developed for the 
detection of antibiotics in milk (Huth et al., 2002). The test system is designed as cartridges, 
each with 4 channels (tests): one cartridge can be used to detect four different analytes in the 
same sample, or one or 2 analytes in 4 or 2 different samples, respectively. Using the β-lactam 
channel, ampicillin, amoxicillin, benzylpenicillin can be detected at 4 ppb, cloxacillin at 20 
ppb and dicloxacillin at 50 ppb in milk. With the cloxacillin channel, cloxacillin and 
dicloxacillin can be detected at 8 and 10 ppb, respectively, in milk. Okerman and coworkers 
(2003) investigated the use of the Parallux™ for the analyses of several antibiotics in bovine 
and porcine kidneys. Using the penicillin cartridge, benzylpenicillin, amoxicillin and 
ampicillin were easily detected at the MRL. The assay was found to be suitable for the second 
screening step where positive samples are analysed to identify the group of antibiotics. 
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Chapter 3: Sulfonamides 
  
3.1. Introduction: use of sulfonamides in veterinary husbandry 
 
The discovery of sulfonamides dates from 1932 when Gerhard Domagk and 
coworkers showed that mice infected with Streptococcus pyrogenes could be protected from 
peritonitis by the chemically synthesized sulfanilamide. Since then, sulfonamides are widely 
used in human and veterinary medicine for the treatment of bacterial infections. Unlike in 
human medicine, they are also applied as feed additive for growth promotion and prevention 
of bacterial infection in food-producing animals (Dupont and Steele, 1987; Long et al. 1990; 
McEvoy, 2002). Many parental, intramammary and oral preparations are authorized for the 
treatment of a variety of conditions in domestic and food producing animals in the EU 
(McEvoy, 2002). In Europe, Canada and the United States, the MRL for the total amount of 
sulfonamides in edible tissues and milk is 100 µg/kg. In Japan, this MRL is 20 µg/kg 
(Anonymous, 1990; Haasnoot et al, 2000a). There is no MRL for eggs, and there are no 
products authorized for laying-hens in the EU. For medicated feedingstuff, the inclusion rates 
for sulfonamides range from 73 to 812 mg/kg for pig and poultry and from 1250 to 5000 
mg/kg in fish feeds (Anonymous, 1996b).  
 
3.2. Physicochemical and biological properties 
 
 The common structure of sulfonamides, sulfanilamide, is composed of a benzene ring 
bearing the sulfonamide group (-SO2NH2-) at position 1 and an aromatic amino group (-NH2) 
at position 4 (Figure 3.1). Derivatives of sulfanilamide are formed by substitution of the 
hydrogen of the sulfonamide group or the aromatic amino group. Sulfonamides with 
antibacterial activity have no substitution at the aromatic amino group. The sulfonamides are 
amphoteric and have different pKa values (SO2-NH; sulfanilamide: 10.43; sulfamethoxine: 
7.4; sulfadiazine: 6.4; sulfachloropyridazine: 5.1). Most sulfonamides are uncharged 
compounds between pH 5.0 and 5.2 (Guggisberg et al, 1992). Sulfonamides are usually very 
soluble in organic solvents like methanol, aceton and alcohol while poorly soluble in aqueous 
solutions, diethylether and chloroform. The solubility increases with increasing pH and 
temperature (Budavari, 1988). Sulfonamides are rather stable molecules, only a few being 
sensitive to UV radiation (Guggisberg et al., 1992). 
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         Figure 3.1: Structure of sulfonamides 
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 The antibacterial activity of sulfonamides is due to the inhibition of the folic acid 
biosynthesis in micro-organisms. Folic acid is, as it is for humans, essential for the synthesis 
of nucleic acids. Mammalian cells utilize dietary folates. Prokaryotes, however, have to 
synthesize the molecule by a cascade of reactions, including the formation of dihydropteroic 
acid catalysed by dihydropteroate synthase (DHPS). Sulfonamides are structural analogues of 
para-aminobenzoic acid (PABA). The target of the sulfonamides is the enzyme 
dihydropteroate synthase (DHPS), that catalyses the condensation of PABA and 7,8-dihydro-
6-hydroxymethylpterin-pyrophosphate (DHPPP) to form dihydropteroic acid.    
 
3.3. Metabolization of sulfonamides 
 
 Drugs like sulfonamides are eliminated from the body as unchanged compounds or 
after extensive metabolization. Excretion of the parent drug and the metabolites may occur via 
urine, bile, faeces or milk depending on their physicochemical properties. In general, the 
resulting metabolites possess a higher polarity and a better water solubility than the parent 
drug, favouring the renal excretion (Rehm et al., 1986). The metabolization and 
pharmacokinetic aspects of sulfonamides depend on various parameters like dose, route of 
administration and molecular structure of the sulfonamide, but also on the age and species 
(Nouws et al., 1989). 
 
 The different metabolic pathways for sulfonamides are acetylation/deacetylation, 
hydroxylation, glucuronidation, sulfatation and deamination (Rehm et al., 1986). 
 
 Acetylation is the major metabolic pathway for most sulfonamides and occurs in all 
tissues. There is an equilibrium between acetylation/deacetylation. The most occurring acetyl 
metabolite is the N4-acetyl derivative. In humans, acetylation predominates, while 
deacetylation in pigs, horses and cattle (Nouws et al., 1988). Glucuronidation was observed in 
milk and urine, but no data are available about occurrence of this pathway in tissues (Rehm et 
al, 1986). However, glucuronide metabolites are formed post mortem in tissues during storage 
(Alfredsson and Ohlsson, 1998). Metabolites formed by hydroxylation can be harmful and 
may cause allergic reactions (Meekins et al., 1994; Knowles et al., 2001). Deamination, in 
contrast to the other pathways, decreases the polarity en thus the excretion of sulfonamides. 
This pathway is preferred in case of low acetylation rate and is therefore not important in 
humans. Deamination however, seemed to be important in poultry. Desamino-metabolites are 
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probably formed by bacteria in the gut after oral administration of sulfonamides (Crabbe, 
2002). Sulfatation occurs in very low amounts (Rehm et al, 1986). The chemical structure of 
sulfamethazine and its main metabolites are shown in figure 3.2. 
 
 
 
Figure 3.2.: Structure of sulfamethazine and its main metabolites 
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3.4. Implication of sulfonamides residues 
 
3.4.1. Bacterial resistance to sulfonamides 
 
A special problem is the effect of sulfonamides on the human intestinal microflora. It 
is well known that an antibiotic treatment can affect the intestinal microflora of the patient. 
Most likely, the same effect will be obtained after routinely intake of food containing 
antibiotics. The intestinal human microflora is composed of anaerobe Gram+ and Gram– 
bacteria. They are responsible for the “barrier-effect” or the inhibition of the colonization by 
obligate aerobe and resistant aerobe micro-organisms. Oral administration of antibiotics can 
disturb the anaerobe microflora and affect the barrier-effect, and consequently allow the 
pathogens to develop.  
 
Another mechanism influencing the intestinal microflora is the selection of antibiotic 
resistance. It is assumed that the continuous intake of antibiotics over a longer period can 
promote the occurrence and spreading of resistant micro-organisms. The minimal inhibitory 
concentration (MIC) is the concentration required for the inhibition of normal sensitive 
bacteria. The MIC of sulfonamides is 25 to 100 µg/ml. The selection can only occur if the 
concentration of antimicrobial that reaches the intestinal flora is as high as the MIC for this 
antimicrobial drug in relation to the normal sensitive intestinal microflora. In this case, the 
growth of sensitive microorganisms is inhibited and consequently the development of 
resistant bacteria is promoted. Since the MRL for sulfonamides is 100 ng/ml, it is assumed 
that a resistance selection due to sulfonamides present in food can only occur when the 
concentration of sulfonamides exceeds the MRL (Haesebrouck and Devriese, 1994).  
  
However, the most important risk of the misuse of antibiotics is the transfer and 
spreading of resistant microorganisms to the environment and to humans (Guillot, 1989; 
Franco et al, 1990). Several studies have demonstrated the correlation between the use of 
antimicrobials in food producing animals and the occurrence of resistant bacteria in the 
intestinal microflora as well as among pathogens. The consumer can be infected with these 
resistant bacteria. Moreover, the resistance genes can be transferred between bacteria, and 
even between different bacterial families (van den Bogaard and Stobberingh, 1999). Identical 
resistant genes have been found in different bacterial species (Bergstrom, 1996). For 
sulfonamides, two resistance genes, sul1 and sul2, were characterized in Gram- bacteria. They 
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produce distinct DHPS molecules (57 % amino acid identity), which show pronounced 
insensitivity to sulfonamide inhibition at a normal substrate saturation (Skold, 2000; Schwarz 
and Chaslus-Dancla, 2001). 
 
3.4.2. Adverse reactions to sulfonamides 
 
Due to the diversity in molecular structure of different sulfonamides, the allergenicity 
of sulfonamides varies considerably (Tilles, 2001). Sulfonamides cause allergic reactions, 
which range from fever and skin rash to urinary and hepatopoietic disorders. Other organs, 
such as the heart, kidney and lung, can also be involved (Ahmad et al, 2002). Studies about 
sulfonamide allergies always discuss the incidence of allergic reactions after intake of the 
chemotherapeutical as medicine (Knowles et al, 2001; Trepanier, 1999). No data are available 
about the occurrence of allergy after consuming food containing sulfonamides. It is assumed 
that no toxic or allergic reactions will occur if the MRL is not exceeded (Okerman, 1995). 
However, it cannot be excluded that sulfonamides, as penicillins, could trigger an allergic 
reaction in already sensitised individuals. While sulfonamide hypersensitivity is relatively 
rare in the general human population, it is very important for HIV patients. Fifty to 80 % of 
patients with HIV treated with sulfonamides develop adverse reactions (Trepanier, 1999). 
    
Sulfonamides may be responsible for the induction of acute toxicity (Poirier et al., 
1999). Sulfamethazine is a suspected carcinogen (Sternesjo et al, 1995). Less data are 
available about the chronic toxicity of sulfonamides. 
 
3.4.3. Environmental risks of sulfonamides 
  
Some of the antimicrobial drugs used in veterinary medicine will be excreted through 
faeces and urine and finally reach the soil and water. Sulfonamides are very stable molecules 
(Guggisberg et al., 1992). Bioaccumulation of sulfadimethoxine has been reported in crops 
after growth on contaminated soil (Bergstrom, 1996). 
  
Several studies have demonstrated the presence of sulfamethazine in edible tissues of 
pigs that received non-medicinated feed (Bevill, 1984; Mc Evoy, 2000; McEvoy, 2002). The 
contamination was due to the carry-over of sulfamethazine between medicinated and non-
medicinated feeds during the production process. The effect of such a carry-over on 
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exceeding the MRL will depend on the molecule as well as the species affected. Indeed, 
several studies reported that equivalent low concentrations of sulfathiazole or sulfadiazine in 
feeds did not lead to violative levels in edible porcine tissues (Bevill, 1984; McEvoy, 2002). 
While not allowed for use in laying hens, sulfadiazine has been detected in eggs (McEvoy, 
2002). Although the reason for the violation was not stated, it is likely that feed contamination 
was the cause.  
 
3.4.4. Implication of sulfonamide metabolites 
 
The MRL for sulfonamides is determined for the parent drug molecule and not for the 
metabolites. The metabolites are not a risk for the human health when the concentration of 
sulfonamides in food products does not exceed the MRL, because the retention time of 
metabolites in the human body is too short (Nouws et al., 1985). Furthermore, metabolites 
should not be detected in order to avoid technical implications during production processes 
and development of resistant pathogenic bacteria since sulfonamide metabolites are 
microbiological inactive after acetylation, glucuronidation, sulfatation and deamination. Only 
hydroxylation metabolites remain active. However, sulfonamides undergo different 
metabolizations and therefore it is improbable that the remaining metabolite is still active 
(Rehm et al., 1986). 
For drug monitoring purposes, the formation of glucuronide metabolites during 
storage of samples should be considered. Since incurred samples cannot always be tested 
immediately, the formation of glucuronide metabolites will cause false-negative results. The 
native sulfonamide molecule however can be formed by heating or under acidic conditions 
(Alfredsson and Ohlsson, 1998; Smit et al, 1999). Glucuronide metabolites are usually not 
detected with the current methods. It is therefore advisable to incorporate a de-
glucuronidation procedure during the sample preparation. 
  
3.5. Current state on detection methods 
 
At the moment, only a few tests are suitable for the detection of sulfonamides at the 
MRL in meat samples. The problem of sulfonamides is that they are poorly water-soluble. 
Usually, simple extraction or even no sample preparation is applied for the analyses in 
screening assays. Sulfonamides remain thus in the matrix. Most microbiological assays are 
not sensitive enough for sulfonamides to allow an efficient extraction. Several studies 
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describe the development of sulfonamide-specific antibodies. These studies are discussed in 
Chapter 8. None of them gave rise to a commercially available group-specific sulfonamide 
assay. 
As for penicillins, liquid chromatography coupled to spectrometry is very efficient for 
the detection of all sulfonamides at the MRL in animal tissues (Van Eeckhout et al., 2000; Ito 
et al., 2000). This technique, like most of the physico-chemical methods, is very expensive 
and laborious and can therefore only be applied for confirmation purposes.  
Some of the currently used or new pre-screening (detection of an antimicrobial agent) 
and screening assays (group identification) are mentioned below. Most assays have already 
been treated for penicillins. The confirmation methods will not be discussed in this review. 
 
3.5.1. Microbiological inhibition assays 
 
For pre-screening purpose, the broad-spectrum New Belgian Kidney Test (NBKT) is 
recommended by the Belgian legislation (Anonymous, 1995), but the assay is not sensitive 
enough (Okerman, 1995). The European four plate test or variants can be applied for group 
identification, but these assays are also not sensitive enough (Okerman et al., 1998a; Okerman 
et al., 1998b). The use of the Premi® test (DSM-Gist, Delft, Netherlands), also a broad-
spectrum microbiological inhibition assay, could offer an alternative (Arts et al., 2000; 
Reybroeck, 2000; Stead et al., 2004).  
 
3.5.2. Receptor assays 
 
The receptor assay Charm II is able to detect sulfonamides below the MRL (Charm 
and Chi, 1988; Nolan et al., 2000). The drawback of this method is the use of radioactive 
labelled agents.  
 
3.5.3. Immunoassays 
 
A lot of ELISA’s are commercially available, each of them highly specific for one or 
two sulfonamides. However, it would be more efficient to have one immunoassay able to 
detect all sulfonamides instead of several immunoassays, each specific for an individual 
sulfonamide. 
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A cartridge for the detection of three sulfonamides is available in the Parallux™ assay, 
enabling the detection of sulfamethazine, sulfadimethoxine and sulfathiazole in one sample.  
Recently, a test kit for the analyses of sulfonamides (Qflex® Kit Sulfonamides) using 
the optical biosensor Biacore®Q has become commercially available. The assay uses a 
sulfonamide-specific monoclonal antibody and is validated for the analysis of pork muscle 
tissues (McGrath et al., 2004). 
 
3.5.4. Thin Layer Chromatography 
 
Due to the lack of a sensitive and group-specific screening assay for sulfonamides, 
thin layer chromatography (TLC) is currently used. Gugissberg and coworkers (1992) 
published a review of the different TLC methods for the detection of sulfonamides in meat. 
Different techniques for the visualisation of sulfonamides on TLC-plates are available. The 
advantage of TLC compared to other chromatographic methods is the possibility of analysing 
several samples simultaneously rather than serially. Newer TLC-materials allow shorter run 
times, resulting in significant timesavings.  
The commercial Sulfa-On-Site test is a TLC-based method for the detection of 
sulfamethazine in porcine urine. The test uses a correlation between sulfamethazine levels in 
urine and tissues, to estimate the concentration of sulfamethazine in tissues. Although claimed 
to be simple and accurate, the method was found not suitable for on-farm monitoring 
(Shearan and O’Keeffe, 1994) 
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Aims of the study and framework 
 
The general aim of this study was to develop group-specific screening assays using 
antibodies. Hereto antibodies had to be produced that were specific for the common structure 
of a group of antimicrobials. In the present thesis, two groups of antimicrobials were selected 
namely penicillins and sulfonamides. Penicillins were chosen since it is well known that 
people or animals which have been shown to be allergic for a penicillin are also allergic for 
the other penicillins. This indicates that the common structure is immunogenic and penicillins 
would be ideal to test the hypothesis that group-specific screening assays could be developed. 
Sulfonamides were chosen since it is an important group for which no easy to perform 
screening assays are available.  
Group-specific antibodies should allow the development of an immunochemical 
screening assay, like an enzyme-linked immunosorbent assay (ELISA) or a biosensor assay. 
In combination with an appropriate extraction procedure, the ELISA’s or biosensor should 
then be applied for the detection of penicillins, respectively sulfonamides in meat samples. 
 
So following questions were posed: 
1. Is it possible to develop antibodies recognizing a group of antimicrobials? 
2. Can a screening assay be developed using group-specific antibodies? 
3. Is it possible to develop one extraction procedure for a group of antimicrobials? 
 
Different strategies were applied for the development of group-specific monoclonal 
antibodies. The search for penicillin-specific antibodies is described in chapter 4, and for the 
sulfonamide-specific antibodies in chapter 8. 
Using the most successful immunogens for monoclonal antibody production, 
polyclonals were induced. In chapter 5 and 9, the production of polyclonal antibodies specific 
for penicillins and sulfonamides, respectively, are described. 
Chapter 6 analyses and compares the penicillin-specific antibodies in ELISA and in 
the Biacore optical biosensor. A comparison between monoclonals and polyclonals is made. 
The application of an ELISA for the analysis of meat samples is examined in chapter 7 
for penicillins and in chapter 9 for sulfonamides. 
Finally, in the general discussion, the results obtained for penicillins and sulfonamides 
are compared.  
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Abstract 
 
In order to develop a penicillin-specific ELISA, different attempts were made to 
obtain monoclonal antibodies specific for the common structure of penicillins. Ampicillin was 
coupled to different carrier-proteins (bovine serum albumin, chicken ovalbumin and 
thyroglobulin) to render it immunogenic. Different coupling methods were compared: two 
methods using a cross-linker (glutaraldehyde or a succinimide ester), one carbodiimide-
mediated coupling method and one method without any cross-linker or mediator molecule 
(physiological binding). Mice were immunized with the conjugates intraperitoneally or in the 
footpad. A screening-ELISA was developed to detect anti-ampicillin antibodies in sera. 
Specificity and affinity of the antibodies were demonstrated by inhibiting their binding with a 
10 mM solution of ampicillin. No difference could be observed using electrofusion or PEG-
mediated fusion. For the production of the monoclonals, an intravenous final boost gave 
antibodies with better specificity and affinity than an intraperitoneal final booster injection. 
At least one anti-ampicillin monoclonal antibody (19C9) cross-reacts with penicillin G, 
oxacillin, dicloxacillin and carbenicillin, and not with sulfanilamide, chloramphenicol, 
neomycin and streptomycin, and is therefore interestingly to be considered for developing a 
penicillin-specific ELISA. 
 
Keywords: β-lactam antibiotics - immunogenicity – enzyme-linked immunosorbent assay - 
monoclonal antibodies 
 
Introduction 
 
Penicillins are widely used in veterinary medicine. As a result, food derived from 
animals treated with antibiotics, may be contaminated with these drugs. To protect consumers 
from risks related to drug residues, maximum residue levels (MRL) are determined by law 
(Anonymous, 1990). To analyse presence or absence of penicillin residues in meat and milk 
products, microbial inhibition tests and receptor assays are most commonly used (Allison, 
1985; Charm and Chi, 1988; Kavanagh, 1989). These methods either are not specific enough 
or do not allow the detection of the whole group of penicillins. Physico-chemical methods, 
like high-performance liquid chromatography (HPLC), need time-consuming sample 
preparation and only one sample can be handled at a time. An alternative for the restrictions 
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inherent to these techniques is the detection of residues by enzyme-linked immunosorbent 
assays (ELISAs) (Paraf and Peltré, 1991). ELISAs are quick, specific, sensitive and have the 
additional advantage of analysing several samples simultaneously. 
The aim of the present study was to develop an ELISA specific for the group of 
penicillin antibiotics. As β-lactam antibiotics share a 6-aminopenicillanic acid structure (a β-
lactam ring structure coupled to a thiazolidin ring, figure 2.1, chapter 2) and differ in their 
acyl-side chain, the strategy followed was to induce and select monoclonal antibodies directed 
against the common 6-aminopenicillanic acid core. Using ampicillin-protein conjugates, 
studies on the antigenicity of penicillins have indicated three important epitopes: the acyl-side 
chain, the common thiazolidin ring and newly formed structures that arise by coupling 
penicillins to a carrier-protein (de Haan et al., 1985; Mayorga et al., 1995). In the present 
study, the immunogenicity in mice of different ampicillin-conjugates was compared and the 
characteristics of the produced ampicillin-specific monoclonal antibodies were determined. 
 
Material and methods 
 
Reagents and chemicals 
Benzylpenicillin, amoxicillin, 6-aminopenicillanic acid, bovine serum albumin (bsa), 
thyroglobulin, ovalbumin (ova), glutaraldehyde, hydroxylamine, tetrahydrofuran, 1-
cyclohexyl-3-(2-morpholino-ethyl)carbodiimidemetho-p-toluenesulfonate (MEDC), s-
acetylmercaptosuccinic anhydride (SAMSA), 3-maleimidobenzoic-N-hydroxisuccinimide 
ester (MBS), Ellman’s reagent (= 5,5’-dithio-bis(2-nitrobenzoic acid), citraconic anhydride, 
Bicinchoninic acid (BCA), Cupper(II)sulphate pentahydrate (CuSO4.5H2O) and OPI 
supplement media were purchased from Sigma-Aldrich (Bornem, Belgium). Oxacillin, 
dicloxacillin, and cloxacillin were obtained from ICN Biochemicals (Asse-Relegem, 
Belgium). Ampicillin, polyethylene glycol 1500 (PEG), ABTS (2,2’-azino-di-(3-
ethylbenzthiazoline-6-sulfonate)) tablet® and ABTS buffer® were obtained from Roche 
Diagnostics (Brussels, Belgium). The ABTS substrate solution was prepared by dissolving 1 
ABTS tablet® (5 mg) in 50 ml ABTS buffer®. Complete Freund’s adjuvant (CFA) and 
incomplete adjuvant (IFA) were provided by Difco Laboratories, Biotrading (Bierbeek, 
Belgium). Tween 20® (polyoxyethylene sorbitan monolaurate) was purchased from Merck-
Belgolabo (Overijse, Belgium). Rabbit anti-mouse immunoglobulins conjugated to peroxidase 
(α-mHRP prosan, code n°P0260) were obtained from DAKO Diagnostica, Prosan (Ghent, 
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Belgium). Dialysis tube VIKING (12 000 –14 000 MW cut off) was provided by ROTH, Fiers 
(Kuurne, Belgium). ELISA microtiter plates (maxisorp) were obtained from NUNC, Life 
technologies (Merelbeke, Belgium). Tissue culture plates were from Greiner (Wemmel, 
Belgium). Dulbecco modified Eagle’s medium (DMEM), glutamine, gentamycin, sodium 
pyruvate, foetal calf serum (FCS) and hypoxanthine, aminopterin and thymidine supplement 
(HAT) were purchased from GibcoBRL, Life technologies (Merelbeke, Belgium). All other 
chemicals were of reagent grade or better. HAT-selection medium consisted of DMEM 
containing 20% FCS, 1% glutamine, 0,1% gentamycin, 1% sodium pyruvate, 1% OPI 
supplement media and 2% HAT. Phosphate buffered saline (PBS) solution (0.15 M pH 7.4) 
was prepared by dissolving 0.8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4 and 0.24 g KH2PO4 in 
800 ml distilled H2O. The pH was adjusted to 7.4 with addition of NaOH or HCl. Finally the 
solution was made up to 1 L with distilled H2O.  
 
Carbodiimide mediated penicillin-carrier conjugation (Van Regenmortel et al., 1988; 
figure 4.1) 
In order to protect the amino groups of the carrier protein for reacting with 
carbodiimide, the amino groups were blocked with citraconic anhydride. The carrier protein 
and citraconic anhydride were dissolved in 4 ml distilled H2O in a molar ratio of peptide 
amino group:citraconic anhydride of 1:10. The pH was then continuously adjusted to 8.5-9 
with 1 M NaOH until the pH remained constant. Subsequently, 100 µl citraconic anhydride 
was added. If the pH did not change, the reaction was gone to completion. Otherwise, the pH 
was again adjusted wit NaOH until it remained stable and the addition of citraconic anhydride 
was repeated. Next, the mixture was incubates during 15 min at RT under slow stirring. 
Subsequently, 1-cyclohexyl-3-(2-morpholino-ethyl)carbodiimidemetho-p-toluenesulfonate 
(MEDC) dissolved in 200 µl distilled H2O, was added in a molar ratio of protein/MEDC of 
1:10. After 5 min incubation at RT, ampicillin was added in a molar ratio of protein/amp of 
1:100 for coupling to albumins, and in a molar ratio of 1:1000 for coupling to thyroglobulin. 
The mixture was then incubated for 2 hrs at RT. Deprotection of the amino groups of the 
carrier protein was done by dialysis (12 000-14 000 cut off) against 1 L of 5% acetic acid for 
3 hrs at 4 °C. Finally, the product was dialyzed (12 000-14 000 cut off) for 24 hrs at 4 °C 
against 3 changes of 1 L PBS. Aliquots of the conjugates carbo amp-bsa, carbo amp-ova and 
carbo amp-thyro were stored at –20 °C. 
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The reaction scheme of the carbodiimide mediated conjugation of ampicillin is given in figure 
4.1. During the reaction ampicillin polymers can be formed. These conjugates are probably 
removed by dialysis.  
  
 
Figure 4.1: carbodiimide mediated conjugation method.
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Preparation of penicillin-succinimide ester-carrier conjugate (van de Water, 1990; 
Kitagawa et al., 1988; figure 4.2)  
a) Introduction of sulfhydryl groups on the carrier-protein (acetylthio-carrier-protein): 
4.08 mmol s-acetylmercaptosuccinic anhydride (SAMSA) was added slowly to 0.077 mmol 
carrier-protein dissolved in 15 ml 0.1 M potassium phosphate buffer pH 7.3. Doing this, the 
pH was maintained between 7 and 7.5. Once all SAMSA was added, the pH was lowered to 
pH 6 by adding 1 N HCl. The solution was dialyzed during 1 week against distilled H2O, 
whereafter the conjugate was lyophilized.  
b) Removal of the acetyl group of acetylthio-carrier-protein: 10 µl deoxygenated 0.1 
M hydroxylamine was added to 20 mg lyophilized acetylthio-carrier-protein dissolved in 500 
µl deoxygenated 0.1 M phosphate buffer pH 7.3. The solution was then mixed under N2 until 
no further increase in number of sulfhydryl groups could be observed. The number of 
sulfhydryl groups was determined using the Ellman standard method (Ellman, 1959). 20 µl 
Ellman’s reagent (5,5’-dithio-bis(2-benzoic acid)) was added together with 20 µl sample to 1 
ml sodium phosphate buffer 0.05 M pH 8 and incubated for 15 min at room temperature. The 
reaction between Ellman’s reagent and free sulfhydryl groups results in a yellow colour that is 
measured with a spectrophotometer at 412 nm. 
c) 3-maleimidobenzoic-N-hydroxisuccinimide ester (0.015 mmol MBS) dissolved in 
0.5 ml tetrahydrofuran was added to 0.015 mmol ampicillin dissolved in 1 ml 0.05 M sodium 
phosphate buffer pH 7. The mixture was then incubated during 1 hr while gently stirring. 
Subsequently, tetrahydrofuran was removed by mixing the solution under N2. The excess of 
MBS was removed by extraction with 3 times 5 ml methyleenchloride/ether (1:2; v/v). The 
aqueous phase contained the MBS coupled ampicillin (ampMBS) and was used in next step. 
d) The thio-carrier-protein solution was added to the ampMBS solution and incubated 
for 2 hrs at 25 °C. The mixture was then dialyzed (12 000-14 000 cut off) against PBS during 
3 days. Aliquots of the conjugates amp-MBS-ova and amp-MBS-bsa were stored at –20 °C. 
 
The coupling efficiency was established by determining the number of sulfhydryl 
groups left after coupling (Ellman, 1959) and subtracting the amount from the number 
determined in step b. As only one ampicillin molecule can be coupled to one sulfhydryl 
group, the amount of bound ampicillin molecules equals the amount of reacted sulfhydryl 
groups: number of ampicillin molecules = [(Ev-En)/Em]*f *NA   
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Ev = absorbance at 412 nm of the thio-carrier solution after reaction with Ellman’s 
reagent 
En = absorbance at 412 nm of the final product after reaction with Ellman’s reagent 
Em = molar extinction coefficient for the Ellman’s reagent at 412 nm (13 600) 
NA = number of Avogadro 
f = dilution factor 
The amount of carrier-protein molecules was determined by measuring the protein 
concentration of the thio-carrier-protein solution via the absorbance at 280 nm before adding 
amp-MBS. The coupling efficiency is expressed as the number of ampicillin molecules bound 
to one carrier molecule in the final product (efficiency = number of ampicillin molecules / 
carrier molecule). 
Figure 4.2: Conjugation of ampicillin to proteins using a succinimide ester coupling method 
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Preparation of penicillin-glutaraldehyde-carrier conjugate (Märtlbauer, 1993; figure 4.3) 
Ampicillin (0.4 mmol) dissolved in 8 ml dimethylformamide was added to 0.003 
mmol carrier-protein dissolved in 16 ml phosphate buffered saline 0.15 M pH 7.4 (PBS). 
Subsequently, 0.15 ml of glutaraldehyde (25%) was added drop wise to the solution. After 3 
hrs gently stirring at RT, the reaction mixture was dialyzed (12 000-14 000 cut off) against 
PBS during 3 days. Aliquots of the conjugates amp-glut-bsa and amp-glut-ova were stored at 
–20 °C. 
The reaction scheme of the glutaraldehyde reaction is given in figure 4.3. The 
coupling reaction is performed at neutral pH. Glutaraldehyde is then transformed in α,β-
unsaturated aldehyde polymers that appear to form labile intermediate Schiff base with amino 
groups of the protein and ampicillin. The resonance interaction of the Schiff base with the 
double bond is believed to lead to a stable product. Another possible stabilization mechanism 
is a Michael-type addition that may occur at various sites when the local amine concentration 
is particularly high (van Regenmortel, 1988). The reaction can also be stabilized by addition 
of sodium borohydride.  
In order to define the coupling efficiency the amount of carrier molecules had first to 
be determined by measuring the protein concentration of the final product via its absorbance 
at 280 nm. (penicillin shows no absorbance at 280 nm.). In a second step, the amount of 
bound penicillin in the final product was determined using the BCA method (Schmidt et al., 
1985): 1 ml BCA-reagent (= 50 parts BCA + 1 part CuSO4.5H2O) is added to 50 µl of the 
sample whereafter the absorbance is measured at 562 nm after 30 min incubation at 37 °C. 
Because the carrier-protein in the final product also reacts with BCA reagent, a sample 
containing only the carrier-protein at a concentration equal to the one that was determined in 
step 1, was also used to react with BCA-reagent. The absorbance of penicillin in the final 
product equals the absorbance of the final product minus the absorbance of the sample with 
the carrier molecule at a concentration equal to the concentration determined in step 1. A 
calibration curve for ampicillin was established plotting the concentration of a standard 
dilution of ampicillin against the absorbance at 562 nm obtained for these standard samples 
after reaction with BCA-reagent. Extrapolation of the absorbance of penicillin in the final 
product lead to the concentration of penicillin in the product, and consequently to the amount 
of ampicillin molecules. 
The efficiency of the reaction is expressed as the number of ampicillin molecules 
bound to one carrier molecule in the final product. 
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Figure 4.3:conjugation of ampicillin to proteins using glutaraldehyde 
 
Preparation of physiological penicillin-carrier conjugate (Katsutani and Shionoya, 1993; 
figure 4.4) 
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Figure 4.4: Physiological conjugation of ampicillin to proteins 
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suspension was transferred into the fusion chamber of the electroporesis apparatus (ICN 
Biomedicals, Asse-Relegem, Belgium). The fusion was performed as follows: 1) 
dielectrophoresis (frequency 1 MHz, field strength 15 V/ 0.5 cm, 30 sec), 2) electroporation 
(field strength 0.15 V/ 0.5 mm, 5 µsec, one pulse) 3) dielectrophoresis again. Finally, the cell 
suspension was removed from the fusion chamber, diluted in HAT-selection medium and 
distributed over 96-well tissue culture plates at 1000 to 10 000 cells per well. Hybridomas 
producing penicillin-specific antibodies were cloned twice by limiting dilution (Harlow and 
Lane, 1988). 
 
Indirect ELISA 
 Microtiter plates were coated overnight at 4 °C with ampicillin-succinimide ester-
ovalbumin conjugate (amp-MBS-ova; 100 µl/well) diluted in bicarbonate coating buffer (0.05 
M; pH 9.4). The plates were washed 3 times with PBS containing 0.05% Tween® 20 between 
each incubation step. Free binding sites were blocked with 200 µl of a glycine solution (5% 
glycine in coating buffer) for 2 hrs at 37 °C. Subsequently 100 µl/well of an appropriate 
dilution of mice sera or hybridoma supernatant in PBS containing 3% bsa and 0.05% Tween® 
20, were added. The plates were incubated for 1 hr at 37 °C. Then, 100 µl/well of the 
secondary antibody (diluted in PBS containing 3% bsa and 0.05% Tween® 20) were added for 
1 hr at 37 °C, where after 50 µl/well enzyme substrate ABTS solution were added. 
Subsequently the plates were incubated at 37 °C. The colour development was measured at 
405 nm using an ELISA reader (Spectrafluor, TECAN) and presented as optical density (OD). 
 
Competitive inhibition ELISA 
 The only difference between the competitive inhibition ELISA and the indirect ELISA 
was that in the former, the samples (mice sera and hybridoma supernatant) were preincubated 
at RT with a 10 mM ampicillin solution or with serial dilutions (concentrations ranging from 
10 mM to 0.01 mM) of a β-lactam antibiotic mixture containing ampicillin, benzylpenicillin, 
carbenicillin, dicloxacillin and oxacillin. After 1 hr the antibody-antibiotic mixture was tested 
in ELISA. 
 The competition in the ELISA between a free penicillin in the sample and the coated 
ampicillin (amp-MBS-ova) was calculated with the formula: competition (%) = (1-
(A/Ao))*100 with A= absorbance of a tested sample solution and Ao the absorbance of a 
similar solution without penicillin. 
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Results 
 
Preparation of penicillin immunogens 
Four coupling procedures were used to develop penicillin-carrier conjugates: the 
carbodiimide mediated coupling, glutaraldehyde, succinimide ester method and a 
physiological reaction method. Ampicillin was chosen as hapten and conjugated to bovine 
serum albumin (bsa), ovalbumin (ova) or thyroglobulin (thyro) using the 4 procedures (Table 
4.1). Conjugation was performed in such a way that the common structure of penicillins, the 
thiazolidin ring, was left unchanged for the induction of common antibodies to β-lactam 
antibiotics. The chemical structures of the obtained immunogens are presented in the reaction 
schemes (figures 4.1, 4.2, 4.3, and 4.4). The efficiency of the coupling reaction was 
determined as the amount of ampicillin molecules bound to one carrier molecule. For each 
procedure, a coupling efficiency of approximately 10 (8 to 16) was obtained (Table 4.1), 
except for the carbodiimide where coupling efficiency could not be determined. When 
determining the amount of bound ampicillin in these carbodiimide-mediated conjugates, 
coupling efficiencies of more than 100 were obtained. Since the carrier protein and ampicillin 
were conjugated in a ratio protein:ampicillin of 1:100, and since no protein was removed from 
the reaction mixture, coupling efficiency cannot be higher than 100. The overestimation of the 
amount of bound ampicillin molecules was probably due to remaining citraconic anhydride 
molecules or carbodiimide molecules not removed by dialysis.   
 
Table 4.1: Methods used for ampicillin-protein conjugation 
 Conjugation method 
 
Coupling efficiency 
(molecampicillin/moleccarrier) 
Determination method 
Carbodiimide ND1 / 
Glutaraldehyde 8.5 – 16 BCA 
Succinimide ester 8 – 13 Ellman standard method 
Physiological 11 – 13 BCA 
1ND: not determined 
 
Antibody response 
 Blood samples were collected 2 weeks after each immunization and were tested for 
anti-ampicillin antibodies in the indirect and the inhibition ELISA (Table 4.2). No anti-
ampicillin antibodies could be detected in the mice immunized with the carbodiimide 
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mediated ampicillin-albumin conjugates. Moderate antibody responses against ampicillin 
were obtained after immunization with the carbodiimide mediated ampicillin-thyroglobulin, 
the glutaraldehyde or succinimide conjugates. Subsequent immunizations did not enhance the 
response. A high antibody response was induced using the physiological ampicillin-protein 
conjugate. Using ova or bsa as the carrier protein, no difference in antibody response against 
the hapten could be observed when comparing immunogens differing only for their carrier 
protein.  
 
 
Table 4.2: Immunogenicity of different ampicillin-protein conjugates 
Immunizations 
Conjugation 
method 
Carrier-
protein1 Route
2
 
Number 
of mice 
Number of mice 
with specific 
response in 
indirect ELISA
Indirect 
ELISA
3
 
Inhibition 
ELISA
4
 
bsa IP1 3 0 - ND5 
ova IP1 3 0 - ND5 Carbodiimide 
thyro IP1 3 3 +/+++ ND5 
bsa IP1 3 3 +/++ + 0/++ 
Glutaraldehyde 
ova IP1 3 3 +/+++ 0/++ 
Succinimide bsa IP1 3 3 ++ +/++ 
Physiological bsa IP2 4 4 ++++ ++++ 
1bsa = bovine serum albumin, ova = chicken egg albumin, thyro = thyroglobulin 
2IP1 = intraperitoneal, interval between subsequent immunization = 3 weeks; IP2= intraperitoneal, interval 
between subsequent immunization = 4 weeks;  
3Scores are given according to O.D. levels obtained with 1/20 diluted sera: - = < 0,200; + = 0.200 - 0.500; ++ = 
0.500 - 1.000; +++ = 1.000 - 1.800; ++++ = > 1.800. 
4Scores are given according to the obtained inhibition of antibody binding by preincubation with 10 mM 
ampicillin: + < 50 %; ++ = 50-75%; +++ = 75-90%; ++++ >90% 
(The percentage of inhibition = 100 - [OD-value inhibition ELISA/ OD-value indirect ELISA] x 100) 
5ND: not determined 
 
 
Production of mAb 
An overview of the fusion experiments is given in Table 4.3 for mouse 4 immunized 
intraperitoneally (IP) with carbo amp-thyro, mouse 15 immunized IP with amp-glut-bsa, 
mouse 24 immunized IP with amp-MBS-bsa, mouse 35 immunized in the footpad (FP) with 
phys amp-ova and mouse 36 immunized FP with amp-MBS-ova. The footpad procedure 
resulted in the collection of only 1 to 2 x 107 cells from the popliteal lymph nodes and in the 
generation of few hybridomas, of which two with low affinity for penicillin: more than 10 
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mM ampicillin was needed to obtain 50% competition in the inhibition ELISA (Table 4.3). 
The IP immunization with carbodiimide mediated thyroglobulin conjugate, glutaraldehyde or 
succinimide-conjugates followed by fusion of spleen lymphocytes resulted in at least 10 times 
higher number of hybridomas. However, again no or only few hybridomas produced 
penicillin-specific antibodies which had moreover a low affinity as presented in Table 4.3 for 
mouse 4, 15 and 24. 
 Four mice immunized intraperitoneally with a physiological conjugate, were selected 
for spleen cell fusion experiments (mouse 161 to 164, Tables 4.4 en 4.5). This selection was 
based upon either a high serum antibody titer (mouse 163 and 164) in the indirect ELISA, or 
a strong competition effect in the competitive inhibition ELISA (mouse 161 and 162). 
 The immunization frequency, the injection method at the final booster injection, the 
detection limit of diluted serum in the indirect ELISA and the competition effect are 
represented in Table 4.4, while data obtained after cell fusions are given in Tables 4.5 and 
4.6. Fusion experiments with mouse 162 and 164 resulted in several hybridomas showing 
strong competition effect (Table 4.5). Unfortunately, the hybridomas derived from mouse 
162 were not stable. 
 The most important finding was that the best hybridomas were obtained after spleen 
cell fusion of a mouse (mouse 164) with an intravenous final booster, whereas the other mice 
got an intraperitoneal final booster injection.  
 
 
Table 4.3: Overview of the data obtained after fusion experiments 
Mouse 
n° 
Immunogen Route1 
Fusion 
procedure 
Number of 
hybridomas 
Number 
positives in 
indirect ELISA 
Number 
positives2 in 
inhibition ELISA
4 carbo amp-thyro IP PEG mediated 313 48 0 
15 amp-glut-bsa IP PEG mediated 81 35 1 
24 amp-MBS-bsa IP Electrofusion 214 2 1 
35 phys Amp-ova IFP Electrofusion 8 2 2 
36 amp-MBS-ova IFP PEG mediated 4 0 0 
1IP1 = intraperitoneal, interval between subsequent immunization = 3 weeks; IFP = footpad 
2Binding of antibodies to the coated ampicillin-carrier conjugate could be partially inhibited by preincubation 
with a 10 mM ampicillin solution (= 3.71 mg/ml). 
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Table 4.4: Analysis of sera of mice immunized intraperitoneally, with the physiological conjugate  
Mouse 
n° 
Number of 
immunizations  
Final booster1 Antibody titer in 
indirect ELISA 
Inhibition ELISA2 
161 2 IP 1000 ++ 
162 2 IP 1000 ++++ 
163 5 IP 8000 + 
164 4 IV 10 000 + 
1IP = intraperitoneal, IV = intravenous 
2Scores are given according to the obtained inhibition of antibody binding by preincubation with 10 mM 
ampicillin: + < 50 %; ++ = 50-75%; +++ = 75-90%; ++++ >90% (The percentage of inhibition = 100 - [OD-
value inhibition ELISA/ OD-value indirect ELISA] x 100) 
 
 
 
Table 4.5: Analysis of hybridomas of mice immunized with the physiological conjugate  
Mouse n° Total number 
Number positives 
in indirect ELISA 
Number positives1 in 
inhibition ELISA 
Number with 
inhibition > 70% 
161 > 3000 95 15 0 
162 > 4000 90 37 (7) 
163 +/- 3000 321 10 0 
164 1417 180 32 21 
1Binding of antibodies to the coated ampicillin-carrier conjugate could be inhibited partially or 
completely by preincubation with a 10 mM (3.71 mg/ml) ampicillin solution 
 
 
 
Table 4.6: Characteristics of the selected mAb, derived from mouse n° 161 and 164 
% inhibition1 with ampicillin Cross-reaction
2 with 
1 µg/ml Mouse 
n° mAb Isotype 5 mg/ml 100 µg/ml 100 ng/ml penG carb Oxa 
161 12F6 IgM 22 10 0 - - - 
161 12F5 IgM 20 11 0 - - - 
161 13B2 IgM 26 12 0 - - - 
164 10E5 IgG1 100 100 10 + + + 
164 19C9 IgG1 100 100 13 + + + 
164 10C2 IgG2a 100 100 0 + + + 
164 23D12 IgM 100 75 0 - + + 
164 2G4 IgG2a 100 75 0 + - - 
164 9H3 NT3 100 78 0 + + + 
1% inhibition was determined in the inhibition ELISA. Therefore the monoclonal was preincubated during 30 
min. with native ampicillin. 
2Cross-reactivity was examined in the inhibition ELISA. penG = penicillin G; carb = carbenicillin; oxa = 
oxacillin 
3NT = not tested 
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Hybridomas selected for further study 
 After subcloning and ascites production the isotype and cross-reactivity with other 
penicillins were investigated. In table 4.6 these characteristics are represented for mAbs 
derived from two mice: mouse 161 and mouse 164. As can be seen, mAbs derived from 
mouse 164 showed a higher percentage of inhibition than the mAbs derived from mouse 161. 
Binding of two of the mAbs (10E5, 19C9) of mouse 164 to an ampicillin-carrier conjugate 
could even be partially inhibited by preincubation with ampicillin at a concentration of 100 
ng/ml. Results therefore indicate that the affinity of the antibodies from mouse 164 for native 
ampicillin is high. Furthermore, 4 of them (19C9, 10E5, 10C2 and 9H3) cross-reacted with 
other penicillins, suggesting that they recognized common epitopes. 
 For the determination of cross-reactivity of the mAb 19C9 for several penicillins at 
their MRL value (Table 4.7), the competitive inhibition ELISA was performed at two 
different incubation temperature (4 °C and 37 °C) and two different incubation times (30 min 
and 60 min). The best results for the detection of ampicillin and penicillin G were obtained 
when the ELISA was incubated during 30 min at 4 °C. Otherwise, the detection of oxacillin, 
carbenicillin and dicloxacillin was more sensitive at 37 °C. Cross-reaction of this antibody 
with sulfanilamide, chloramphenicol, neomycin and streptomycin was not observed. 
 
 
Table 4.7: Cross-reactivity (at Maximum Residue Level, MRL) of mAb 19C9 with other penicillins 
and some other antibiotics and sulfanilamide, measured in the inhibition ELISA 
Molecules Concentration1 
(ng/ml) 
% inhibition MRL detection 
level? 
Incubation conditions 
on ELISA-plate 
Ampicillin 50 31 Yes 4 °C, 30 min. 
Penicillin G 50 25 Yes 4 °C, 30 min. 
Carbenicillin 50 25 Yes 37 °C, 15 min. 
Oxacillin 300 40 Yes 37 °C, 60 min. 
Dicloxacillin 300 40 Yes 37 °C, 60 min. 
Sulfanilamide 500 0  4 and 37 °C, 15 and 30 min. 
Chloramphenicol 500 0  4 and 37 °C, 15 and 30 min. 
Neomycin 500 0  4 and 37 °C, 15 and 30 min. 
Streptomycin 500 0  4 and 37 °C, 15 and 30 min. 
1MRL maximum residue level 
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Discussion 
 
 The carrier-hapten conjugates used for immunization in the present study were 
characterized by determining the number of ampicillin molecules per carrier molecule and by 
their capacity to induce polyclonal antibody responses in mice. For the carbodiimide 
mediated conjugates, no appropriate method was available for determining the number of 
ampicillin molecules per carrier molecule. Since these conjugates were found to be poorly 
immunogenic, no further research was done for the characterisation of these conjugates. For 
the other conjugates, the number of ampicillin molecules coupled to one molecule protein 
could be measured, and was similar to or slightly higher than these obtained by other 
investigators (Van Regenmortel et al., 1988; Märtlbauer, 1993; Katsutani and Shionoya, 
1993). Katsutani and Shionoya (1993) constructed physiological benzylpenicillin-bsa and -
ova conjugates with a hapten/carrier coupling efficiency of 18/1 and 10/1 respectively. 
Märtlbauer (1993) used the glutaraldehyde method to obtain sulfonamide-carrier conjugates 
with a coupling efficiency of 7/1, and the active ester method (succinimide) for coupling 
natamycin to a carrier with a coupling efficiency of 5/1. Van Regenmortel et al. (1993) stated 
that a coupling efficiency of 5 to 20 mol hapten per mol carrier was high enough to render 
the hapten immunogenic. This was consistent with findings in the present study, as most 
immunizations induced antibody responses. However, the antibody response against non-
physiological conjugates was moderate to low. Also, Usleber et al. (2000) immunized with 
ampicillin coupled to different carriers using glutaraldehyde as cross-linker and found the 
conjugates being non- or weakly immunogenic. 
  
 Immunizations with the carbodiimide-mediated ampicillin-albumin conjugates did not 
induce anti-ampicillin antibodies whereas antibodies against the carrier-protein could be 
demonstrated. However, when thyroglobulin was used as the carrier-protein, an ampicillin-
specific response was induced. Because thyroglobulin is at least ten times larger than 
albumin, the lack of antibody response to the carbodiimide mediated ampicillin-albumin 
conjugate suggests that albumin did not carry as many ampicillin molecules as thyroglobulin.  
  
 Using the immunogens constructed with cross-linker or the carbodiimide mediated 
conjugate, few hybridomas were obtained. Only some of them produced low affinity 
penicillin-specific antibodies (Table 4.3). This indicates that these immunogens or the 
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immunization procedures were unfavorable. Immunization using the footpad method resulted 
in few hybridomas compared to spleen cell fusion experiments. Consequently, lower number 
penicillin-specific hybridomas were obtained (mouse 35 and 36; Table 4.3). Interestingly, the 
two hybridomas of mouse 35, which were found positive in the indirect ELISA, were also 
positive in the inhibition ELISA. Fusion experiments following intraperitoneal immunization 
always resulted in a higher amount of hybridomas, but only very few were found positive in 
the inhibition ELISA (Table 4.3, mouse 4, 15, 24). Mirza et al. (1987) used human insulin as 
immunogen to compare different routes of immunization for hybridoma production. They 
found that footpad immunization followed by popliteal lymph node lymphocyte fusion 
yielded 100% of the hybridomas secreting specific antibody, compared to subcutaneous or 
intraperitoneal immunization followed by splenic lymphocyte fusion (8%). However, another 
study using the footpad immunization procedure for the production of antibodies against 
viral and bacterial antigens, resulted in 6 to 28% hybridomas secreting specific antibodies 
(Coyle et al., 1992). A disadvantage of the footpad immunization is the low number of 
lymphocytes that can be used for cell fusion. Furthermore, this kind of immunization is very 
painful and should therefore only be used if really necessary (Harlow and Lane, 1988). 
 In this study two methods were used for fusion: electrofusion and polyethylene glycol 
(PEG) mediated fusion. Electrofusion is widely described to yield higher fusion efficiency 
with more antigen-specific hybridomas than the PEG mediated fusion (Karsten et al., 1988; 
Harlow and Lane, 1988; van Duijn et al., 1989). However, in the present study no difference 
could be observed between both methods. 
  
 A high antibody response was obtained against the physiological ampicillin-protein 
conjugates. Similar conjugates are formed in vivo following penicillin administration 
(Katsutani and Shionoya, 1993). Natural conjugation results in an open β-lactam ring 
structure with loss of antimicrobial activity, but not immunogenicity (Dewdney et al., 1991). 
The mAbs obtained from mice immunized with physiological conjugates showed strong 
competition in the inhibition ELISA. The antibodies could partially be inhibited for binding 
to the coated ampicillin-carrier conjugate after preincubation of these antibodies with 
ampicillin at a concentration of 50 ng/ml. 
  
 From the results it appears that the route of antigen administration during the final 
booster injection could be very important. The mAbs derived from mouse 164, which was 
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boosted intravenously, recognize penicillin better than these obtained from mouse 161, 
which was boosted intraperitoneally. Intravenous injection will result in a rapid and strong 
response of splenic lymphocytes, as the antigen will be captured quickly in the spleen 
(Harlow and Lane, 1988). So, directing the antigen during the final boost toward the 
lymphocytes that will be used in the fusion seems to increase the number of antigen-specific 
antibodies. Monoclonal 19C9 displayed a specific cross-reactivity, as defined in the 
inhibition ELISA, with ampicillin, penicillin G, oxacillin, dicloxacillin and carbenicillin, and 
not with sulfanilamide, chloramphenicol, neomycin and streptomycin. Consequently, mAb 
19C9 appears a β-lactam-specific antibody and looks very promising for developing an 
ELISA able to detect most penicillins at their MRL concentration. 
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Abstract 
 
Polyclonal penicillin-specific antibodies were obtained after immunization of rabbits 
(K2, K6 and K8) with physiological ampicillin- and benzylpenicillin-protein conjugates (pAb 
K2) or with physiological ampicillin-, benzylpenicillin-, oxacillin and dicloxacillin-protein 
conjugates (pAb K6 and pAb K8). The broad-specificity of the antisera induced by 
physiological penicillin-protein conjugates was improved by alternately immunization with 
different penicillins as hapten. With each of the polyclonals, an antigen coated and an 
antibody coated competitive inhibition (ci)ELISA was constructed. For the three antisera, the 
detection of ampicillin, amoxicillin, benzylpenicillin, oxacillin, cloxacillin and dicloxacillin 
was more sensitive in the antibody ciELISA as compared to the antigen ciELISA. The 
detection of all penicillins in buffer solutions below the MRL in the antibody ciELISA was 
achieved when the penicillins were hydrolysed with Penicillinase I. 
 
Keywords: Penicillin – polyclonal antibodies – ELISA 
 
Introduction 
 
 Penicillins are frequently used in veterinary medicine to treat and prevent bacterial 
infections. They are also used as feeder additive to increase feed efficiency, promote growth 
and prevent disease (Boison, 1995). Consequently, residues can be found in food derived 
from treated animals and harm the health of consumers (Milhaud and Person, 1981). 
Microbiological and immunological assays are usually used to screen food products for the 
presence of anti-microbial drug residues (Allison, 1985; Charm and Chi, 1988; Kavanagh, 
1989). Microbiological assays do not differentiate between families of antimicrobial drugs 
whereas immunological assays allow the group-specific detection. For the development of a 
penicillin-specific immunological assay, monoclonal or polyclonal antibodies against the 
common penicillin structure are required. 
Monoclonal antibodies bind to just one epitope of a molecule and are therefore very 
specific, have a high degree of purity, are easily reproducible and are therefore very suitable 
for the development and standardisation of a test system. In contrast, large variations can 
occur during the production of polyclonal antibodies. On the other hand, polyclonals are less 
influenced by physiological parameters (pH, temperature, …) and have a higher avidity as 
compared to monoclonals (Cambell, 1984; Tijssen, 1985; Booman, 1988). In ELISA, 
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antibodies with high affinity or avidity are required because low affinity interactions are 
rapidly dissociated during the wash steps. As a result, it is possible that an ELISA using 
polyclonal antibodies is more sensitive than an ELISA using monoclonals (Tijssen, 1985). 
The aim of our research was to develop a penicillin-specific ELISA. Therefore, 
monoclonal (Cliquet et al., 2001) and polyclonal antibodies against the common penicillin 
structure were developed. This article describes the production and analysis of the 
polyclonals.  
The production of a sensitive penicillin-specific antiserum is difficult. Different 
chemical methods have been reported to couple ampicillin to the carrier protein via the amino 
group to synthesize immunogens, which are able to induce antibodies against the intact 
penicillin structure (Kitagawa et al., 1978; Nagakura et al., 1991; Usleber et al., 1998). Only 
Usleber and coworkers (1998) obtained a rabbit antiserum for which an ELISA could be 
developed able to detect several penicillins at concentrations in the range of 5 to 20 ng/ml. 
Using 6-aminopenicillanic acid as hapten for the development of a penicillin-protein 
conjugate with intact β-lactam structure provided weak immunogens (De Leuw et al., 1997). 
Other attemps to produce group-specific antisera using as immunogen β-lactam coupled to the 
carrier protein through the carboxy-group led to highly specific antisera but again not 
sensitive enough (Kachab et al., 1992; Usleber et al., 1994). Direct covalent binding of the 
penicillin to the carrier protein (physiological conjugation) led to antisera highly reactive for 
the open β-lactam ring structure and less against the native molecule (Rohner et al., 1985; 
Usleber et al., 1998; Grubelnik et al., 2001). The commercial immunoassay, LacTek™ ELISA 
for the detection of penicillins in the range of the MRL (Idetek, Mitchell et al., 1999) is not 
available anymore and is replaced by the Parallux™ assay (Idexx Laboratories). The 
Parallux™ assay is developed for the detection of ampicillin, amoxicillin and benzylpenicillin 
in milk (Huth et al., 2002) but can also be applied for the detection of these pencillins at the 
MRL in bovine and porcine kidney tissues (Okerman et al., 2003). Unfortunately, no details 
are published on the production and characterization of the antibodies used in these assays.  
In the present study, polyclonal rabbit antibodies against the group of penicillins were 
produced using physiological penicillin-carrier protein conjugates as immunogens. The 
production of these conjugates has already been described (Cliquet et al., 2001). To improve 
the broad-specificity of the antisera, immunogens with different penicillins were used for 
subsequent immunization. The antisera were analysed in an antigen and in an antibody 
competitive inhibition (ci) ELISA for detection of different penicillins. 
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Material and methods 
 
Reagents and chemicals 
Benzylpenicillin, oxacillin, dicloxacillin, cefaclor, cephadrin, cephalexin, cefazolin, 
sulfanilamide, chloramphenicol, bovine serum albumin (bsa), kaolin (hydrated aluminum 
silicate), Penicillinase (EC 3.5.2.6, type 1, from B. cereus) and 3, 3’, 5, 5’-
tetramethylbenzidin (TMB) were purchased from Sigma Chemicals (Bornem, Belgium). The 
TMB enzyme-substrate solution was prepared by adding 100 µl of a TMB stock solution (10 
mg TMB dissolved in 1 ml dimethylsulfoxide) to 10 ml phosphate-citrate buffer pH 5 (25.7 
ml 0.2 M Na2HPO4 + 24.3 ml 0.1 M citrate + 50 ml distilled water) supplemented with 1.3 µl 
H2O2. Amoxicillin and cloxacillin were from ICN Biochemicals (Asse-Relegem, Belgium) 
and ampicillin and ABTS® (2,2’-azino-di-(3-ethylbenzthiazoline-6-sulfonate) (Tablet and 
buffer) from Roche Diagnostics (Brussels, Belgium). The ABTS enzyme-substrate solution 
was prepared by dissolving 1 ABTS tablet® (50 mg) in 50 ml ABTS buffer®. Tween® 20 
(polyoxyethylene sorbitan monolaurate) was purchased from Merck-Belgolabo (Overijse, 
Belgium). Peroxidase-labelled swine anti-rabbit immunoglobulins (code n° P0217) were from 
DAKO Diagnostica (Prosan, Ghent, Belgium). EZ-link™ Sulfo-NHS-LC-Biotin was 
purchased from Pierce (Perbio, Erembodegem-Aalst, Belgium). Complete Freund’s adjuvant 
(CFA) and incomplete Freund’s adjuvant (IFA) were provided by Difco Laboratories, 
Biotrading (Bierbeek, Belgium). ELISA microtiter plates (Maxisorp®) were provided by 
NUNC (VWR international, Leuven, Belgium). All other chemicals were of reagent grade.  
The ELISA coating antigen, an ampicillin-ovalbumin conjugate (ampMBSova), was 
synthesized with an activated ester method using the hetero-bifunctional reagent m-maleimido 
benzoyl-N-hydroxisuccinimide ester (MBS) (Cliquet et al., 2001). 
 
Production of polyclonal antibodies 
New Zealand white rabbits were immunized subcutaneously with 500 µg of the 
physiological penicillin-carrier conjugate (Cliquet et al., 2001). For the first immunization, 
the conjugate was emulsified in 500 µl sterile saline and 500 µl complete Freund’s adjuvant. 
For all subsequent immunizations, at six weeks interval, incomplete Freund’s adjuvant was 
used. Blood was sampled two weeks after each immunization. The serum was collected (3000 
g, 20 min) and treated with kaolin (Van den Broeck et al., 1999). Therefore one part of serum 
was mixed with four parts of kaolin and incubated for 30 min at room temperature. The 
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mixture was centrifuged (3000 g, 20 min) and the supernatant was stored frozen (-20°C). The 
polyclonal antibodies (pAb) were analysed in ciELISAs. 
 
Biotinylation of penicillin 
Ampicillin or amoxicillin (1.2 mg) were diluted in 300 µl phosphate buffer 0.1 M, pH 
7.2 and added to 3.7 mg of a succinimide ester-biotin conjugate (EZ-link™ Sulfo-NHS-LC-
Biotin) diluted in 700 µl phosphate buffer 0.1 M, pH 7.2. The reaction mixture was incubated 
for 24 hours at room temperature while shaking. It was not necessary to remove the unreacted 
biotin: the conjugate was diluted at least 1000 times in ELISA. At this dilution no background 
signals were observed. Aliquots of the conjugate were stored at –20 °C.   
 
Competitive inhibition ELISA coated with antigen (antigen ciELISA) 
Microtiter plates were coated overnight with 2.5 µg/ml ampMBSova (Cliquet et al., 
2001) diluted in bicarbonate coating buffer (0.05 M; pH 9.4) followed by blocking for two 
hours at 37 °C with 5% glycin in coating buffer. Subsequently, a penicillin was added (100 
µl/well) diluted in PBS (0.15 M; pH 7.4) containing 3% bsa and 0.05% Tween® 20 (dilution 
buffer) together with an appropriate concentration of the penicillin-specific polyclonal 
antibodies pAb K2, pAB K6 or pAb K8 (100 µl/well). The microtiter plates were then 
incubated for one hour at 37 °C. Next, the plates were incubated with peroxidase labelled 
swine anti-rabbit antibodies in dilution buffer for 60 min at 37 °C. Between each step, the 
plates were washed three times with PBS containing 0.05 % Tween® 20. Finally, the plates 
were incubated for one hour at 37 °C with the enzyme substrate solution (ABTS, 50 µl/well). 
The color development (absorbance (A) or optical density (OD)) was measured at 405 nm 
using an ELISA reader (Spectrofluor, TECAN). 
 
Competitive inhibition (ci)ELISA coated with antibody (antibody ciELISA) 
Microtiter plates were coated overnight with pAb K2, pAB K6 or pAb K8 (1/1000) 
diluted in bicarbonate coating buffer (0.05 M; pH 9.4). After coating, the plates were blocked 
for two hours at 37 °C with 0.2 % Tween®80 in coating buffer. Subsequently, a penicillin was 
added in dilution buffer, as for the antigen ciELISA. The plates were then incubated for one 
hour at 4 °C. Next, 100 µl of biotinylated ampicillin (for pAb K2 and pAb K6) or biotinylated 
amoxicillin (for pAb K8) in dilution buffer was added, without washing the plate, for 30 min 
at 4 °C. The other wash steps occurred as for the antigen ciELISA. Then, the plates were 
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incubated for 30 min at 37 °C with streptavidin-peroxidase conjugate in dilution buffer. 
Finally, the enzyme substrate solution (TMB) was added to the plates for one hour at 37 °C. 
The color development was measured at 650 nm. 
 
Interpretation of the ELISA results 
The competition in the antibody ciELISA between a free penicillin in the sample and 
the biotinylated penicillin was calculated with the same formula as in the antigen ciELISA: 
competition (%) = (1- (A/Ao))*100 with A = absorbance of a tested sample solution and Ao 
the absorbance of a similar solution without free penicillin. 
 
The calibration curve was obtained by plotting the concentration of a standard dilution 
of penicillin against the absorbance measured for the binding of the antibodies (in the antigen 
ciELISA) or biotinylated penicillin (in the antibody ciELISA) in the presence of standard 
dilutions. 
  
 The limit of detection (LOD = average signal – 3* SD) and IC50-value (concentration 
of free penicillin for which the binding of the antibodies is inhibited for 50 %) in ng/ml are 
obtained by extrapolation of the response or absorbance in a calibration curve.  
 
Hydrolysis of the sample penicillin 
 
Without hydrolysis: penicillin was diluted in PBS just before use, to avoid 
spontaneous hydrolysis. 
 
Spontaneous hydrolysis: penicillin was diluted in PBS and incubated overnight at 
room temperature.  
 
Enzyme mediated hydrolysis: Penicillinase was diluted in PBS (1000 unit/ml) and 
stored at –80°C. Prior to use, the penicillinase I stock was further diluted (0.1 unit/ml). Five 
microliter of this penicillinase dilution was added to 1 ml sample. Next, the mixture was 
incubated during one hour at 37°C followed by a 30 min incubation at 4°C to inactivate the 
enzyme (Medina et al., 1998).  
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Results and discussion 
 
Development of penicillin-specific antibodies and an antigen ciELISA 
 The polyclonal antisera (pAb) were obtained after immunization of rabbits (K2, K6, 
K8) with physiological ampicillin- and benzylpenicillin-protein conjugates (pAb K2) or with 
physiological ampicillin-, benzylpenicillin-, oxacillin and dicloxacillin-protein conjugates 
(pAb K6 and pAb K8). 
 Based on the allergenicity of penicillins, no differences in immunogenicity should be 
observed when using different penicillins as hapten. The β-lactam ring of all penicillins 
spontaneously opens under physiological conditions, forming the penicilloyl group. This 
group is designated as the major determinant because approximately 95% of the penicillin 
molecules that irreversibly combine with proteins form penicilloyl moieties. Penicillins are 
also degraded by other metabolic pathways to form, in smaller quantities, other antigenic 
derivatives, called minor determinants. Both major and minor determinants can bind to 
proteins and elicit an immune reaction (Chowdhury and Lieberman, 1999). Thus, a strong 
immune response should be elicited with physiological penicillin-protein conjugates, 
independent of the penicillin used as hapten (Katsutani and Shionoya, 1993). This was in 
accordance with our results since high serum antibody titers were obtained after immunization 
of rabbits and mice (Cliquet et al., 2001). 
Patients allergic to any member of the penicillins should be considered allergic to all 
of them (Raynor, 1997). Thus, cross-reactivity for the other members of the penicillin family 
was expected and also obtained. The IC50-values of the three antisera for six penicillins 
analysed in the antigen ciELISA are shown in table 5.1. Although four different conjugates 
were used for the immunization of K6 and K8 in contrast to only two different immunogens 
for K2, the same pattern of recognition was obtained for pAb K2 and pAb K8 and a slightly 
different pattern for pAb K6 (Table 5.1). Ampicillin and benzylpenicillin are best recognized 
by pAb K2 and pAb K8, and ampicillin also by pAb K6. Amoxicillin is also very well 
recognized by pAb K2 and pAB K8, but not by pAb K6 (which recognizes amoxicillin the 
worst). The antiserum pAb K6 is more sensitive to cloxacillin and dicloxacillin as compared 
to pAb K8, despite the fact that both antisera were obtained after immunization with oxacillin 
and dicloxacillin-protein conjugates. Even pAb K2 is more sensitive for these penicillins than 
pAb K8. From the specificity of the three antisera, it could be concluded that it is sufficient to 
immunize with ampicillin- and benzylpenicillin-protein conjugates for the induction of 
penicillin-specific antibodies, except for the dicloxacillin recognition.  
           Chapter 5: Penicillin-specific ELISA using polyclonal antibodies 
 79
 However, to deduce scientifically and statistically which conjugate is the most 
appropriated for the development of penicillin-specific polyclonal antibodies more than three 
rabbits should be immunized. And even so, it is well known that the immune response to the 
same immunogen can vary between animals. 
 
Table 5.1: IC50-values (ng/ml) for 6 penicillins in buffer, not hydrolysed and analysed in the antigen 
ciELISA with polyclonal antibodies pAb K2, pAb K6 and pAb K8. 
IC50-values (ng/ml) for penicillins1 in the antigen ciELISA 
Polyclonal Hydrolysis 
amp amox bpg ox clox diclox 
pAb K2 no 1000 6000 1800 10000 8000 20000 
pAb K8 no 400 4000 3000 10000 10000 30000 
pAb K6 no 200 30000 9000 15000 8000 8000 
1 amp = ampicillin; amox = amoxicillin; bpg = benzylpenicillin; ox = oxacillin; clox = cloxacillin; 
diclox = dicloxacillin. 
 
Development of an antibody ciELISA 
 Biotin was conjugated to the side chain of ampicillin (Figure 5.1) and amoxicillin, 
leaving the common penicillin structure free for antibody binding. These conjugates allowed 
the development of an antibody ciELISA with the three antisera. For all pAbs, the detection 
of penicillins is more sensitive in the antibody ciELISA as compared to the antigen ciELISA 
(Table 5.3 and 5.4, no hydrolysis).  
 
Figure 5.1: Biotinylated ampicillin 
 
 
 
 
 
 
 
The difference in sensitivity between both ELISAs could be ascribed to a combination 
of factors such as the use of a different competitor molecule (Choi et al., 2002), the 
immunogen used to produce the antibodies (Kirkley et al., 2001) as well as the set-up of the 
test system: 
In the antigen ciELISA, the competition occurs between the penicillin in the sample 
and the coated ampicillin-ovalbumin conjugate whereas in the antibody ciELISA, biotinylated 
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ampicillin is used as competitor. In both cases, ampicillin is linked via its free amino group at 
the side chain of the molecule to biotin or to ovalbumin using the same coupling reaction 
between ampicillin and the linker molecule (succinimide ester) but using a different cross 
linker molecule (succinimide ester resp. maleimide ester). Moreover, the ampicillin coupled 
to biotin has more freedom of movement than the ampicillin coupled to ovalbumin because of 
the longer spacer arm of the linker molecule (length spacer arm of the succinimide ester = 
22.4Å vs maleimide ester  = 11.6 Å) and the smaller size of the linked molecule (MW biotin 
<1kD vs MW ovalbumin = 45 kD). Kirkley and coworkers (2001) demonstrated the influence 
of the conjugation method for hapten-carrier linkage on the immune response, and thus on the 
antibody binding. We made the same observation during the development of sulfonamide-
specific antibodies (Cliquet et al., 2003). Our penicillin-specific antibodies are induced using 
physiologically linked penicillin-protein conjugates. No spacer arm at all is involved, thus 
resulting in a rather constrained conformation. The antibodies therefore probably have higher 
affinity for the ampicillin-ovalbumin conjugate as compared to the ampicillin, decreasing the 
sensitivity of the ELISA. Due to the longer spacer arm in the ampicillin-biotin conjugate in 
combination with the small size of biotin, the antibodies probably make no or less difference 
between the biotinylated ampicillin and the ampicillin in the sample.  
In the antibody ciELISA, the antibodies are immobilized and the sample is incubated 
in the plate for one hour whereafter the biotinylated penicillin is added. The penicillins in the 
sample can thus bind to the coated antibodies before the biotinylated penicillin. In ELISA, 
dissociation rates are sometimes so low that the reactions can be considered practically 
irreversible. Consequently, the equilibrium may not be reached within the usual incubation 
time in ELISA (Van Regenmortel and Azimzadeh, 1994). This means that the penicillins 
bound to the coated antibodies will not dissociate during the assay incubation, inhibiting the 
binding of the biotinylated penicillin to form complexes with the coated antibodies.  
In the antigen ciELISA, the antibodies preferentially bind to the coated ampicillin. The 
binding of antibodies to the coated ampicillin is probably favoured above the binding to free 
penicillins due to the higher affinity of the antibodies for a more constrained conformation of 
ampicillin. However, in the antibody ciELISA, the binding of the sample penicillins is 
favoured above the binding of the biotinylated penicillins due to the preincubation of sample 
and coated antibodies. As a result, higher sensitivities can be measured in the antibody 
ciELISA as compared to the antigen ciELISA. 
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Specificity of the polyclonals 
The polyclonal antibodies pAb K2, pAb K6 and pAb K8 are highly specific for 
penicillins. No cross-reactions were observed for cephadrin, cephalexin, cefazolin, clavulanic 
acid, sulfanilamide or chloramphenicol (50, 500 and 5000 ppb) analysed in the antibody 
ciELISA. Cross-reactivities were only noticed for cefaclor when analysed at high 
concentration as compared to the penicillins (IC50 cefaclor approx. 5000 ppb as compared to 
IC50 < 200 ppb for all tested penicillins, table 5.2). It is not clear why the antibodies 
recognize cefaclor but not cephalexin or cephadrin. These three cephalosporins mainly differ 
in the substitution on the dihydrothiazin ring (-Cl for cefaclor vs –CH3 for cephalexin and 
cephadrin). Probably the polyclonals mainly recognize the upper part of the thiazolidin and 
dihydrothiazin ring, since they do not recognize clavulanic acid (oxygen instead of sulphur). 
Other cephalosporins have larger side groups causing steric hindrance to the antibodies for 
binding the upper part of the dihydrothiazin ring. 
 
Table 5.2: IC50-values (ng/ml) for 6 penicillins in buffer without hydrolysis, spontaneously 
hydrolysed and hydrolysed with an enzyme, and analysed in the antibody ciELISA with pAb K2, pAb 
K6 and pAb K8. 
IC50-values (ng/ml) for penicillins1 in the antibody ciELISA 
Polyclonal Hydrolysis 
amp amox bpg ox clox diclox 
 no 55 150 450 150 800 >1000 
pAb K2 spontaneous 2 40 150 150 500 >1000 
 enzyme 0.08 2 7 6 50 200 
 no 20 100 60 >1000 >1000 650 
pAb K8 spontaneous 15 80 50 300 1000 500 
 enzyme 2 3.5 0.8 10 6 10 
 no 2.5 500 250 >1000 >1000 >1000 
pAb K6 spontaneous 2.5 300 250 >1000 >1000 >1000 
 enzyme 1.5 150 40 60 200 150 
1 amp = ampicillin; amox = amoxicillin; bpg = benzylpenicillin; ox = oxacillin; clox = cloxacillin; diclox = 
dicloxacillin. 
 
Table 5.3: Detection limit (LOD, ng/ml) for 6 non-hydrolysed penicillins in buffer, analysed in the 
antigen ciELISA with pAb K2, pAb K6 and pAb K8. 
LOD (ng/ml) for penicillins1 in the antigen ciELISA 
Polyclonal Hydrolysis 
amp amox bpg ox clox diclox 
pAb K2 no 6 200 150 500 550 1050 
pAb K8 no 20 300 60 200 500 2000 
pAb K6 no 20 2000 300 700 200 200 
1 amp = ampicillin; amox = amoxicillin; bpg = benzylpenicillin; ox = oxacillin; clox = cloxacillin; diclox = 
dicloxacillin. 
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Table 5.4: Detection limit (LOD, ng/ml) for 6 penicillins in buffer without hydrolysis, spontaneously 
hydrolysed and hydrolysed with an enzyme, and analysed in the antibody ciELISA with pAb K2, pAb 
K6 en pAb K8. 
LOD (ng/ml) for penicillins1 in the antibody ciELISA 
Polyclonal Hydrolysis 
amp amox bpg ox clox diclox 
 no 1 10 30 7 60 200 
pAb K2 spontaneous 0.3 3 20 7 50 200 
 enzyme < 0.1 < 1 1 0.6 7 30 
 no 1.5 15 5 150 80 90 
pAb K8 spontaneous 1.5 8 5 50 60 90 
 enzyme < 1 < 1 < 1 < 1 < 1 1 
 no 0.3 50 20 100 200 200 
pAb K6 spontaneous 0.1 25 20 100 200 200 
 enzyme < 0.1 7 2 2 10 10 
1 amp = ampicillin; amox = amoxicillin; bpg = benzylpenicillin; ox = oxacillin; clox = cloxacillin; diclox = 
dicloxacillin. 
  
Improving the sensitivity of the antibody ciELISA by hydrolysis of the test penicillin 
The antigen ciELISA as well as the antibody ciELISA using the penicillin-specific 
polyclonal antisera are still not sensitive enough to detect the penicillins at the MRL in meat 
samples. The MRL in meat and meat products is 50 ppb for ampicillin, benzylpenicillin and 
amoxicillin, and 300 ppb for oxacillin, cloxacillin and dicloxacillin (Anonymous, 1990). 
Taking into account that the penicillin concentration is usually diluted ten times during the 
meat sample preparation, the sensitivity of the ELISAs must be at least ten times lower than 
the MRL. None of the three antibody ciELISAs nor antigen ciELISAs is able to detect all 
penicillins at 5 or 30 ng/ml. From the limit of detection concentrations (LOD, table 5.4, 
without hydrolysis) it is clear that the antibody ciELISA with pAb K2 is only sensitive 
enough for ampicillin and oxacillin (LOD = 1 and 7 ng/ml, respectively). The antibody 
ciELISA with pAb K8 can only detect ampicillin and benzylpenicillin at the MRL (LOD = 
1.5 and 5 ng/ml, respectively) and with pAb K6 only ampicillin (LOD = 0.3 ng/ml). Because 
the antibody ciELISA was more sensitive for all three antisera than the antigen ciELISA, the 
first one was chosen for further improvement of the assay. 
 Physiological penicillin-protein conjugates were used to induce the polyclonal 
antibodies. In such conjugates, the β-lactam ring of the penicillins is open (Cliquet et al., 
2001). Therefore it could be expected that the pAb have a higher affinity for the open ring 
structure of penicillins. Antibodies elicited by a certain conformation of the antigen are 
extremely sensitive to this form of the antigen (Jemmerson, 1995). The β-lactam ring can 
hydrolyse spontaneously when dissolving penicillins in an aqueous solution or can be 
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hydrolysed enzymatically with the enzyme Penicillinase I (Kleirolomoon et al., 1999, Boison 
et al., 1995). Even cloxacillin, considered to be poorly hydrolysed by penicillinase from B. 
cereus (Bush et al., 1995), can be hydrolysed by this enzyme (one unit for 1 µg of cloxacillin) 
within 30 min (Grubelnik et al., 2003; Fink et al., 1987). The structure of the native and 
hydrolysed ampicillin molecule is shown in Figure 5.2. 
 
  
 Figure 5.2: Structure of the hydrolysed and native ampicillin molecule 
 
  To investigate the influence of the hydrolysis of penicillins on the recognition by the 
antibodies in the antibody ciELISA, buffer dilutions of hydrolysed and non-hydrolysed 
penicillin were tested for each penicillin using the three pAbs (Table 5.2 and 5.4). Two 
methods for hydrolysis were compared: spontaneous hydrolysis by incubating a penicillin 
solution overnight at room temperature and enzyme mediated hydrolysis. Care was taken 
while preparing the samples containing non-hydrolysed penicillins to avoid spontaneous 
hydrolysis: the penicillins were dissolved in buffer just before the samples were added to the 
ELISA. From the results it is clear that the hydrolysis of the sample penicillins strongly 
improved the sensitivity of the assay. The enzyme-mediated hydrolysis is even more efficient 
than the spontaneous hydrolysis. The LOD of all tested penicillins in buffer solution analysed 
after enzyme hydrolysis is lower than 5 ng/ml or 30 ng/ml in each antibody ciELISA (Table 
5.4), except for the detection of amoxicillin with pAb K6.  
 The same approach was followed by Grubelnik and coworkers (2001). They 
developed ELISAs for the detection of benzylpenicillin, resp. cloxacillin using enzymatic 
hydrolysis (with Penicillinase I) and antibodies specific for the hydrolysed form of the 
antibiotics. Hydrolysis of the antibiotics induced a shift of the IC50-value from 3.5 ng/ml to 
0.2 ng/ml in the case of benzylpenicillin and from 2 ng/ml to 0.65 ng/ml in the case of 
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cloxacillin. In our ELISAs, the impact of hydrolysis was more radical. Using the pAb K2 for 
example, a shift of the IC50-value from 450 ng/ml to 7 ng/ml in the case of benzylpenicillin 
and from 800 ng/ml to 50 ng/ml in the case of cloxacillin. Grubelnik and coworkers (2001) 
used 20 to 100 times more Penicillinase I for hydrolysis purpose as compared to our 
procedure. The difference of effect of hydrolysis is probably due to the different concentration 
range at which the antibiotics are hydrolysed. 
  
Thus, for the three antisera pAb K2, pAb K6 and pAb K8, the detection of all 
penicillins in buffer solutions below the MRL in the antibody ciELISA was achieved when 
the penicillins were hydrolysed with Penicillinase I. In table 5.5, a comparison is made 
between the antisera pAb K2 and pAb K8 and the antisera obtained by other investigators 
(Usleber et al., 1998; Grubelnik et al., 2001).  
 
Table 5.5: Comparison of the IC50-values for six penicillins obtained for antisera pAb K2 
and pAb K8 (hydrolysed, antibody ciELISA), and three antisera described in literature. 
Antiserum pAb K2 pAb K8 pAb Usleber1 pAb Grubelnik2 pAb Grubelnik2 
Immunogen3 amp-bsa, bpg-bsa 
amp-bsa, bpg-
bsa, ox-bsa, 
diclox-bsa 
amp-glut-bsa bpg-bsa clox-bsa 
Animal species rabbit rabbit rabbit rabbit Rabbit 
 IC50-values (ng/ml) 
Ampicillin 0.08 2 42 4.6 >105 
Amoxicillin 2 3.5 44 2500 >105 
Benzylpenicillin 7 0.8 18 0.2 >105 
Oxacillin 6 10 22 3000 29 
Cloxacillin 50 10 48 140 0.65 
Dicloxacillin 200 6 44 3000 105 
1Usleber et al., 1998 
2Grubelnik et al., 2001 
3pen-bsa = physiologic penicillin-bovine serum albumin conjugate; amp-glut-bsa = ampicillin coupled to bovine 
serum albumin using glutaraldehyde as linker molecule 
 
With the antisera pAb K2 or pAb K8 lower IC50-value, and thus higher sensitivities, 
were obtained for all tested penicillins as compared to the properties of the antisera described 
by Grubelnik and coworkers (2001), except for cloxacillin. This can be explained by the fact 
that we did not immunize the rabbits with a cloxacillin conjugate. The antisera of Grubelnik 
and coworkers (2001) are clearly more specific for the penicillin used as hapten. Thus, the 
broad specificity and sensitivity of the antisera pAb K2 and pAb K8 can be ascribed to the 
alternately administration of different physiological penicillin-protein conjugates for 
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immunization. With the antisera pAb K8 lower IC50-values, and thus higher sensitivities, 
were obtained for all tested penicillins as compared to the antiserum described by Usleber and 
coworkers (1998). This antiserum was obtained after immunization with a glutaraldehyde 
coupled ampicillin-protein conjugate and is specific for the intact β-lactam structure of 
penicillins. The conjugate was found to be a weak immunogen since only one of three rabbits 
produced a penicillin-specific antiserum. They observed no cross-reaction with hydrolysed 
penicillins. We demonstrated that glutaraldehyde conjugates were weaker conjugates than 
physiological penicillin-protein conjugates (Cliquet et al., 2001). 
 
With the antisera of Usleber and coworkers (1998) a test system is developed, not 
sensitive enough and detects the intact penicillin structure. The MRL is set up for this 
structure. With our antisera, a sensitive method is developed, that mainly detects the 
degradation products, which are not taken into account in the MRL. However, the detection of 
the hydrolysed penicillin can be important. Although no scientific evidence is provided that 
people can have adverse reactions after intake of penicillin through food products, the risk in 
case of already sensitised individuals may not be underestimated (Dewdney, 1991). De Baere 
and coworkers (2002) detected high amounts of metabolites after administration of 
amoxycillin to pigs, contrary to what is usually assumed. Furthermore, spontaneous 
hydrolysis of penicillins will occur during sample handling and will always give an 
underestimation of the intact penicillin concentration. 
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Penicillin-specific antibodies: monoclonals versus 
polyclonals in ELISA and in an optical biosensor 
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Abstract 
 
Two penicillin-specific monoclonal antibodies mAb 19C9 and mAb 9H3 and the 
penicillin-specific polyclonal antibodies pAb K2 were evaluated for their use in a competitive 
inhibition (ci)ELISA and in the BIAcore™ optical biosensor. In the ciELISA, an ampicillin-
protein conjugate was used as coating molecule. For the biosensor assay, ampicillin was 
immobilized on a CM5 chip. With both monoclonal antibodies and in both testsystems, 
ampicillin, amoxicillin and benzylpenicillin were better recognized than oxacillin, cloxacillin 
and dicloxacillin. Because the reproducibility was better in the biosensor (CV = 1.6 %) than 
in the ciELISA (CV = 8.9 %), the limit of detection for ampicillin in buffer solution using 
mAb 19C9 was lower in the biosensor (46 ng/ml) as compared to the ciELISA (356 ng/ml). 
Ampicillin can thus be detected below the MRL (50 ng/ml) in the biosensor assay but not in 
the ciELISA.  
Both the ELISA and biosensor assay using the polyclonal antibodies pAb K2 were 
more sensitive as compared to the assays with the monoclonals. The ELISA using pAb K2 
allowed the detection of all tested penicillins below the MRL. In the biosensor assay, 
ampicillin was also detected below the MRL (IC50 = 10 ng/ml). In contrast to the binding of 
the monoclonals, no spontaneous dissociation was observed after injection of the polyclonal 
antibodies in the biosensor. Whereas the monoclonals were completely removed from the 
sensor surface using ampicillin in buffer solution as regeneration solution, stronger conditions 
were necessary for the pAb binding.  
 
Keywords: ELISA- optical biosensor- monoclonal and polyclonal antibodies-penicillins 
 
Introduction 
 
Penicillins are widely used for the treatment of bacterial infectious diseases. Despite 
their low toxicity, residues of penicillins in food can be harmful for the consumer (Milhaud & 
Person, 1981). Traditionally, microbiological methods and receptor assays are used to trace 
the presence of anti-microbial drug residues (Allison, 1985; Charm and Chi, 1988; Kavanagh, 
1989). Such screening tests are usually cheap and easy to perform, but only the active form of 
an antibiotic is detected, not its residue. Penicillin residues have lost their anti-microbial 
activity but can still act as an allergen (Dewdney et al., 1991). An alternative for the 
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microbiological assays is the detection of residues by ELISA (Paraf and Peltre, 1991) or using 
a biosensor assay (Sternesjo et al., 1995). 
ELISA offers the possibility of a very quick, specific and sensitive assay in addition to 
the advantage of analysing more samples simultaneously. Using antibodies specific for the 
common structure of penicillin residues, it should be possible to develop an ELISA for the 
detection of all penicillins in one analysis. Indeed, penicillins share a 6-aminopenicillanic acid 
structure: a ß-lactam ring coupled to a thiazolidin ring (Figure 2.1, Chapter 2). In a previous 
study, two monoclonal antibodies (mAb 19C9 and mAb 9H3) and polyclonal antibodies (pAb 
K2) specific for the common structure of penicillins were obtained after immunization of 
mice, respectively rabbits with physiological ampicillin-protein conjugates (Cliquet et al., 
2001; Cliquet et al., submitted). With the polyclonal antibodies, a competitive inhibition 
ELISA was developed in which all penicillins can be detected at the MRL (Cliquet et al., 
submitted).  
Optical biosensors, such as BIAcore™ are becoming widely considered for food 
quality and safety control. The BIAcore™ technology provides fast, automated, reliable, 
robust and high capacity multi-residue analysis. Analysis of one sample is completed within 
minutes. Immunobiosensor assays for the detection of sulfonamide residues in milk, chicken 
sera, porcine bile and muscle tissues have been described (Sternesjo et al., 1995; Crooks et al., 
1998; Elliott et al., 1999; Bjurling et al., 2000; Haasnoot et al., 2003). Test kits for 
clenbuterol, streptomycine, sulfadiazine, sulfamethazine, and for the group-specific detection 
of all sulfonamides are already commercially available.  
In the BIAcore™ biosensor, one reactant is immobilized onto the sensor surface and 
the other is injected over the surface using a constant flow rate (Panayotou, 1998). Because 
the response is proportional to the mass of bound analyte, the binding of low molecular 
weight analytes may be difficult to detect. In that case a competitive assay can be used: a high 
molecular weight molecule (residue-specific antibody) and a low molecular weight analyte 
(residue) are together injected over the sensor surface with the immobilized residue (Karlsson 
and Stahlberg, 1995). However, the BIAcore™ 3000 allows monitoring the binding of 
molecules with molecular weights as low as 180 dalton (Markey, 1998; Karlsson et al., 2000; 
Haasnoot et al., 2002). Thus, it may be possible to monitor the binding of penicillins (300 –
600 D) to immobilized penicillin-specific antibodies. Interesting about this biosensor is that 
interactions are measured in real time so that binding of low affinity antibodies can be 
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observed, whereas in ELISA low affinity bindings are washed away. Furthermore, reactants 
need not to be labelled, as compared to ELISA (Panayotou, 1998; Tijssen, 1985). 
The aim of the present study was to develop a sensitive competitive inhibition ELISA 
using the monoclonal antibodies mAb 19C9 and mAb 9H3, and compare the detection of 
penicillins in the ELISA with the previously described ELISA using the polyclonals pAb K2. 
The binding properties of the antibodies were investigated in the BIAcore™ biosensor to 
explore the possibility to develop a biosensor assay for the detection of penicillins using our 
antibodies. 
 
Material and methods 
 
Reagents and chemicals 
Benzylpenicillin, oxacillin, dicloxacillin, carbenicillin, 6-aminopenicillanic acid, 
cefaclor, cephadrin, cephalexin, sulfanilamide, chloramphenicol, streptomycin, 3-maleimido 
benzoyl-N-hydroxysuccinimide ester (MBS), Penicillinase (EC 3.5.2.6, type 1, from B. 
cereus), bovine serum albumin (BSA), ovalbumin (OVA) and 3, 3’, 5, 5’-tetramethylbenzidin 
(TMB) were purchased from Sigma Chemicals (Bornem, Belgium). The TMB enzyme-
substrate solution was prepared by adding 100 µl of a TMB stock solution (10 mg TMB 
dissolved in 1 ml dimethylsulfoxide) to 10 ml phosphate-citrate buffer pH 5 (25.7 ml 0.2 M 
Na2HPO4 + 24.3 ml 0.1 M citrate + 50 ml distilled water) supplemented with 1.3 µl H2O2. 
Amoxicillin and cloxacillin were from ICN Biochemicals (Asse-Relegem, Belgium) and 
ampicillin and ABTS® (2,2’-azino-di-(3-ethylbenzthiazoline-6-sulfonate) (Tablet and buffer) 
from Roche Diagnostics (Brussels, Belgium). The ABTS enzyme-substrate solution was 
prepared by dissolving 1 ABTS tablet® (50 mg) in 50 ml ABTS buffer®. Tween® 20 
(polyoxyethylene sorbitan monolaurate) and neomycin were purchased from Merck-
Belgolabo (Overijse, Belgium). EZ-link™ Sulfo-NHS-LC-Biotin was purchased from Pierce 
(Perbio, Erembodegem-Aalst, Belgium). Peroxidase-labelled rabbit anti-mouse 
immunoglobulins (code n°P0260) and peroxidase-labelled swine anti-rabbit immunoglobulins 
(code n° P0217) were from DAKO Diagnostica (Prosan, Ghent, Belgium). ELISA microtiter 
plates (Maxisorp®) were provided by NUNC (VWR international, Leuven, Belgium). All 
other chemicals were of reagent grade.  
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The CM5 sensor chips, amine coupling kit (N-hydroxisuccinimide (NHS), N-ethyl-N’-
(3-diethylaminopropyl) carbodiimide (EDC) and ethanolamine-HCl) and 10mM hepes 
buffered saline pH 7.4 (HBS) were purchased from BIAcore (Uppsala, Sweden).  
The ELISA coating antigen, an ampicillin-ovalbumin conjugate (ampMBSova), was 
synthesized with an activated ester method using the hetero-bifunctional reagent m-maleimido 
benzoyl-N-hydroxisuccinimide ester (MBS) (Cliquet et al., 2001). 
 
Penicillin-specific antibodies 
Two monoclonal antibodies (mAb 19C9 and mAb 9H3; ascites fluids treated with 
saturated ammonium sulfate) and the polyclonal antiserum pAb K2 (sera treated with kaolin, 
Van den Broeck et al., 1999) were obtained after immunization of Balb/c mice, respectively 
rabbits with ampicillin and benzylpenicillin coupled without cross-linker to BSA (Cliquet et 
al., 2001; Cliquet et al., submitted).  
 
Biotinylation of ampicillin  
Ampicillin (1.2 mg) was diluted in 300 µl phosphate buffer 0.1 M, pH 7.2 and added 
to 3.7 mg of a succinimide ester-biotin conjugate (EZ-link™ Sulfo-NHS-LC-Biotin) diluted in 
700 µl phosphate buffer 0.1 M, pH 7.2. The reaction mixture was incubated during 24 hours 
at room temperature while shaking. Aliquots of the conjugate were stored at –20 °C.  
  
Hydrolysis of penicillins 
Penicillinase was diluted in PBS (1000 unit/ml) and stored at –80°C. Prior to use, the 
penicillinase I stock was further diluted (0.1 unit/ml). Five microliter of this penicillinase 
dilution was added to 1 ml sample. Next, the mixture was incubated during one hour at 37°C 
followed by a 30 min incubation at 4°C to inactivate the enzyme (Medina et al., 1998).  
 
Competitive inhibition ELISA coated with antigen (antigen ciELISA) 
Microtiter plates were coated overnight with 2.5 µg/ml ampMBSova diluted in 
bicarbonate coating buffer (0.05 M; pH 9.4) followed by blocking for two hours at 37 °C with 
5% glycine in coating buffer. Subsequently, the samples were added diluted in PBS (0.15 M; 
pH 7.4) containing 3% BSA and 0.05% Tween®20 (dilution buffer) together with an 
appropriate concentration of the penicillin-specific antibodies (mAb 19C9: 0.46 µg/ml; mAb 
9H3: 0.53 µg/ml, pAb K2: 0.27 µg/ml). The microtiter plates were then incubated for one 
hour at 37 °C with mAb 9H3 or pAb K2, and for 30 min at 4 °C with mAb 19C9. Next, the 
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plates were incubated with the secondary antibodies in dilution buffer for 60 min at 37 °C. 
Between each step, the plates were washed three times with PBS containing 0.05 % 
Tween®20. Finally, the plates were incubated for one hour at 37 °C with the enzyme substrate 
solution (ABTS, 50 µl/well). The colour development (absorbance (A) or optical density 
(OD)) was measured at 405 nm using an ELISA reader (Spectrofluor, TECAN). The 
competition in the ELISA between a free penicillin in the sample and the coated ampicillin 
(ampMBSova) is calculated with the formula: competition (%) = (1- (A/Ao))*100 with A = 
absorbance of a tested sample solution and Ao the absorbance of the solution without 
penicillin. 
 
Competitive inhibition (ci)ELISA coated with antibody (antibody ciELISA) 
Microtiter plates were coated overnight with pAb K2 (2 µg/ml) diluted in bicarbonate 
coating buffer (0.05 M; pH 9.4). After coating, the plates were blocked for two hours at 37 °C 
with 0.2 % Tween®80 in the coating buffer. Subsequently, the samples were added (100 
µl/well) in dilution buffer, as for the antigen ciELISA. The plates were then incubated for one 
hour at 4 °C. Next, 100 µl of biotinylated ampicillin in dilution buffer was added, without 
washing the plate, for 30 min at 4 °C. The other wash steps occurred as for the antigen 
ciELISA. Then, the plates were incubated for 30 min at 37 °C with streptavidin-peroxidase 
conjugate in dilution buffer. Finally, the enzyme substrate solution (TMB) was added to the 
plates for one hour at 37 °C. The colour development was measured at 650 nm. The 
competition in the ELISA between a free penicillin in the sample and the biotinylated 
ampicillin is calculated with the same formula as in the antigen ciELISA: competition (%) = 
(1- (A/Ao))*100 with A = absorbance of a tested sample solution and Ao the absorbance of a 
similar solution without a penicillin. 
 
Biosensor 
Instrumentation: The optical biosensor BIAcore™ 3000 system from BIAcore 
(Uppsala, Sweden) was used. Data analysis was performed using BIAevaluation 3.1 software. 
Sensor surface: 
 1) Immobilization of penicillin: ampicillin was covalently immobilized to the surface 
of one of the four channels of the sensor chip by subsequent injections of several reagents via 
the autoinjector unit of the BIAcore™ instrument. All injections were performed at a flow rate 
of 10 µl/min. First, the carboxyl groups of the dextran layer of the sensor chip were activated 
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by injection of 70 µl of a mixture of EDC and NHS (1:1). Then, 70 µl of 10 mM ampicillin 
diluted in borate buffer 50 mM pH 8.5 was injected. To block the remaining reactive carboxyl 
groups of the dextran layer 10 µl of 1 M ethanolamine-HCl was injected. Another channel 
was designed as reference channel and was just activated and blocked.  
2) Immobilization of antibody: mAb 19C9 was covalently bound using the 
immobilization wizard of the BIAcore™ 3000 control 3.1.1 software. After activation of the 
carboxyl groups of the dextran layer, mAb 19C9 (100 µg/ml diluted in 5 mM maleate buffer 
pH 6) was injected until a signal of 25 000 RU (Response Units) was achieved. The 
remaining reactive carboxyl groups of the dextran layer were blocked with an injection of 10 
µl of 1 M ethanolamine-HCl. Another channel was just activated and blocked for use as 
reference channel. 
Sample analysis on immobilized ampicillin: 
The method was designed as an inhibition assay. A fixed concentration of antibody is 
mixed with the sample prior to injection. Binding of the penicillin-specific antibodies on the 
prepared surface is measured. Any penicillin in the sample will bind to the antibody and 
subsequently inhibit the antibody binding to the surface. The response is inversely related to 
the amount of penicillin present in the sample. The surface is then regenerated, ready for the 
next sample. 
When the samples were mixed with an equal volume of mAb (22 µg/ml for mAb 
19C9, 96 µg/ml for mAb 9H3, in PBS), the mixtures were injected during 7 min with a 
constant flow rate of 40 µl/min. Regeneration of the sensor surface was achieved with an 
excess of ampicillin (20 µl of 500 µg/ml ampicillin). Each cycle took about 10 min. Between 
two analyses the sensor surface was rinsed with HBS.  
When the samples were mixed with an equal volume of pAb K2 (50 µg/ml), they were 
injected during 4 min with a flow rate of 20 µl/min. For regeneration, different solutions were 
tried out: excess of ampicillin (500 µg/ml), sodium acetate (10 mM), sodium hydroxide (50 
mM), glycine solution (pH3), sodium hydroxide (0.1 M) containing 20% acetonitril. 
Sample analysis on immobilized mAb 19C9 
A constant flow rate of 10 µl/min was used during the analysis. Samples consisted of a 
known concentration of penicillin or ampMBSova in PBS. The samples were injected during 
4 min. For regeneration, different solutions were tried out: excess of ampicillin (500 µg/ml), 
sodium acetate (10 mM), sodium hydroxide (50 mM), glycine solution (pH 3). Between two 
analyses the sensor chip was rinsed with HBS. 
                 Chapter 6: Monoclonal vs polyclonal antibodies in ELISA and in a biosensor 
 93
Storage: Between each analysis, the chip was rinsed with HBS at a flow rate of 10 
µl/min. Otherwise, the chips were removed and stored dry at 4 °C. 
 
Results and discussion 
 
Development of an ELISA with the monoclonal antibodies 
The IC50-values (the concentration at which the binding of the antibody to the coating 
was inhibited for 50%) for different penicillins in buffer solution analysed in the antigen 
ciELISA with mAb 19C9, demonstrate that the ELISA was most sensitive for amoxicillin, 
followed by ampicillin, benzylpenicillin, oxacillin, cloxacillin and dicloxacillin (Table 6.1). 
The ELISA with mAb 9H3 was slightly less sensitive for ampicillin, amoxicillin, oxacillin, 
cloxacillin and dicloxacillin than the ELISA with mAb 19C9. However, both monoclonals 
recognized ampicillin, amoxicillin and benzylpenicillin better than oxacillin, cloxacillin and 
dicloxacillin. The latter ones have a larger side chain (Figure 2.1, Chapter 2), possibly causing 
steric hindrance for the binding of the monoclonals to the common penicillin core. 
 
Table 6.1: Concentration at 50% competition (IC50, ng/ml) and limit of detection (LOD, ng/ml) for 
different penicillins detected with mAb 19C9 and mAb 9H3 in the antigen ciELISA. 
IC50 (ng/ml) LOD (ng/ml) 
Penicillin 
mAb 19C9 mAb 9H3 mAb 19C9 mAb 9H3 
Ampicillin 1350 3500 356 782 
Benzylpenicillin 3100 1930 729 325 
Amoxicillin 140 1650 18 257 
Oxacillin 5580 18040 1029 2660 
Cloxacillin 9850 16270 2599 2431 
Dicloxacillin 15500 20050 3702 3598 
 
The monoclonals are highly specific for penicillins. No cross-reactions were observed 
for cephalosporins (cephadrin, cephalexin, cefaclor), clavulanic acid, sulfanilamide, 
chloramphenicol, neomycin and streptomycin analysed in the ELISA at a concentration of 20 
µg/ml. Low cross-reactivities were noticed for carbenicillin and 6-aminopenicillanic acid 
(IC50 > 20 µg/ml). The monoclonals were deduced from mice immunized with physiological 
penicillin-protein conjugates (Cliquet et al., 2001). In such conjugates, the β-lactam ring of 
the penicillins is open. As a result, antibodies elicited with these conjugates could have higher 
affinity for hydrolysed penicillins as compared to the native molecule. However, mAb 19C9 
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and mAb 9H3 showed lower recognition for some penicillins (ampicillin, amoxicillin, 
benzylpenicillin and oxacillin for mAb 19C9; ampicillin, amoxicillin for mAb 9H3) treated 
with Penicillinase as compared to these penicillins freshly dissolved in buffer before analyses 
and thus not hydrolysed. In resume, both the β-lactam ring and the thiazolidin ring are 
important for the detection by the monoclonals since cephalosporins are not recognized and 
some hydrolysed penicillins are less well recognized than the native penicillins.  
 
No ciELISA coated with antibodies (antibody ciELISA) could be developed using the 
monoclonal antibodies. Different strategies for immobilization of the monoclonals to the 
assay surface were tried out: passive coating on MAXIsorp and POLYsorp plates, 
immobilization on precoated surface with mouse-specific antibodies or with protein G, and 
covalent binding of the monoclonals to COVALINK-aminoplates (Nunc), CARBObind plates 
(Costar), and SULFHYDRYLbind plates (Costar). Immobilization of the monoclonals was 
first controlled using enzyme labelled mouse-specific antibodies and next with biotinylated 
ampicillin. In all cases, immobilized monoclonal antibodies were detected. However, specific 
binding of the biotinylated ampicillin to the immobilized antibodies could never be achieved.  
 
Monoclonals vs polyclonal antibodies in ELISA 
In contrast to using the monoclonals, an antibody ciELISA could be developed using 
the polyclonal antibodies pAb K2. Moreover, with the pAb K2, a better recognition of all 
tested penicillins was observed in the antibody ciELISA as compared to the antigen ciELISA. 
The sensitivity of the ELISA using the polyclonals was improved when the penicillin samples 
were first hydrolysed with Penicillinase  (Table 6.2; Cliquet et al., submitted). 
 
The MRL-value for ampicillin, benzylpenicillin and amoxicillin is 50 ppb (µg/kg, 
ng/ml) in meat products and 4 ppb in milk and for oxacillin, cloxacillin and dicloxacillin 300 
ppb in meat and 30 ppb in milk (Anonymous, 1990). From the LOD-values (limit of 
detection, table 6.2) it is clear that all penicillins can be detected at their MRL in the antibody 
ciELISA using the pAb K2. The MRL is not reached for any penicillin when mAb 9H3 is 
used (LOD > 50 ng/ml, table 6.1). With mAb 19C9, only amoxicillin (LOD = 18 ng/ml) is 
detected at the MRL (Table 6.1). However, when analysing meat samples in ELISA, the 
penicillins have to be extracted from the meat. During this step, the samples become diluted 
ten times so that the ELISA must be at least ten times more sensitive than the MRL-value. 
Different attempts were made to improve the sensitivity of the antigen ciELISA using mAb 
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19C9: e.g. different buffer solutions (pH, salts), different incubation temperature, 
polyethylene glycol addition to the sample incubation step, different enzyme labelled 
conjugates, … (Cliquet et al., 1998). None of them did increase the sensitivity significantly, 
except for lowering the incubation temperature. The sensitivity of the detection of free 
penicillins by mAb 19C9 was improved when the assay was performed at 4 °C instead of 
37°C or room temperature (RT).  
 
Table 6.2: Concentration at 50% competition (IC50, ng/ml) and limit of detection (LOD, ng/ml) for 
different penicillins (hydrolysed or not) detected with pAb K2 in the antigen ciELISA (Ag coat) and in 
the antibody ciELISA (Ab coat). 
IC50 (ng/ml) LOD (ng/ml) 
Ag coat  Ab coat Ag coat Ab coat 
Penicillin 
not 
hydrolysed 
not 
hydrolysed 
hydrolysed not 
hydrolysed 
not 
hydrolysed 
hydrolysed 
Ampicillin 1000 50 0.08 15 1 <0.1 
Benzylpenicillin 1800 450 7 150 30 1 
Amoxicillin 6000 150 2 200 10 <1 
Oxacillin 1000 150 6 500 7 0.6 
Cloxacillin 8000 800 50 550 60 7 
Dicloxacillin 20000 > 1000 200 1050 200 30 
 
Detection of penicillins in the biosensor assay with immobilized antibodies 
Binding of low molecular weight analytes (>180 dalton) to immobilized ligand can be 
detected with the BIAcore™ 3000 (Markey, 1998). Haasnoot and coworkers developed such 
biosensor assays for gentamycin (2001) and for streptomycin (2002). Thus, it might be 
possible to monitor the binding of penicillins (300 – 600 D) to immobilized penicillin-specific 
antibodies. However, no signal was detected when ampicillin was injected over the 
immobilized mAb 19C9. On the other hand, a strong interaction between ampMBSova (the 
coating antigen of the ciELISA) and the immobilized mAb 19C9 was observed (Figure 6.1), 
indicating a good immobilization of the mAb on the sensor surface. It is possible that the 
signal from the binding of ampicillin to the immobilized mAb 19C9 is masked by the 
background signal of the buffer (Karlsson & Falt, 1997). Indeed, because the signal is 
proportional to the molecular weight of the binder molecule, a small molecule will always 
provide a low signal, typically in the range of 5 to 100 RU. The signal can therefore be 
masked by the buffer bulk effect. The buffer bulk effect occurs when the sample buffer (in 
this case PBS) is different from the running buffer (HBS). When the same buffer composition 
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is used for the running buffer and the sample, it should be possible to recover the specific 
signal and thus make the binding events clearly visible (Karlsson & Falt, 1997). 
Unfortunately, this was not tested in the present study. Using a reference channel in which an 
irrelevant monoclonal is immobilized should also help to make the binding more visible 
(Haasnoot et al., 2002). In our study the reference channel was activated and deactivated in 
the same way as for the specific channel, but without the immobilized molecule. 
 
 
Figure 6.1: Binding of ampMBSova to the immobilized monoclonal antibodies mAb 19C9 in the 
biosensor. 
 
Detection of penicillins in the biosensor assay with immobilized ampicillin 
Some characteristics of the binding of mAb 19C9 and mAb 9H3 to the coated 
ampicillin in the ELISA and in the biosensor assay are given in table 6.3. The binding 
response of the monoclonals was determined by calculating the average of six runs. The 
variation on the average (standard deviation, SD) is much higher in the ELISA than in the 
biosensor assay. As a result, the reproducibility of analyses will be better in the biosensor. 
The limit of detection (LOD = average response – 3x SD) and the concentration at which the 
binding of the antibody to the coating was inhibited for 50% (expressed as IC50 value) were 
determined for the dose-response curve using ampicillin as free penicillin. Because the 
standard deviation (SD) is higher in the ELISA than in the biosensor, the LOD is lower in the 
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biosensor than in the ELISA. The LOD for ampicillin in buffer solution in de biosensor is 46 
ng/ml. Consequently, the MRL for ampicillin is reached (50 ppb or ng/ml). 
 
Table 6.3: Determination of the limit of detection (LOD) and concentration at 50% competition 
(IC50) for ampicillin detected with mAb 19C9 and mAb 9H3 in the ciELISA coated with antigen and 
in the biosensor, at room temperature (RT) or 4°C. 
 mAb 19C9 mAb 9H3 
 ELISA 4°C Biosensor RT 
Biosensor 
4°C ELISA RT Biosensor RT 
Signala 0.5167 7350 7380 0.7122 7676 
SDb 0.0462 37 120 0.275 109.5 
CVc (%) 8.9 0.5 1.6 3.8 1.4 
LODd (µg/ml) 0.356 0.054 0.046 0.782 0.030 
IC50d (µg/ml) 1.350 >1.000 0.524 3500 >1.000 
aSignal: average of repeated measurements of the binding of the antibody to the coated (ELISA) or immobilized 
(biosensor) ampicillin, in absence of penicillin in the sample. The signal measured in ELISA is expressed as 
absorbance (OD) and in the biosensor as Response Units (RU). 
bSD = standard deviation of the average response or absorbance 
cCV = coefficient of variation of the average response or absorbance 
dLOD (= limit of detection = average signal – 3* SD) and IC50 (signal obtained when the binding of the 
antibodies is inhibited for 50 %): concentration (µg/ml) is obtained by extrapolation of the response or 
absorbance in a calibration curve. The calibration curve was established by plotting the concentration of a 
standard dilution of ampicillin against the signal (RU or OD) obtained for the binding of the antibodies in 
presence of the standard dilutions. 
 
In ELISA the sensitivity of the detection of free penicillins by mAb 19C9 was 
improved when the assay was performed at 4 °C instead of 37°C or room temperature (RT) 
(Cliquet et al., 1998). The same observation was made in the biosensor assay (Table 6.3). The 
IC50 for ampicillin in the biosensor assay was lower when the runs were done at 4 °C instead 
of RT (0.524 and >1.000 µg/ml, respectively). The LOD however, was only slightly lower at 
4°C as compared to RT (0.046 and 0.054 µg/ml, respectively). In figure 6.2 the sensorgrams 
are given for mAb 19C9 (4 °C vs RT) and mAb 9H3 (only RT). The dissociation curves 
reveal that the binding of mAb 19C9 to the immobilized ampicillin is stronger at 4 °C than at 
RT, and is stronger than the binding of mAb 9H3 (Gunnarsson, 1998). 
 
The cross-reactivity values (CR) of several penicillins at 1 µg/ml in PBS in regard to 
ampicillin (CR = 100 %) were determined in the ELISA and in the biosensor assay (Table 
6.4). With both antibodies, but especially with mAb 9H3, oxacillin, cloxacillin and 
dicloxacillin were better recognized in the biosensor system than in the ELISA. In ELISA, it 
was not possible to detect these penicillins at concentrations below 1 µg/ml. A possible 
explanation is that in ELISA the binding of the antibodies to the coating molecule is favoured 
above the binding to antigens with lower affinity (oxacillin, cloxacillin and dicloxacillin). 
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Indeed, the incubation time allows the dissociation of weak antibody-antigen interactions in 
the advantage of the strong antibody-antigen interactions (coating antigen), resulting in lower 
cross-reactivities for the lower affinity antigens (Tijssen, 1985). In the biosensor the antigen-
antibody interaction is measured in real-time and therefore higher cross-reactivities can be 
monitored for low affinity binders.   
  
Figure 6.2: Sensorgram of the binding of mAb 19C9 (at RT and at 4°C) and of mAb 9H3 (at RT) on 
immobilized ampicillin in the biosensor. 
 
 
Table 6.4: Cross-reactivities (%) for different penicillins (1 µg/ml) compared to ampicillin, in the 
antigen ciELISA and in the biosensor, using mAb 19C9 (test performed at 4°C) and using mAb 9H3 
(test performed at RT). 
 mAb 19C9 mAb 9H3 
Penicillin ELISA Biosensor ELISA Biosensor 
Ampicillin 100 100 100 100 
Amoxicillin 153 204 193 163 
Benzylpenicillin 69 70 155 136 
Oxacillin -a 81 - 73 
Cloxacillin - 55 - 65 
Dicloxacillin - 53 - 61 
a Cross-reactivity could not be determined because the LOD for the given penicillin is more than 1 µg/ml. 
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The binding of the pAb K2 on immobilized ampicillin is visualized in figure 6.3. No 
spontaneous dissociation of the interaction was observed what points out the high affinity of 
pAb K2 for ampicillin (Gunnarsson, 1998). High affinity antibodies are suitable for ELISA 
because the affinity of the antibody strongly influences the stability of antigen-antibody 
complex during the washing steps of the assay (Tijssen, 1985). Indeed, the ELISA using the 
pAb K2 is more sensitive for the detection of penicillins than the ELISA with the mAb (Table 
6.1 and 6.2).  
 
Whereas the monoclonals were completely removed from the sensor surface using 
ampicillin in buffer solution as regeneration solution, stronger conditions were necessary for 
the pAb binding. Different solutions were tried out: sodium acetate (10 mM), sodium 
hydroxide (50 mM), glycine solution (pH3) and sodium hydroxide (0.1 M) containing 20% 
acetonitril. The latter one was the most suitable one.  
 
When the polyclonals were injected at concentrations higher than 50 µg/ml, the sensor 
surface could not be completely regenerated. Lower concentrations of pAb K2 led to very low 
specific signals (RU = 160 for 25 µg/ml). The binding of pAb K2 (50 µg/ml) to immobilized 
ampicillin was inhibited for 50 % in presence of 10 ng/ml ampicillin (Figure 6.4). The IC50-
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Figure 6.3: Sensorgram of the binding of pAb
K2 to the immobilized ampicillin in the
biosensor. 
Figure 6.4: Dose-response curve for ampicillin
in buffer solution analysed in the biosensor
assay on immobilized ampicillin using pAb K2.
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value for ampicillin in the antibody ciELISA with pAb K2 is 50 ng/ml for the native molecule 
and 0.08 ng/ml for hydrolysed ampicillin (Table 6.3). In the biosensor assay but not in the 
ELISA, antibodies and ampicillin solution were preincubated. It is possible that the ampicillin 
solution is partially hydrolysed during this incubation. As for the ELISA, the sensitivity of the 
biosensor assay can probably be improved using ampicillin solutions treated with 
penicillinase.    
 
Results from the biosensor assays support our findings in ELISA: the difference in 
sensitivity between the polyclonals and the monoclonals in ELISA can be ascribed to the fact 
the polyclonals have higher affinity for penicillins than the monoclonals, as was observed in 
the biosensor assay. Also, the improvement of the detection of penicillin in the ELISA with 
the monoclonals when incubated at 4°C instead of 37°C or room temperature was visualized 
in the biosensor. Thus, the biosensor assay helped understanding the interactions in ELISA. 
Using mAb 19C9, ampicillin can be detected at the MRL-value in the biosensor but not in 
ELISA. Moreover, using the monoclonals, the isoxazoyl penicillins are better recognized in 
the biosensor assay as compared to the ELISA. Thus, it should be interesting to apply the 
mAb for the development of a biosensor assay. 
 
However, the results obtained in our biosensor assays should be questioned. Firstly, 
very high amounts of antibodies were used in the biosensor. As compared to the amounts used 
in ELISA, 50 times more mAb 19C9 were used, 180 times more mAb 9H3 and 185 times 
more pAb K2. It was expected that the biosensor assays require higher amounts of antibodies, 
due to the continuous flow over the sensor surface (Bergstrom, 1996). Haasnoot and 
coworkers (2003) reported the use of ten times more antibodies in a biosensor assay as 
compared to an ELISA using the same antibodies. Compared to these results, the amount of 
monoclonal antibodies used in our biosensor assay is tremendously high. Moreover, despite 
the use of such large amounts of mAb 19C9 the saturation of the immobilized surface was 
even only reached after 5 min at room temperature, and not reached at all after 7 min at 4°C 
(Figure 6.2). A possible explanation for the high amounts of antibodies is the presence of 
contaminating ampicillin molecules in the system, as a result of the immobilization and 
regeneration procedure (Bergstrom, 1996; Haasnoot et al., 2002). In both cases a large 
amount of ampicillin was injected into the system (259 µg for the immobilization and 10 µg 
for each regeneration cycle). These contaminating ampicillins can bind the antibodies so that 
large amounts are necessary to saturate the surface. For the mAb 19C9, this effect was more 
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explicit at 4°C as compared to room temperature (Figure 6.2; association curve), what seems 
to correspond with the higher affinity of the antibody for the free ampicillin at reduced 
temperature. It is recommended for low molecular weight analytes to immobilize these 
analytes on the sensor surface outside the system (Bergstrom, 1996, Haasnoot et al., 2003). 
However, other similar investigations were published where the immobilization was 
performed inside the system, without mentioning the risk or interference of contamination. 
For example, Gaudin and Marris (2000) used the same procedure as we did for the 
immobilization of ampicillin to a CM5 chip. Ahmad et al. (2002) even injected 3.45 mg 
sulfamethazine during their immobilization procedure. The authors did not mention the 
relative response nor the time of interaction for the antibodies. In addition the immobilization 
of analyte inside the system, we regenerated the surface with an excess of ampicillin to avoid 
the degeneration of the immobilized ampicillin when using alkali or acid regeneration 
conditions.  
 
Possibly, ampicillin molecules remained in the system after the regeneration step so 
that for each antibody binding event a large amount of antibody was needed. Probably there 
was no accumulation of contaminating molecules after the regeneration step because the 
reproducibility of the signal of the antibody binding was very high (Coefficient of variation of 
six subsequent runs = 0.5%, Table 6.3). 
 
An alternative to avoid contaminating analyte and reduce the amount of antibody is 
the immobilization of ampicillin-protein conjugates instead of ampicillin. Haasnoot and 
coworkers (2003) immobilized a sulfonamide-protein conjugate. Lower amounts of 
sulfonamides are available for binding to antibodies than when sulfonamides are immobilized 
directly on the surface like our biosensor set up. This means that we could possibly reduce the 
amount of antibodies by working with a surface coated with ampicillin-protein conjugates 
instead of ampicillin. This was indeed observed by Bonroy and coworkers (2002). In an 
optimised biosensor assay on an immobilized ampicillin-protein conjugate, they used less 
than 10 µg/ml purified mAb 19C9. They obtained better detection limits for test penicillins 
when analysed on a surface coated with ampicillin-protein conjugates as compared to 
ampicillin coating.     
 
Thus, our biosensor assay could still be optimized. Performing the immobilization 
outside the system should avoid contamination with the analyte. Regeneration with an excess 
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of analyte should also be avoided. Moreover, immobilization of an ampicillin-protein 
conjugate will improve the assay sensitivity. Such immobilization could allow other 
regeneration conditions to be used. Nowadays, the development of a biosensor assay using 
mAb 19C9 is under investigation at the Interuniversity Microelectronics Center (IMEC), 
Heverlee, Belgium. 
 
Conclusion 
 
With the pAb K2, but not with the mAb 19C9 and mAb 9H3, an ELISA and a 
biosensor assay was developed able to detect penicillins and ampicillin, respectively, far 
below the MRL-value for meat. Despite the fact that the biosensor assay was not performed in 
optimized conditions, the monoclonals showed higher sensitivities for the penicillins in the 
biosensor assay as compared to the ELISA. Therefore, it should be interesting to apply the 
monoclonals for the development of a suitable biosensor assay.  
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Chapter 7 
 
 
Detection of penicillins in tissue samples using the 
ciELISA with polyclonal antibodies pAb K2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from: P. Cliquet, E. Cox, L. Okerman, K. De Wasch, B. M. Goddeeris. ELISA for the 
detection of residues of the penicillin group in food of animal origin. Med. Fac. Landbouww. Univ. 
Gent. 1999, 64(5b) 507-512. 
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Abstract 
 
Extraction procedures were developed for the analysis of porcine and bovine tissues in 
two different competitive inhibition ELISAs using the same penicillin-specific polyclonal 
rabbit antibodies (pAb K2): an antigen ciELISA in which antigen was coated on the plate and 
an antibody ciELISA coated with the polyclonal antibodies. A rather simple extraction 
procedure was developed for the detection of ampicillin in porcine kidney, muscle and liver 
tissues in the antigen ciELISA with pAb K2, using two phosphate buffer solutions (Sodium 
phosphate pH 5 and phosphate buffered saline pH 7.4, respectively), a centrifugation step, a 
filtration step and a pH adjustment. For the analysis of penicillins in incurred samples in the 
antibody ciELISA with pAb K2, tissue fluids were used instead of the whole meat matrix, 
what simplifies the sample preparation. Before analysis in ELISA, the fluids were treated 
with kaolin to reduce the background signals in ELISA. 
The specificity, sensitivity, repeatability, decision limit (CCα) and detection 
capability (CCβ) were determined for both assays. The antibody ciELISA using pAb K2 is 
preferred above the antigen ciELISA with pAb K2 because the detection limit of the antibody 
ciELISA for penicillins is far below the MRL. Furthermore, the precision of the antibody 
ciELISA is higher than the precision of the antigen ciELISA: the range between CCα and 
CCβ is smaller for the analysis of kidney samples in the antibody ciELISA (9 – 19 ng/ml) as 
compared to the antigen ciELISA (21-69 ng/ml).  
The suitability of the antibody ciELISA and the respectively extraction procedure for 
screening purposes was demonstrated by comparison of the analysis of incurred samples 
using different screening assays. Almost 100 % correlation (r = 0.96) was found between the 
ELISA and a commercial immunochemical method, the Parallux™ assay. 
 
Introduction 
 
High specific monoclonal and polyclonal antibodies were induced against the 
thiazolidin ring of the common 6-aminopenicillanic acid core of the β-lactam antibiotics after 
immunization of respectively mice and rabbits with ampicillin- and benzylpenicillin-carrier 
conjugates (Cliquet et al, 2001; Cliquet et al., submitted). With the monoclonals (mAb 19C9 
and mAb 9H3) as well as with the polyclonal antibodies (pAb K2, pAb K6 and pAb K8), an 
antigen ciELISA was developed for the detection of ampicillin, amoxicillin, benzylpenicillin, 
oxacillin, cloxacillin and dicloxacillin in buffer solutions (Cliquet et al., submitted; Cliquet et 
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al., 2004). However, the antigen ciELISAs were not able to detect all tested penicillins at the 
MRL (50 µg/kg for ampicillin, amoxicillin and benzylpenicillin; 300 µg/kg for oxacillin, 
cloxacillin and dicloxacillin). Only ampicillin could be detected below the MRL in the 
antigen ciELISA with the polyclonals (LOD = 6 µg/kg with pAb K2; LOD = 20 µg/ml with 
pAb K6 and pAb K8) and amoxicillin in the antigen ciELISA with mAb 19C9 (LOD = 18 
µg/kg). With the polyclonals, but not with the monoclonals, an antibody ciELISA could be 
developed that was ten times more sensitive than the antigen ciELISA (Cliquet et al., 
submitted). Therefore only the ELISA using pAb K2 was chosen to assess the possibility of 
analysing porcine or bovine tissues according to the requirements for screening tests used for 
the inspection of food derived from treated animals (Anonymous, 2002). 
 
Each member of the European Union has a monitoring program to test for the 
presence of veterinary drugs in edible tissues, according to Council Directive 96/23/EC.  In 
Belgium, the residue control program for meat and meat products is currently operating in 
three steps. First, the kidney and sometimes muscle tissues collected at slaughterhouse are 
analysed using the New Belgian Kidney Test (NBKT) for the presence of antibiotics and 
other anti-microbiological substances (pre-screening). The NBKT is a microbiological assay 
based on the growth inhibition of bacteria on an agar plate in the presence of a paper disk 
impregnated with kidney fluid or a piece of tissue (Okerman, 1995). The assay only indicates 
the presence of an anti-microbial agent but does not discriminate between different families 
of antibiotics or chemotherapeutics. Therefore, positive samples are further screened using 
other microbiological assays or using immunoassays to identify the inhibitory substance or 
the group to which it belongs (screening). Finally, the present analyte is identified and 
quantified using a confirmatory method (confirmation).  
 
Any method or combination of methods may only be used for screening or 
confirmatory purposes if it can be proven that they fulfill the relevant requirements 
established in the Commission Decision 2002/657/EC. For screening purpose, only those 
methods are allowed that are validated and have a false-compliant rate lower than 5% at the 
MRL. Validation of a method means the demonstration that the method complies with the 
criteria applicable for the relevant performance characteristics. For a qualitative screening 
method, the detection capability (CCβ), the selectivity/specificity and the 
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applicability/ruggedness/stability must be demonstrated. When a screening assay will be used 
quantitatively, the precision must additionally be determined.  
  
The aim of this study was firstly to develop an appropriate extraction procedure for 
the detection of penicillins in porcine tissues in the antigen ciELISA and in the antibody 
ciELISA using pAb K2. In a second step, it was investigated if the ELISAs could be validated 
according to the Commission Decision 2002/657/EC. Some of the relevant performance 
characteristics for the validation of both assays were determined and are discussed in this 
study. Thirdly, the analysis of incurred samples using the ELISA procedures was compared to 
the analysis of the same samples using a confirmation method or other screening tests. 
 
Material and methods 
 
Origin of the animal tissue samples  
Twelve pigs (22kg-43kg) were injected twice intramuscularly in the neck with an 
interval of 12 hours with ampicillin trihydrate (AMPILUX 200, Pharmalux Belgium, 
withdrawal time = 6 days). The doses used as well as the interval between the second 
injection and the time of slaughter, are presented in Tables 7.4, 7.5 and 7.6. The injections 
were performed in such a way that all pigs could be slaughtered at the same day. Euthanasia 
occurred by giving an overdose of penthobarbital (24 mg/kg) followed by exsanguination. At 
slaughter, kidney, and diaphragmatical muscles and muscles at the injection place were 
sampled and tested the same day in the antigen ciELISA. The kidneys were tested 
simultaneously in the New Belgian Kidney Test (NBKT). In addition, all samples were stored 
at -20°C until analysis in a variant of the European Four-Plate Test (muscles and 
diaphragmatical muscles) and in the HPLC-UV (all tissues). Porcine kidney and muscle 
tissues free of any antimicrobial substance (tested compliant in the Belgian residue control 
program) were used as reference control samples. The HPLC-UV analysis and the 
microbiological assays were performed at the Department of Veterinary Public Health and 
Food Safety, Ghent University.  
 The samples (15 porcine or bovine kidneys) analysed in the antibody ciELISA, the 
Parallux™ assay and the NBKT were collected at slaughterhouses by the Belgian Institute for 
Veterinary Inspection and were stored at –20°C until analysed. The porcine kidneys used as 
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reference control samples in the antibody ciELISA were obtained at slaughter from animals 
reared on an experimental unit, without penicillin treatment. 
 
Sample analysis in the antigen ciELISA 
Sample preparation. The meat samples were cut into small pieces (0.5 cm2) 
whereafter 4 g of sample was added to 18 ml extraction solution (Sodium phosphate buffer 
0.1 M pH 5). After shaking briefly, 18 ml diluent (PBS + 6 % BSA + 0.1 % Tween 20®) was 
added. Subsequently, the samples were shaken and centrifuged (10 min, 12000 rpm or 17210 
g). The supernatant was collected, filtered over Whatmanpaper no. 2 whereafter the pH was 
adjusted to pH 6.5-7 with 1N NaOH or HCl.  
Sample analysis. The extracts were tested in the antigen ciELISA with pAb K2, as 
described in Chapter 5. A serial dilution of ampicillin in the extraction fluid of the 
corresponding control tissue was used as standard. The competition in the ELISA between 
free ampicillin in the sample and the coated ampicillin (ampMBSova) was calculated with the 
formula: competition (%) = (1-(B/Bo))*100 with B = absorbance of a tested sample solution 
and Bo the absorbance of a tested similar solution without a penicillin. The calibration curve 
was established by plotting the concentration of a standard dilution of ampicillin against the 
competition obtained for the ampicillin standard dilutions. The concentration of ampicillin in 
the samples could then be determined using the calibration curve. 
 
Sample analysis in the antibody ciELISA 
Sample preparation: tissue fluids were collected after centrifugation of 10 gram of 
minced tissue (10 min, 2000g). Kaolin (800 µl of 25% kaolin in PBS) was added to 100 µl 
tissue fluid. The mixtures were shaken thoroughly and incubated for 30 min at room 
temperature. After centrifugation (12000 g, 10 min), 650 µl of the supernatant was added to 
350 µl PBS supplemented with bovine serum albumin (BSA, 6%) and Tween®20 (0.1%).  
Sample analysis: the ELISA was performed as described (Cliquet et al., submitted). 
Test penicillins were hydrolyzed with Penicillinase I. Fluids from negative tissues and fluids 
from negative tissues spiked with amoxicillin at the MRL-value (50 ppb) were analysed as 
negative and positive control, respectively. A serial dilution of amoxicillin in the extraction 
fluid of the corresponding control tissue was used to construct a calibration curve 
(concentration vs competition). The competition in the ELISA between a free penicillin in the 
sample and the biotinylated ampicillin) was calculated with the formula: competition (%) = 
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(1-(B/Bo))*100 with B = absorbance of a tested sample solution and Bo the absorbance of a 
tested similar solution without a penicillin. The sample analyses were considered as valid, if 
the competition value for the positive control sample was in the range of the expected value 
(67%±4%). A sample was considered non-compliant when the concentration was higher than 
the detection capability (CCβ), compliant when lower than the decision limit (CCα) and 
suspected when between CCα and CCβ. 
 
Repeatability of the ELISA 
 The repeatability of the antigen ciELISA (within-laboratory) was determined by 
repeating the analysis of ampicillin in buffer solution (8 different concentrations) six times on 
the same day and in the same assay (intra-assay variation), but also in six different assays 
(inter-assay variation) and by repeating the analysis on six different days (inter-day variation). 
The repeatability of the antibody ciELISA was determined similarly, but using hydrolysed 
amoxicillin. 
 
Decision limit and detection capability of the ELISA 
Control porcine tissue samples spiked with ampicillin (5 kidneys and 5 muscle tissues, 
antigen ciELISA) or amoxicillin (14 kidneys, antibody ciELISA) at the MRL (50 ppb) were 
analysed on different days. The average B/Bo for CCα  and CCβ  was calculated according to 
the Commission Decision 2002/657/EC. The corresponding concentrations were obtained by 
plotting the competition values (= (1-B/Bo)*100) in a calibration curve of ampicillin or 
amoxicillin in tissue extract (antigen ciELISA) or buffer solution (antibody ciELISA).  
 
 
High Performance Liquid Chromatography (HPLC-UV) 
The analyses were performed following the sample preparation procedure and HPLC 
method previously described (Boison et al., 1998). Briefly, the sample preparation occurred in 
three steps:  
1) extraction of the penicillins with a phosphate buffer 0.1 M pH 9.2  
2) clarification and concentration of the extract on a C18 column, eluted with 
acetonitril. After the acetonitril in the eluate was evaporated to dryness, the 
residue was dissolved in 200 µl acetonitril-phosphate buffer pH 6.5 (40:60, v/v).  
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3) precolumn derivatization of the penicillins in the extract by acetylation of the side 
chain amino group of ampicillin using benzoic anhydride followed by 
derivatization using mercuric chloride in presence of 1,2,4 triazole at 65°C for 30 
min.  
Nafcillin was included as internal standard. The extracts were analysed using HPLC 
with UV-photometrical detection (325 nm). A serial dilution of ampicillin in the extraction 
buffer was also analysed to determine a standard curve. Furthermore, the corresponding tissue 
control sample was spiked with ampicillin at the MRL-value (50 ppb) and was also analysed. 
The concentration of ampicillin in that spiked sample was then calculated using the standard 
curve and the recovery was determined. This factor and the standard curve are used to 
determine the concentration of ampicillin in the samples. A sample was considered non-
compliant when the concentration of ampicillin was higher than 50 ppb. 
 
The New Belgian Kidney Test (NBKT) 
Paper disks (12.7 mm diameter) impregnated with kidney pelvis fluid and a piece of 
kidney cortex (a few mm) were incubated on an agar layer (pH 7.2) previously seeded with a 
susceptible bacterial strain (Bacillus subtilis). The growth inhibition zone was measured in 
millimeters. The samples were analysed twice. Samples producing an inhibition zone larger 
than 20 mm for the paper disk (zone inclusive the diameter of the disk) and larger than 2 mm 
around the cortex were considered as positive for the presence of antimicrobial substances. 
 
Variant of the European Four-Plate test 
Four agar plates were used: plate one was seeded with Bacillus subtilis, plate two with 
Micrococcus luteus, plate three with E. coli and plate four with Bacillus cereus. Penicillins 
can be detected on plate one and two. Plate three, seeded with E. coli, is more sensitive for the 
detection of quinolones and some cephalosporines. The fourth plate, seeded with Bacillus 
cereus is used for the detection of tetracyclines. Frozen pieces (disks, 8 mm diameter, 2 mm 
thick, approximately 100 µg) of muscles, liver and diaphragmatical muscle tissues were 
placed on the plates. The inhibition zone around the pieces was measured in millimeters. 
Samples producing an inhibition zone larger than 2 mm were considered as positive for the 
presence of antimicrobial substances. Inhibition zones larger than 12 mm correspond to 
standard buffer solution containing 3 ng ampicillin on the B. subtilis plate, and 0.8 ng 
ampicillin on the M. luteus plate. The presence of penicillins was confirmed by using 
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Penicillinase I (penase test). Hereto, the positive samples were retested on plate one and two, 
with and without paper disks impregnated with penicillinase, deposited at a distance of 2 mm 
from the samples. A penase test was recorded as positive when the inhibition zone was 
interrupted around the penase disk. 
 
The Parallux™ assay (IDEXX Laboratories) 
Assay design: the method is a competitive fluorescent immunoassays, simultaneously 
carried out in 4 capillary tubes on a cartridge. For the detection of β-lactams, ampicillin, 
amoxicillin and benzylpenicillin, and in a lesser extent also cloxacillin and dicloxacillin, are 
detected in the first capillary, cephapirin in the second, ceftiofur in the third and finally, 
cloxacillin and dicloxacillin in the last tube. The fluorescent signals are measured and 
reported by the processor of the Parallux™ device within 5 minutes. 
Sample preparation: Five grams of partially thawed tissue are diluted with 10 ml of 
phosphate buffer pH 7.6, and mixed using a stomacher. Two ml of the dilution are centrifuged 
at 20000 g for 5 min. The supernatants are ready for analysis in the Parallux™ device. 
Sample analysis: the extract (100 µL) is added to the reagent tray containing the 
fluorescent-labelled antibodies. Sample and reagents are automatically mixed and transferred 
to the cartridge capillary tubes coated with antigen. Penicillin in the sample will bind to the 
labelled antibodies. The unbound antibodies will bind to the immobilized antigen. After a 
short incubation, the sample penicillin–antibody complexes are washed away and the 
fluorescent signal of the antibodies bound on the coated antigen is measured. A test sample 
was considered non-compliant if the signal obtained for the kidney sample was higher than 
1.50 (Okerman et al., 2003). 
 
Results and discussion 
  
Specificity and limit of detection (LOD) of the ELISAs 
The polyclonal antibodies pAb K2 are highly specific for penicillins (Cliquet et al., 
submitted). No cross-reactions were observed for cephadrin, cephalexin, cefazolin, 
sulfanilamide or chloramphenicol analysed in the antibody ciELISA (without hydrolysis). 
Low cross-reactivities were only noticed for cefaclor when analysed at high concentration 
(concentration cefaclor for which the binding of the antibodies is inhibited for 50% (IC50) = 
5000 ppb) compared to the penicillins. The cross-reactivities within the group of penicillins 
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and the detection limit for the different penicillins in buffer solutions in the antigen ciELISA 
as well as in the antibody ciELISA using pAb K2 are described in Chapter 5 (Cliquet et al., 
submitted). In the antigen ciELISA, only ampicillin is detected below the MRL (LOD = 6 
ppb). With the antibody ciELISA, it is possible to detect the tested hydrolysed penicillins at 
concentrations below the MRL. The ELISA is most sensitive for ampicillin (LOD < 0.1 ppb), 
followed by amoxicillin (LOD < 1 ppb), benzylpenicillin (LOD = 1 ppb) and oxacillin (LOD 
= 0.6 ppb). Although in a lesser extent, cloxacillin and dicloxacillin are also detected below 
the MRL (LOD = 7 and 30 ppb, respectively). 
 
During the analysis of samples, a reference penicillin is also analysed. Decision of 
compliance for samples should be made in regard to that reference penicillin. The antigen 
ciELISA is only suitable for the detection of ampicillin below the MRL and therefore 
ampicillin is also used as reference. With the antibody ciELISA, all tested penicillins can be 
detected below the MRL. Ampicillin is not a suitable reference in this case because the 
detection is at least ten times more sensitive as compared to the other penicillins. Therefore 
amoxicillin was chosen as reference penicillin. Consequently, the validation characteristics 
were determined for the reference penicillin.  
  
Repeatability of the ELISA 
The highest within-laboratory variation observed was seen in the same assay and was 
15% for the antibody ciELISA (Table 7.1) and 14 % for the antigen ciELISA (Table 7.2). For 
immunoassays, the coefficient of variation should not exceed 15 % (Crabbe, 2002). The inter-
laboratory variation was not assessed. 
 
Table 7.1: Repeatability (Coefficient of variation, %) of the antibody ciELISA with pAb K2. 
 Coefficient of variation (%) for amoxicillin 
(ppb) 
 40 20 10 5 2.5 1.25 
Intra-assay 5-11 5-12 1-13 5-15 6-12 6-14 
Inter-assay 0 1 1 2 4 7 
Inter day 1 1 2 4 3 4 
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Table 7.2: Repeatability (Coefficient of variation, %) of the antigen ciELISA with pAb K2. 
Coefficient of variation (%) for ampicilline (ppb) 
 5000 1000 500 100 50 10 5 2.5 
Intra-assay 1-2 2-3 1-14 2-9 2-7 1-8 2-7 1-4 
Inter-assay 5 7 6 6 13 5 5 4 
Inter day 14 9 8 7 7 6 8 5 
 
Sample preparation 
Two different sample preparations were applied for the analysis in the antigen 
ciELISA and in the antibody ciELISA. The antigen ciELISA and corresponding extraction 
procedure using meat tissue were developed before the antibody ciELISA. The latter one was 
more sensitive for the detection of penicillins and therefore it was decided to look for a simple 
sample preparation using meat fluids only for the antibody ciELISA. The use of meat fluids 
was thus not investigated for analysis in the antigen ciELISA. Because this sample 
preparation was very satisfying for the antibody ciELISA, the previously developed 
extraction procedure using meat tissue was not applied for analysis in the antibody ciELISA. 
Usually, tissue samples are minced with a conventional kitchen mixer before adding 
extraction buffer (Mc Cracken et al., 2000). This procedure however, led to high background 
signals in the antigen ciELISA. Therefore, the samples where cut into small pieces and 
subsequently mixed with extraction buffer. Interestingly is the matrix effect of porcine kidney 
and muscle tissues on the detection of ampicillin in the antigen ciELISA. The LOD for 
ampicillin in porcine kidney or muscle extracts is lower (1 ppb and <1 ppb, resp.; Table 7.3) 
than the LOD for buffer solution (6 ppb, Cliquet et al., submitted). Mostly, higher LODs are 
reported for tissue samples as compared to buffer solutions (Okerman et al., 1998a). 
Apparently, the kidney and muscle matrix favourably influenced the detection of ampicillin in 
the antigen ciELISA. Moreover, a calibration curve built up by spiked muscle or kidney 
samples is identically to a calibration curve built up by spiked extraction fluids of the 
respectively tissues. This means that ampicillin is extracted from spiked samples with 100 % 
recovery. Therefore, when analyzing incurred samples in the antigen ciELISA, ampicillin 
dilutions in extracts are used as reference. 
Penicillins are present in the intercellular fluid of tissues (Divers, 1996). Therefore, 
tissue fluids were used for analyzing samples in the antibody ciELISA. The use of tissue fluid 
simplifies the sample preparation and analysis. Before analysis in ELISA, the fluids were 
treated with kaolin. Kaolin treatment reduces the background signals in ELISA by removing 
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disturbing fat or other matrix components (Van den Broeck et al, 1999). Contrary to the 
extraction procedure applied for the analysis in the antigen ciELISA, a calibration curve built 
up by spiked kidney tissues is identically to a calibration curve built up by buffer solutions 
(Figure 7.2). Therefore, when analyzing incurred samples in the antibody ciELISA, buffer 
solutions of amoxicillin are used as reference. The LOD for amoxicillin in buffer solutions or 
kidney tissues is lower than 1 ppb (Table 7.3). 
During both extraction procedures, samples are diluted ten times. As a result, the 
ELISA must be at least ten times more sensitive than the MRL. This requirement is thus 
fulfilled for both ELISAs.  
 
Decision limit and detection capability 
The decision limit (CCα) in the case of substances with a permitted limit (MRL) is the 
limit at and above which can be concluded with an error probability of 1-α that a sample is 
non-compliant. The α-error is the probability to obtain a non-compliant result for a sample 
that is truly compliant (false non-compliant). The detection capability (CCβ) is the 
concentration at which a method is able to detect permitted limit levels with a statistical 
certainty of 1-β. The β−error is the probability that a sample is considered compliant while 
being truly non-compliant (false-compliant result) (Anonymous, 2002). According to the 
Commission Decision 2002/657/EC, at least 20 samples should be analysed to determine 
CCα and CCβ. The more samples are analysed, the more precise will be the estimation of 
CCα and CCβ. In this study, the sample analysis for the antigen ciELISA and the antibody 
ciELISA were performed in 1999 and 2001, respectively, and thus before publication of the 
Commission Decision. Consequently, CCα and CCβ were calculated using the available data 
(5 kidneys and 5 livers for the antigen ciELISA, 14 kidneys for the antibody ciELISA). The 
resulting values are therefore an estimation of CCα and CCβ. 
A sample is considered non-compliant when the concentration is higher than 
CCβ, compliant when lower than CCα and suspected when between CCα and CCβ. The 
range between CCα and CCβ is larger for kidneys (21-69 ppb) as for muscle samples (8 – 21 
ppb) in the antigen ciELISA (Table 7.3). This means that analysis of muscle samples is more 
precise than the analysis of kidney samples in the antigen ciELISA. The precision of the 
kidney analysis in the antibody ciELISA is comparable to the muscle analysis in the antigen 
ciELISA (Table 7.3).  
 
RL 
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Table 7.3: Decision limit (CCα), detection capability (CCβ) and limit of detection (LOD) for 
ampicillin in muscle and kidney samples analysed in the antigen ciELISA, and for amoxicillin in 
kidney samples analysed in the antibody ciELISA. 
  Antigen ciELISA Antibody ciELISA 
Penicillin Ampicillin Amoxicillin 
Matrix  Muscle Kidney Kidney 
XMRL Number of samples 
B/Bo1 (average ± SD) 
5 
0.8780 ± 0.0327 
5 
0.8392 ± 0.0459 
14 
0.3300 ± 0.0380 
 Competition (average ± SD) 12 % ± 3 % 16 % ± 5 % 67 % ± 4 % 
 Concentration4 5 ppb 5 ppb 5 ppb 
CCα B/Bo2 0.8243 0.7639 0.2676 
 Competition 18 % 23 % 73 % 
 Concentration4 8 ppb 21 ppb 9 ppb 
CCβ B/Bo3 0.7707 0.6886 0.2052 
 Competition 23 % 31 % 79 % 
 Concentration4 21 ppb 69 ppb 19 ppb 
LOD Concentration < 1 ppb 1 ppb < 1 ppb (< 56%) 
1B/Bo (XMRL)= average absorbance of the sample / average absorbance of the control tissue samples  
2B/Bo (CCα) = B/Bo(XMRL) – 1.64* SD, (Anonymous, 2002)  
3B/Bo (CCβ) = B/Bo(CCα) – 1.64* SD, (Anonymous, 2002) 
4Concentration calculated using the corresponding calibration curve (competition versus concentration) 
 
The lower precision of the kidney analysis in the antigen ciELISA can be ascribed to 
two factors. Firstly, the variation (standard deviation, SD) on the average XMRL is slightly 
larger for kidney as compared to muscle tissues. Consequently, larger differences between the 
calculated CCα and CCβ are noticed. Secondly, the flatness of the calibration curve for 
muscle and kidney samples in the antigen ciELISA has as consequence that little variations in 
the y-value (signal or competition, Figure 7.1) cause large differences in the extrapolated x-
value (concentrations) (Tijssen, 1985). The calibration curve of the antibody ciELISA is 
steeper, especially in the region around the MRL (Figure 7.2). Consequently, small 
differences in signal correspond to small differences in concentrations, and large differences 
in signal correspond to large differences in concentrations. Such a calibration curve combined 
with a high repeatability and thus small variation, provide analyses of samples with high 
precision. 
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Analysis of incurred samples in the antigen and antibody ciELISA 
To determine the detection capability of the ELISA in accordance to the Commission 
Decision 2002/657/EC, spiked samples containing penicillin at the MRL should be used. 
Spiked samples are more appropriate for that purpose than samples obtained from in vivo 
experiments because it is difficult to predict the concentration that will be obtained in the 
tissues after administration of the drug to animals. On the other hand, care must be taken 
when validating a method using spiked samples. An extraction protocol optimized using 
spiked samples will not necessarily be efficient for incurred samples. The efficiency of the 
extraction procedure to extract analytes from the tissue matrix cannot be determined using 
spiked samples because the interaction between analyte and the sample matrix is different for 
incurred samples (Mc Cracken et al., 2000). Therefore, the analysis of incurred samples in the 
antigen and in the antibody ciELISA was compared to the analysis of the same samples using 
other qualitative or quantitative methods.  
The antigen ciELISA versus HPLC-UV and microbiological assays 
Twelve pigs were treated with ampicillin and slaughtered at different time points 
during the withdrawal period. The kidney and muscle tissues (at the injection place and 
diaphragmatical muscle tissues) were analysed in the antigen ciELISA for the presence of 
ampicillin. The results were compared following the analysis of the same samples using a 
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Figure 7.2: Calibration curve of 
amoxicillin in buffer solution (hydrolysed 
or not) and spiked porcine kidney samples 
(hydrolysed), analysed in the antibody 
ciELISA with pAb K2 
Figure 7.1: Calibration curve of ampicillin
in buffer solution, porcine muscle and 
kidney extract, analysed in the antigen
ciELISA with pAb K2 
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physicochemical method (HPLC-UV) and two microbiological assays (variant of the Four-
Plate test and the NBKT). The results of the analysis of muscles (injection side), kidneys, and 
diaphragmatical muscles using the antigen ciELISA and using the three other methods are 
shown in Table 7.4, 7.5 and 7.6, respectively. 
 
Table 7.4: Comparison of the analysis of the muscles (injection side) with the 4 methods. 
 Pig 
no. 
Dose Euthanasia1 Muscle 
ELISA 
(µg/kg) 
Micro Bs2 
(mm) 
Micro Ml 
(mm) 
HPLC-UV
(µg/kg) 
 (mg/kg) (hours) 
  no penase3 penase4  
7 3.75 48 0 <2/<2 10.0/6.3 3.8/3.2 33 ± 6 
10 3.75 48 84.8 <2/<2 4.7/3.0 <2/<2 30 ± 7 
1 7.5 48 62.2 5.3/7.0 >12/>12 <2/<2 483 ± 155
8 7.5 48 450 3.7/<2 >12/>12 <2/<2 119 ± 23 
2 15 48 35.3 <2/<2 >12/>12 <2/<2 61 ± 11 
4 15 48 1.1 <2/<2 4.2/4.5 <2/<2 46 ± 4 
13 15 24 190 >12/>12 >12/>12 <2/<2 234 ± 64 
14 15 24 2723 7.1/7.2 >12/>12 8.5/<2 118 ± 25 
20 15 4 >10000 >12/>12 >12/>12 ND5 >1000 
22 15 4 >10000 >12/>12 >12/>12 ND >1000 
16 15 2 >10000 >12/>12 >12/>12 ND >1000 
19 15 2 >10000 >12/>12 >12/>12 <2/<2 >1000 
1time after 2de injection 
2Micro Bs = microbiological assay using Bacillus subtilis   
3Micro Ml no penase= microbiological assay using Micrococcus luteus 
4Micro Ml penase= microbiological assay using Micrococcus luteus and Penicillinase I 
5ND = no data 
 
Table 7.5: Comparison of the analysis of the kidneys with the ELISA, the NBKT and the HPLC-UV. 
 Pig 
no. 
Dose Euthanasia1 Kidney 
 (mg/kg) (hours) ELISA 
(µg/kg) 
NBKT 
Paper disk 
(mm) 
NBKT 
Cortex 
(mm) 
HPLC-UV 
(µg/kg) 
7 3.75 48 2.6 14.75 <2 0 
10 3.75 48 13.6 20.4 <2 0 
1 7.5 48 12.3 <12.7 <2 0 
8 7.5 48 40.5 12.7 <2 0 
2 15 48 10.3 <12.7 <2 0 
4 15 48 10.2 <12.7 <2 0 
13 15 24 1100.0 19.35 <2 0 
14 15 24 18.1 18.15 <2 0 
20 15 4 >10000 42.15 8.7 >1000 
22 15 4 >10000 40.35 8.9 >1000 
16 15 2 >10000 48.1 12.1 >1000 
19 15 2 >10000 48 12 >1000 
1time after 2de injection 
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Table 7.6: Analysis of the diaphragmatical muscle tissues with the ELISA, the microbiological assay 
using B. subtilis and the HPLC-UV.  
Pig no. Dose Euthanasia1 Diaphragmatical muscle 
ELISA 
(µg/kg) 
Micro Bs 
(mm) 
HPLC-UV 
(µg/kg) 
 (mg/kg) (hours) 
 No penase2 Penase3  
7 3.75 48 0,0 <2/<2  0 
10 3.75 48 0.0 <2/<2  0 
1 7.5 48 19.0 <2/<2  0 
8 7.5 48 4.2 <2/<2  0 
2 15 48 12.8 <2/<2  0 
4 15 48 0.0 <2/<2  0 
13 15 24 1480.0 8/>12 <2/<2 0 
14 15 24 509.0 <2/<2  0 
20 15 4 907.0 8.9/9.6 <2/<2 >1000 
22 15 4 46.0 6.5/9 <2/<2 >1000 
16 15 2 459.0 10/10.4 <2/<2 >1000 
19 15 2 347.0 11.3/10.6 <2/<2 >1000 
1time after 2de injection 
2Micro Bs no penase= microbiological assay using Bacillus subtilis 
3Micro Bs penase= microbiological assay using Bacillus subtilis and Penicillinase I 
 
 
A comparison was made between the ELISA and HPLC-UV for the quantitative 
analysis of the samples. HPLC-UV is a chemical analytical method combining liquid 
chromatography with UV-detection and was used for the detection of penicillins before the 
introduction of the LC-MS/MS method (Boison, 1995; Blanchflower et al., 1994). The 
disadvantage of the HPLC-UV method is the need of a derivatization of the penicillins using 
toxic reagents to allow detection because penicillins do not have any specific strong 
ultraviolet (UV) absorption (Ito et al., 1999). The concentrations of penicillins determined by 
HPLC-UV did not match with the concentrations determined with the ELISA (Table 7.4, 7.5, 
7.6). When comparing two methods, care must be taken that the same metabolite of the 
analyte is detected. The ELISA does not discriminate between native and hydrolysed 
ampicillin (Cliquet et al., submitted), whereas only the native molecule is detected in HPLC-
UV (Boison, 1995; Blanchflower et al., 1994). Moreover, the ratio hydrolysed/native 
penicillins in a sample is not equal for all samples and thus no correlation using a conversion 
factor can be made between both methods. Another difference between both methods is the 
extraction procedure. A phosphate buffer with pH 5 is used for the analysis in ELISA as 
compared to a phosphate buffer with pH 9 for HPLC-UV. The lower the pH of an extraction 
buffer, the more water is extracted from the tissue matrix. Penicillins are present in the 
intercellular fluid of tissues (Divers, 1996). Thus, it is possible that more penicillins are 
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extracted using the ELISA extraction procedure as compared to the one used for HPLC-UV 
analysis. All these factors could explain the different concentrations and made that the 
precision and efficiency of the ELISA could not be based on a quantitative comparison of 
both methods. 
For the qualitative analysis of the samples, a comparison was made between the 
ELISA, the HPLC-UV and microbiological assays. The NBKT and the variant of the 
European Four-Plate test are bacterial inhibition assays and are qualitative tests (Okerman, 
1995; Okerman et al., 1998b; Okerman et al., 1999). When a sample is found positive, it only 
indicates the presence of an antimicrobial agent. However, in the present study pigs were only 
treated with ampicillin. Therefore a positive result indicates the presence of ampicillin in the 
sample. When the same sample was found negative in the HPLC-UV analysis, this proves 
that the HPLC-UV produced false compliant results. Therefore, a sample found positive in 
the microbiological assay but negative in HPLC-UV should be considered non-compliant. On 
the other hand, HPLC-UV analysis could only detect ampicillin. Therefore, a sample found 
positive in HPLC-UV but negative in the microbiological assay was also considered non-
compliant. Taking this into account, both assays together had to be used as reference method. 
The sensitivity and specificity of the ELISA in regard to the other methods were determined 
to obtain information on the correlation between ELISA and these methods. For the ELISA, 
samples were considered positive (non-compliant) if the concentration was higher than CCβ. 
Doing this, two of the 36 samples were positive in ELISA but negative (compliant) in the 
reference method, and three samples were negative in ELISA but positive (non-compliant) in 
the reference method (Table 7.7). The sensitivity of the ELISA was 0.82 and the specificity 
was 0.89. 
 
Table 7.7: Determination of the sensitivity and specificity of the antigen ciELISA (in regard to CCβ).  
  Reference method: HPLC-UV and 
microbiological assay 
  Non-compliant Compliant 
Positive a = 14 b = 2 Method to validate: 
ELISA Negative c = 3 d = 17 
N = total amount of samples analysed = a+b+c+d 
a+c = total amount of non-compliant (really positive) samples 
b+d = total amount of compliant (really negative) samples 
Sensitivity = a / (a + c) = 0.82 
Specificity = d / (b + d) = 0.89 
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However, since CCβ was not determined for the HPLC-UV and the microbiological 
assays, the positive/negative estimations for these methods were done in regard to a positive 
control sample spiked at the MRL (HPLC) or in regard to a given inhibition zone (20 mm for 
the NBKT, 2 mm for the four-plate assay). If the ELISA results are estimated in the same 
manner (positive when concentration higher than 50 ppb instead of CCβ), a sensitivity of 0.95 
and specificity of 0.94 is obtained (Table 7.8). 
 
 Table 7.8: Determination of the sensitivity and specificity of the antigen ciELISA (in regard to the 
MRL).  
  Reference method: HPLC-UV and 
microbiological assay 
  Non-compliant Compliant 
Positive a = 18 b = 1 Method to validate: 
ELISA Negative c = 1 d = 16 
N = total amount of samples analysed = a+b+c+d 
a+c = total amount of non-compliant (really positive) samples 
b+d = total amount of compliant (really negative) samples 
Sensitivity = a / (a + c) = 0.95 
Specificity = d / (b + d) = 0.94 
 
According to the Commission Decision 2002/657/EC, the sensitivity or the capability 
of a screening assay to detect non-compliant samples as really non-compliant, should be at 
least 0.95 (β−error = 5%). So, based on the first calculation (sensitivity = 0.82), the ELISA 
procedure should be rejected or further optimized. However, based on the second calculation 
(sensitivity = 0.95), the ELISA meets the requirement of the Commission Decision 
2002/657/EC and could thus be applied for screening purposes of ampicillin in porcine 
kidney and muscle tissues. However, none of both calculations are correct because the 
methods are not compared using the same parameters. As for the comparison of the 
quantitative analysis, these results demonstrate that it is difficult to compare results obtained 
with different methods validated using different parameters. It also demonstrates that 
comparison should be made in regard to a validated physico-chemical reference method or a 
similar, but also validated immunochemical method.  
  
The antibody ciELISA versus microbiological assay and Parallux™ assay 
As for the antigen ciELISA, the efficiency of the extraction procedure and analysis of 
samples in the antibody ciELISA was assessed with incurred samples. Porcine and bovine 
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kidney samples were obtained from the Belgian monitoring program and analysed in the 
antibody ciELISA, the NBKT and the Parallux™ assay.  
 
The Parallux™ is a commercial screening assay for the detection of β-lactam 
antibiotics in milk (Huth et al., 2002). Although developed for the detection of antibiotics in 
milk, the Parallux™ assay was found suitable for the qualitative screening of different 
antibiotics (tetracyclins, β-lactams and cephalosporins) in porcine and bovine kidneys 
(Okerman et al., 2003). The Parallux™ and ELISA detect ampicillin, amoxicillin, 
benzylpenicillin, cloxacillin and dicloxacillin. The ELISA also recognizes oxacillin. 
Amoxicillin was chosen as standard penicillin in the ELISA. The detection capability and 
decision limit were established for that standard penicillin. However, the different penicillins 
are detected with different sensitivities (different cross-reactivities) in the ELISA. 
Consequently, CCβ will be different for each penicillin. If a sample is positive during 
screening, the identity of the penicillin in the sample is not known. Therefore, for multi-
analyte methods, decision based on CCβ will not necessarily give certainty about the false 
compliant rate of the ELISA. 
 
The results of the analysis of incurred samples in the NBKT, the Parallux™ assay and 
the ELISA are given in Table 7.9. Not only penicillins, but also other substances with 
antimicrobial activity are detected in the NBKT. Because the incurred samples came from 
animals with unknown treatment, a positive result in this test indicates the presence of one or 
more antimicrobial substances and thus not only penicillins. This is the reason why some 
samples (sample n° 407, 454) are tested positive in the NBKT, but negative in the Parallux™ 
and the ELISA. High correlation (r2 = 0.94) was found between the Parallux™ and the 
ELISA. Only sample n°1199 was tested negative for the presence of penicillins in the 
Parallux™ while positive in the NBKT and slightly positive in the ELISA (although far below 
CCα, 73%). However, it was found positive for ceftiofur in the Parallux™. It is possible that 
the ELISA also detected ceftiofur instead of penicillins. The ELISA shows some cross-
reactivity toward the structural related cefaclor (Cliquet et al., submitted). However, cross-
reactivity for ceftiofur was not tested.  
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Table 7.9: Results of the analysis of incurred kidney samples in the NBKT, the Parallux™ and the 
antibody ciELISA 
Sample NBKT Parallux™ ELISA 
N° Cortex (mm) Signal Competition (%) 
1508 NT1 2 74 
1770 >2/>2 2 72 
1703 2/2 0 0 
1390 >2/<2 2.03 62 
1109 >2/>2 2.48 76 
407 >2/>2 0 0 
1199 4.5/7.6 ceft2 12 
1388 >2/>2 2.3 73 
1393 <2/<2 2.07 55 
1511 >2/>2 2.63 66 
1408 <2/<2 0 0 
1332 <2/<2 2.57 66 
1679 > 2/ >2 2.5 74 
1329 <2/<2 0.77 30 
454 >2/>2 0 0 
            1NT = not tested 
            2ceft: The suspected analyte was identified as ceftiofur with LC-MS/MS  
 
Conclusion 
 
The antibody ciELISA using pAb K2 is preferred above the antigen ciELISA with 
pAb K2 because the detection limit of the antibody ciELISA for penicillins is far below the 
MRL. Furthermore, the precision of the antibody ciELISA is higher than the antigen 
ciELISA: the range between CCα and CCβ is smaller for the analysis of kidney samples in 
the antibody ciELISA as compared to the antigen ciELISA. Moreover, the suitability of the 
ELISA and extraction procedure for screening purposes was demonstrated by comparing the 
analysis of incurred samples. Almost 100 % correlation was found between the ELISA and a 
commercial immunochemical method, the Parallux™ assay.  
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Abstract 
  
To develop a sulfonamide specific ELISA, different attempts were made to obtain 
monoclonal antibodies specific for the common structure of sulfonamides. In a first approach, 
sulfanilamide was linked to albumins using glutaraldehyde or a succinimide ester as cross-
linker. No or a weak immune response was induced after immunization of mice with these 
conjugates. High antibody titers were obtained with conjugates where sulfanilamide was 
linked to albumins or casein (azocasein) with a diazotation reaction. However, the antibodies 
were only highly specific for the bound sulfanilamide molecule. In a second approach, 
sulfonamide-protein conjugates were used in which the sulfonamide molecule is linked at its 
side chain, leaving the common structure of sulfonamides unchanged. Three sulfonamide 
derivatives (S, TS and PS; previously described in literature) containing a carboxyl group in 
their side chain were linked to proteins using a carbodiimide mediated reaction. Immunization 
with the S-conjugates led to high antibody titers, but the antibodies were only highly specific 
for the bound S-molecule. Group-specific antibodies were obtained after immunization with 
the PS- and TS-conjugates. It was described that immunization with PS-conjugates lead to the 
recognition of other sulfonamides (sulfamethazine, -merazine, -diazine and –dimethoxine) 
that are not well recognized by antibodies induced after immunization with TS-conjugates. 
Therefore, we tried to guide the immune response in the direction of recognition of the 
common structure of sulfonamides by immunizing the animals alternately with PS- and TS-
conjugates. The polyclonal antibodies of the mice had indeed a broader specificity, but the 
specificity of the monoclonals obtained after fusion experiments was not influenced. 
Immunization with TS-conjugates seemed sufficient to obtain sulfonamide-specific 
monoclonal antibodies. With the best monoclonal (mAb 3B5B10E3) two competitive 
inhibition (ci) ELISAs were developed: one coated with antigen and the other coated with the 
monoclonal antibody. Sulfadiazine, –dimethoxine, -thiazole, -pyridine and -methoxazole were 
detected in both ELISAs at their MRL-value (100 ppb) in buffer solution. Sulfadiazine, 
sulfathiazole and sulfamethoxazole could even be detected at 10 ppb.  
 
Keywords: Sulfonamide – monoclonal antibody - ELISA  
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Introduction 
 
Sulfonamides are chemotherapeutical reagents widely used in human as well as in 
veterinary medicine for the treatment of bacterial infections. They are also used as growth 
promoting feed additives (Long et al., 1990). As a consequence, sulfonamides have appeared 
in food products from animal origin (Franco et al., 1990). To protect consumers from risks 
related to drug residues, maximum residue limits (MRL) are determined by law. In Europe, 
Canada and the United States, the MRL for total sulfonamides in edible tissues and milk is 
100 ppb (Anonymous, 1999; Anonymous, 1991), whereas it is 20 ppb in Japan. In Europe, at 
least nine sulfonamides are allowed for use in veterinary medicine (sulfamethazine, 
sulfadiazine, sulfadimethoxine, sulfanilamide, sulfathiazole, sulfadoxine, sulfamethoxazole, 
sulfatroxazole, sulfachloropyridazine…). Screening methods for sulfonamides include 
bioassays, immunoassays, thin-layer chromatography (TLC) and high performance liquid 
chromatography (HPLC, LC-MS/MS). Liquid chromatography is a sensitive and specific 
assay but is also very laborious and expensive. The method is more suitable for confirmation 
than for screening of large amounts of samples. A rapid, sensitive and specific assay is needed 
to pick up positive samples in routine analyses, which then can be confirmed for the presence 
of sulfonamides by liquid chromatography. Therefore, during the past ten years, a variety of 
immunoassays were developed, each highly specific for an individual sulfonamide (Fleeker 
and Lovett, 1985; Dixon-Holland and Katz, 1988; Sheth and Sporns, 1990; Garden and 
Sporns, 1994; Muldoon et al., 2000; Lee et al., 2001; Spinks et al., 2001). However, it would 
be more efficient to have one immunoassay able to detect all sulfonamides instead of several 
immunoassays, each specific for an individual sulfonamide. 
 
The sulfonamides share a common p-aminobenzoyl ring moiety with an aromatic 
amino group at the N4-position and differ in the substitution at the N1-position (Figure 3.1, 
chapter 3). For the group-specific detection of sulfonamides, antibodies against the aromatic 
amino group are needed. Sheth and Sporns (1991) were the first who reported the 
development of sulfonamide-specific antibodies. They immunized rabbits with a sulfathiazole 
derivative (N1-[4-(carboxymethyl)-2-thiazolyl]-sulfonamide, TS) linked at its side chain to 
limulus polyphemus haemocyanin (TS-LPH). The polyclonals recognized nine sulfonamides 
showing 50 % inhibition at a concentration of less than 5 µg/mL. Assil et al. (1992) 
synthesized another sulfonamide derivative with a larger side chain (N1-[4-methyl-5-[2-4-
carboxyethyl-1-hydroxyphenyl)]-azo-2-pyridyl]-sulfanilamide, PS). The polyclonal serum 
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they obtained was purified by affinity chromatography and the purified fraction showed 50 % 
inhibition with seven sulfonamides at concentrations less than 10 µg/mL. The first published 
study about sulfonamide-specific monoclonal antibodies (mAb) was from Muldoon et al. 
(1999). After immunization with a N-sulfanilyl-4-aminobenzoic acid-protein conjugate, only 
one mAb was obtained that recognized eight sulfonamides at levels less than 10 µg/mL. 
Haasnoot et al. (2000a; 2000b) used the sulfonamide derivatives of Sheth and Sporns (1991) 
and Assil et al. (1992) to induce mAb. The best mAb showed 50 % inhibition with 18 tested 
sulfonamides at values less than 10 µg/mL, and with eight at a concentration of less than 0.1 
µg/mL. Unfortunately, the relevant sulfonamides sulfamethazine, sulfatroxazole and 
sulfachloropyrazine were not detected at the MRL value (100 ppb). Spinks et al. (1999) 
carried out molecular modeling studies on the sulfonamide structure revealing that the 
molecule has a characteristic bend around the tetrahedral –SO2- grouping. Recognition of the 
common structure would be maximal in these drugs where the bend had the greatest angle. 
They deduced that cross-reactive antibodies could possibly be obtained using a sulfonamide 
as hapten with a more planar structure (sulfacetamide) or a greater bend 
(sulfachloropyridazine). Despite this interesting hypothesis, immunization with such 
conjugates did not lead to antiserum with a broad specificity for sulfonamides. Finally, Li et 
al. (2000) reported the detection of sulfonamides in swine meat by immunoaffinity 
chromatography using cross-reactive polyclonal antibodies (pAb) induced with three different 
sulfonamide haptens: N1-(4-carboxyphenyl)sulfanilamide (H1), N1-(4-carboxyphenyl)-N4-
(4-aminobenzenesulfonyl)sulfanilamide (H2) and N1-(6-carboxyhexyl)sulfanilamide (H3). 
Sulfonamides were best recognized by the antibodies induced with H2-protein conjugates, 
slightly lesser with H1-protein and worst with H3-protein conjugates. None of the reported 
mAbs or pAbs (except these of Li et al. (2000), which cross-reactivity values were not 
mentioned) were able to detect all of the relevant sulfonamides (sulfamethazine, -doxine, -
chloropyridazine, -quinoxaline, sulfatroxazole, …) at the MRL.  
 
In this study, different strategies for the development of sulfonamide-specific mouse 
antibodies are compared. In a first approach, sulfanilamide was chosen for the construction of 
hapten-protein conjugates because this molecule is the common structure of the sulfonamides. 
Antibodies against sulfanilamide should therefore be group-specific. The conjugations were 
achieved using glutaraldehyde or succinimide ester as cross-linker, or using a diazotation 
reaction. In a second approach, sulfonamide-protein conjugates were used in which the 
sulfonamide molecule is linked at its side chain, leaving the common structure of 
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sulfonamides unchanged and thus free for the induction of group-specific antibodies. In 
previous studies it was demonstrated that the specificity of antibodies obtained after 
immunization with PS-protein conjugates was different from the specificity of antibodies 
induced with TS-protein conjugates (Haasnoot et al., 2000a; Haasnoot et al., 2000b). 
Therefore, mice were immunized alternately with PS- and TS-conjugates in order to induce 
antibodies with a broader specificity.  
 
Material and methods 
 
Reagents and chemicals 
Sulfamethazine, sulfamerazine, sulfathiazole, sulfadiazine, sulfadimethoxine, 
sulfamethoxazole, sulfachloropyridazine, sulfapyridine, sulfisoxazole, sulfanilamide, para-
aminobenzoic acid, bovine serum albumin (bsa), thyroglobulin, ovalbumin (ova), 1-
cyclohexyl-3-(2-morpholino-ethyl)carbodiimidemetho-p-toluenesulfonate (MEDC), 1-ethyl-
3-(3-dimethylamino-propyl)carbodiimide (EDAC), s-acetylmercaptosuccinic anhydride 
(SAMSA), 3-maleimidobenzoic-N-hydroxysuccinimide ester (MBS), Ellman’s reagent (= 
5,5’-dithio-bis(2-nitrobenzoic acid), citraconic anhydride, bicinchoninic acid (BCA), 
cupper(II)sulphate pentahydrate (CuSO4.5H2O), kaolin, OPI supplement media and 3,3’,5,5’-
tetramethylbenzidine (TMB) were purchased from Sigma-Aldrich (Bornem, Belgium). 
Furosemide, acetazolamide, hydrochlorothiazide, bumetanide, thiamphenicol, florphenicol 
and lidocaine were a kindly gift of the Department of Pharmacology, Pharmacy and 
Toxicology, Faculty of Veterinary Medicine, Ghent University. The TMB substrate solution 
was prepared by adding 3.3 mg TMB in 250 µL DMSO to 25 mL phosphate-citrate buffer 
(0.1M citric acid + 0.2M Na2HPO4; pH 4.3) containing 3.25 µL of a 30 % H2O2 solution. 
Biotin-LC-PEO-amine and keyhole lympet hemocyanin (klh) were purchased from Pierce, 
(Perbio, Erembodegem-Aalst, Belgium). Polyethylene glycol 1500 (PEG), ABTS (2,2’-azino-
di-(3-ethylbenzthiazoline-6-sulfonate)) tablet® and ABTS buffer® were obtained from Roche 
Diagnostics (Brussels, Belgium). The ABTS substrate solution was prepared by dissolving 1 
ABTS tablet® (5 mg) in 50 mL ABTS buffer®. Complete Freund’s adjuvant (CFA) and 
incomplete Freund’s adjuvant (IFA) were provided by Difco Laboratories (Biotrading, 
Bierbeek, Belgium). Tween®20 (polyoxyethylene sorbitan monolaurate) and Tween®80 
(polyoxyethylene sorbitan monooleate) were purchased from Merck-Belgolabo (Overijse, 
Belgium). Rabbit anti-mouse immunoglobulins (code n° Z0259) and rabbit anti-mouse 
immunoglobulins conjugated to peroxidase (code n°P0260) were obtained from DAKO 
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Diagnostica (Prosan, Ghent, Belgium). Dialysis tube VIKING (12 000 –14 000 MW cut off) 
was provided by ROTH (Fiers, Kuurne, Belgium). Dimethylformamide (DMF) was supplied 
by SERVA (Polylab, Antwerp, Belgium). Dimethylsulfoxide (DMSO) was from VWR 
(Leuven, Belgium), ELISA microtiter plates (maxisorp) from NUNC (Life technologies, 
Merelbeke, Belgium), tissue culture plates from Greiner (Wemmel, Belgium). Dulbecco 
modified Eagle’s medium (DMEM), glutamine, gentamycin, sodium pyruvate, foetal calf 
serum (FCS) and hypoxanthine, aminopterin and thymidine supplement (HAT) were 
purchased from GibcoBRL (Life technologies, Merelbeke, Belgium). All other chemicals 
were of reagent grade or better. HAT-selection medium consisted of DMEM containing 20% 
FCS, 1% glutamine, 0.1% gentamycin, 1% sodium pyruvate, 1% OPI supplement media and 
2% HAT.  
 
Commercially available sulfonamide-protein conjugates 
Azocaseïne was purchased from Sigma-Aldrich (Bornem, Belgium), sulfamethazine-
bovine gamma globulin antigen conjugate (smt-bgg) was obtained from Chemicon 
International INC. (Biognost, Wevelgem, Belgium).  
 
Synthesis of sulfanilamide-protein conjugates 
Conjugation by diazotation: sulfanilamide was conjugated to bsa according to Fleeker 
and Lovett (1985). Briefly, sulfanilamide (34.5 mg) was diluted in 0.5 N H2SO4 by heating. 
After cooling, 1 mL NaNO2 (19 mg/mL) was added over 3 min. The solution was stirred for 
another five minutes whereafter it was added over 10 min to a cooled bsa solution (100 mg in 
4 mL sodium carbonate 1M pH 10) and subsequently incubated during 4 h at room 
temperature: sulfa-bsa. 
 
Conjugation with glutaraldehyde according to Van Regenmortel et al. (1988). Briefly, 
7.6 mg sulfanilamide was diluted in 1 mL PBS and added to 5 mL ova solution (1 mg/mL 
PBS) (ratio sulfanilamide/ovalbumin = 400/1). Next, 4 mL glutaraldehyde (0.5%) was added 
in drops to the mixture, whereafter the reaction mixture was stirred for 3 h at room 
temperature: sulfa-glut-ova (1). 
 
Conjugation with glutaraldehyde according to Märtlbauer (1993). Briefly, 0.4 mmol 
sulfanilamide was diluted in 8 mL dimethylformamide and added to a solution of 0.003 mmol 
bsa or ova in 16 mL phosphate buffered saline (PBS, 0.15 M pH 7.4) (ratio 
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sulfanilamide/ovalbumin = 133/1). Next, 0.15 mL glutaraldehyde (25%) was added in drops 
to the reaction mixture and subsequently stirred for 3 h at room temperature: sulfa-glut-bsa 
(2) and sulfa-glut-ova (2). 
 
All conjugates were dialyzed during 3 days against several changes of PBS before 
they were stored at –20°C.  
 
In order to determine the amount of sulfonamide molecules bound to the carrier 
protein (molar incorporation), the protein concentrations were first determined with the BCA 
assay (Schmidt et al., 1985). Sulfonamides do not react with the BCA components. Next, the 
amount of bound sulfonamide in the conjugate was determined by measuring the absorbance 
at 280 nm. Because the carrier-protein and the bound sulfonamide in the conjugate both show 
absorbance at 280 nm, the absorbance of a sample containing only the carrier-protein at a 
concentration equal to the one in the conjugate, was also measured and substracted from the 
absorbance of the conjugate to obtain the absorbance of the sulfonamide. A calibration curve 
for the sulfonamide was established plotting the concentration of a standard dilution of the 
sulfonamide against the absorbances at 280 nm and was used to extrapolate the concentration 
of sulfonamide in the product, and consequently to calculate the amount of sulfonamide 
molecules per carrier molecule. 
Figure 8.1: Conjugation of sulfanilamide to proteins by diazotation 
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Figure 8.2: Conjugation of sulfanilamide to proteins using glutaraldehyde  
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further increase in number of sulfhydryl groups could be observed. The number of sulfhydryl 
groups was determined using the Ellman standard method (Ellman, 1959).  
 
c) 3-maleimidobenzoic-n-hydroxysuccinimide ester (0.015 mmol MBS) in 0.5 mL 
tetrahydrofuran was added to 0.015 mmol sulfanilamide dissolved in 1 mL 0.05 M sodium 
phosphate buffer pH 7. The mixture was then incubated during 1 h while gently stirring. 
Subsequently, tetrahydrofuran was removed by mixing the solution under N2 and the excess 
of MBS by extraction with 3 times 5 mL methyleenchloride/ether (1:2; vol/vol). The aqueous 
phase contained the MBS coupled sulfanilamide (sulfa-MBS) and was used in the next step. 
 
d) The thio-carrier-protein solution was added to the sulfa-MBS solution and incubated for 
2 h at 25 °C.  The mixture was dialyzed against PBS during 3 days. Aliquots of the conjugates 
sulfa-MBS-ova and sulfa-MBS-bsa were stored at -20°C. 
The molar incorporation was established by determining the number of free sulfhydryl 
groups left after coupling (Ellman, 1959) and substracting this amount from the number 
determined in step b.  Since one sulfanilamide molecule only binds to one sulfhydryl group, 
the amount of bound sulfanilamide molecules equals the amount of reacted sulfhydryl groups: 
number of sulfanilamide molecules = [(Ev-En)/Em]*f *NA   
Ev = absorbance at 412 nm of the thio-carrier solution after reaction with Ellman’s reagens 
En = absorbance at 412 nm of the final product after reaction with Ellman’s reagens 
Em = molar extinction coefficient for the Ellman’s reagens at 412 nm (13600) 
NA = number of Avogadro 
f = dilution factor 
The amount of carrier-protein molecules was determined by measuring the absorbance at 
280 nm of the thio-carrier-protein solution before adding sulfa-MBS. The molar incorporation 
is expressed as the number of sulfanilamide molecules bound to one carrier molecule in the 
final product. 
 
Conjugates with sulfonamide derivatives 
The synthesis of N-sulfanyl-4-aminobenzoic acid (S) was described by Muldoon et al. 
(1999). For the coupling of S to bsa and ova, the aromatic amino group of S was protected 
with citraconic anhydride. Hereto, 20 mg of S was diluted in 1 mL DMSO whereafter 1 mL 
distilled water was added. The pH of this solution was adjusted to pH 8.5 using 1 M NaOH. 
Then, 2 mL citraconic anhydride solution (3.2 mg citraconic anhydride /mL distilled water) 
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was added in drops whereafter 1-cyclohexyl-3-(2-morpholino-ethyl)carbodiimidemetho-p-
toluenesulfonate (MEDC, 24.2 mg in 200 µL distilled water) was added to the mixture for 10 
min at room temperature maintaining the pH at 8.5. Meanwhile, the carrier protein (39 mg bsa 
or 26 mg ova) was diluted in 2 mL distilled water and the pH was adjusted to pH 8.5. The 
diluted protein was then added to the reaction mixture and incubated for 2 h at room 
temperature. Citraconic anhydride was removed from the aromatic amino group of S by 
dialysis of the reaction mixture against 100 mM sodium acetate for 3 h at room temperature. 
Then the mixture was dialyzed against PBS. The conjugates S-ova and S-bsa were stored at –
20 °C. The coupling efficiency was determined as done for the conjugations with 
glutaraldehyde. 
The synthesis of the sulfathiazole derivative (N1-[4-(carboxymethyl)-2-
thiazolyl]sulfanilamide (TS) was described by Sheth and Sporns (1991). TS was coupled to 
klh, bsa and ova according to Haasnoot et al. (2000a). Briefly, TS (60 mg), N-
hydroxysuccinimide (NHS, 35 mg) and 1-ethyl-3-(3-dimethylamino-propyl)carbodiimide 
(EDAC, 37.6 mg) were diluted in 1.5 mL DMF and incubated overnight at 4°C. The 
dicyclohexylurea precipitate was removed by centrifugation (12 000 g, 10 min) and 0.5 mL of 
the supernatant was added to 1mL of the cooled protein solution (5 mg/mL in PBS) 
whereafter the pH of the mixture was adjusted to 7.6. After stirring overnight at 4°C, the 
reaction mixture was dialyzed against 8M urea, then against 0.5M ammonium bicarbonate 
and finally against 0.25M ammonium bicarbonate (4l). The conjugates TS-ova, TS-bsa and 
TS-klh were stored at –20 °C. The coupling efficiency was determined as done for the 
conjugations with glutaraldehyde, except for the klh-conjugates.  
N1-[4-methyl-5-[2-4-carboxyethyl-1-hydroxyphenyl)]-azo-2-pyridyl]-sulfanilamide 
(PS) was synthesized and conjugated to klh, ova and bsa as described (Assil et al., 1992; 
Haasnoot et al., 2000a). 
 
Biotinylation of TS and PS 
TS (1.8 mg) or PS (2.6 mg), N-hydroxysuccinimide (NHS, 1.25 mg) and MEDC (4.8 
mg) were diluted in 300 µL DMSO and incubated overnight at room temperature while 
shacking. The mixture was added to a biotin-LC-PEO-amine solution (4.6 mg diluted in 400 
µL PBS). After shacking overnight at room temperature, the reaction mixture was brought to 
1 mL with PBS and aliquots of TS-bio and PS-bio were stored at –20°C. It was not necessary 
to separate the unreacted biotin from the biotin-labelled sulfonamide because no background 
signals were observed when using TS-bio or PS-bio in the antibody ciELISA. 
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Figure 8.3: Conjugation of sulfanilamide to proteins using a succinimide ester coupling method 
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Figure 8.4: carbodiimide mediated conjugation method. 
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Figure 8.5: Carbodiimide mediated coupling method for the conjugation of TS-
sulfonamide to proteins. The conjugation of PS-sulfonamide to protein was 
performed with the same procedure. 
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this risk, the final boost consisted of an intravenous (100 µg conjugate in sterile PBS) and an 
intraperitoneal injection (100 µg of conjugate emulsified in sterile PBS and IFA), and fusion 
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was performed 4 days later instead of three (for intravenous injection) or five (for 
intraperitoneal injections). In our hands, this procedure works excellent.  
Hybridomas were obtained by polyethylene glycol mediated fusion of SP2OAG/14 
mouse myeloma cells with splenocytes from immunized mice. The isolation of lymphocytes, 
the culturing of the myeloma cells, the polyethylene glycol mediated fusion and the cloning of 
the hybridomas were performed according to the procedures previously described (Harlow 
and Lane, 1988; Cliquet et al., 2001). The supernatants of the hybridomas were tested twice in 
the screening ELISA coated with TS-ova. Hybridomas exhibiting absorbances higher then 2.0 
were expanded to 24-well culture plates and tested for their specificity in the antigen ciELISA 
coated with PS-ova. The hybridomas with the highest specificity and sensitivity were cloned 
twice. 
 
Screening ELISA 
Microtiter plates were coated overnight at 4 °C with sulfonamide-protein conjugate 
(100 µL/well) diluted in bicarbonate coating buffer (0.05 M; pH 9.4). The plates were washed 
3 times with PBS containing 0.05% Tween®20 between each incubation step. Free binding 
sites were blocked with 200 µL of 5% glycine in coating buffer for 2 h at 37 °C. 
Subsequently, 100 µL/well of an appropriate dilution of sera or hybridoma supernatant in 
dilution buffer (PBS containing 3% bsa and 0.05% Tween®20), was added. The plates were 
incubated for 1 h at 37 °C. Then, 100 µL/well of rabbit anti-mouse immunoglobulins 
conjugated to peroxidase in dilution buffer was added for 1 h at 37 °C. Subsequently, 50 
µL/well enzyme substrate ABTS solution was added. After incubation at 37 °C, the 
absorbance was measured at 405 nm. 
 
Antigen-coated competitive inhibition ELISA (antigen ciELISA) 
The only difference between the antigen ciELISA and the screening ELISA was that 
in the former, the samples (sera and hybridoma supernatant) were incubated in the wells of 
the coated plate with a sulfonamide mixture (10 µg/mL) containing sulfamethazine, 
sulfadiazine, sulfadimethoxine and sulfathiazole, or with serial dilutions (concentrations 
ranging from 10 to 0.001 µg/mL) of a sulfonamide.  
The competition in the ELISA between a free sulfonamide in the sample and the 
coated sulfonamide was calculated with the formula: competition (%) = (1-(A/Ao))*100 with 
A= absorbance of a tested sample solution and Ao the absorbance of a similar solution without 
sulfonamide. 
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Antibody-coated competitive inhibition ELISA (antibody ciELISA) 
Microtiter plates were coated overnight at 4 °C with rabbit anti-mouse 
immunoglobulins (0.1 µg/100 µL/well) diluted in bicarbonate coating buffer. Between each 
step, the plates were washed 3 times with PBS containing 0.05% Tween®20. Free binding 
sites were blocked with 5% Tween®80 in coating buffer for 2 h at 37 °C. Then, 100 µL/well 
of an appropriate dilution of the monoclonal antibody in PBS (or only PBS for background 
measurements) was added for 1 h at 37 °C. Subsequently, sulfonamides in dilution buffer 
were added and incubated for 1 h at 37°C. Without washing the plates, a biotinylated 
sulfonamide in dilution buffer was added for 30 min at 37 °C. After washing 100 µL/well of 
streptavidine-peroxidase in dilution buffer was added for 30 min at 37 °C. Finally, the plates 
were washed again whereafter TMB solution (100 µL/well) was added. The absorbance was 
measured at 650 nm. 
 
Results 
 
Sulfonamide immunogens and antibody response 
Different sulfonamide-protein conjugates were used for immunization (Table 8.1). 
Smt-bgg and azocasein were commercially available. Sulfanilamide was coupled to albumins 
using glutaraldehyde or a succinimide ester as cross-linker, and using a diazotation reaction. 
Three sulfonamide derivatives were synthesized containing a carboxyl group in their side 
chain (PS, TS and S; Figure 8.6) and were linked to proteins using a carbodiimide coupling 
method. In these conjugates the common structure of sulfonamides was left unchanged, so 
that they could induce group-specific antibodies. 
Blood samples were collected two weeks after each immunization and were tested in 
ELISA for the presence of anti-sulfonamide antibodies (Tables 8.2 and 8.3).  
No sulfanilamide-specific antibodies were induced after immunization with the 
glutaraldehyde (sulfa-glut-albumin (1) and (2)) or succinimide (sulfa-MBS-albumin) 
conjugates. Sera of mice immunized with sulfa-bsa showed high absorbances in the ELISA 
coated with azocasein (Tables 8.2 and 8.3). However, the binding of these antibodies to 
azocasein could only be slightly inhibited by adding sulfonamides (Table 8.2). This was 
independent of the number of immunizations. Similarly, high absorbances were also detected 
for blood samples collected after immunizations with azocasein and analyzed in the ELISA 
coated with sulfa-bsa, and again only a slight inhibition was observed in the presence of 
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sulfonamides (Table 8.2). So again competition average remained low, independent of the 
number of immunizations. 
 
Table 8.1: Methods used for sulfonamide-protein conjugation 
Sulfonamide-protein conjugate Coupling method Hapten/protein ratio 
sulfa-glut-ova(1) Glutaraldehyde, method Van Regenmortel 165/1 
sulfa-glut-bsa(2), sulfa-glut-ova(2) Glutaraldehyde, method Martlbauer ND1 
sulfa-bsa Diazotation ND 
azocaseïn, smt-bgg Commercial conjugates No data available 
sulfa-MBS-bsa 
sulfa-MBS-ova 
Succinimide ester 
Succinimide ester 
10/1 
ND 
S-ova, S-bsa Carbodiimide 3/1 – 8/1 
PS-ova, PS-bsa, PS-klh Carbodiimide ND 
TS-ova 
TS-klh 
Carbodiimide 
Carbodiimide 
37/1 
ND 
1ND = not determined 
 
 
Figure 8.6: Structures of the sulfonamide derivatives. S-sulfonamide = N-sulfanyl-4-aminobenzoic 
acid; PS-sulfonamide = N1-[4-methyl-5-[2-4-carboxyethyl-1-hydroxyphenyl)]-azo-2-pyridyl]-
sulfanilamide; TS-sulfonamide = (N1-[4-(carboxymethyl)-2-thiazolyl]sulfanilamide. 
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Table 8.2: Immunogenicity of different sulfonamide-protein conjugates  
Antigen ciELISA 
Immunogen 
Number 
of mice 
Number of 
injections 
Dilution 
serum 
Coating antigen 
Absorbance1 
Average 
(SD) 
Competitor 
10 µg/mL 
Competition2  
average (SD) 
% 
Sulfa-glut-bsa(1) 2 4 100 Sulfa-MBS-ova -   
Sulfa-glut-ova(2) 2 4 100 Sulfa-MBS-bsa -   
Sulfa-MBS-bsa 2 4 100 Sulfa-glut-ova(1) -   
Sulfa-bsa 2 9 1000 Azocaseïn +++   (+) Smix3 < 20% 
Azocaseïn 4 7 1000 Sulfa-bsa +++   (++) Smix < 20% 
Smt-bgg 3 7 1000 S-albumin +  ( +) Sulfanilamide < 20% 
   1000 TS-ova4 ++++ Smix 80 % 
S-albumin 12 4 1000 S-albumin5 ++++  (+) Smix < 20% 
TS-klh 6 3 (2) 10000 TS-ova +++  (++) Smix 79 (10) 
   10000 PS-ova + (+) Smix 44 (36) 
TS- & PS-klh 4 4 10000 TS-ova ++  (++) Smix 65 (12) 
   10000 PS-ova ++ (++) Smix 60 (32) 
1Scores are given for the average of the absorbance obtained in the antigen ciELISA for the sera of a number of 
mice in absence of competitor: - = < 0.200; + = 0.200 – 0.500; ++ = 0.500 – 1.000; +++ = 1.000 – 1.800; ++++ 
= > 1.800.  
2Competition (%) = [100 – (absorbance in presence of competitor/ absorbance in absence of competitor)] x 100 
3Smix = mixture of four sulfonamides (sulfamethazine, -diazine, -dimethoxine and –thiazole) at a final 
concentration of 10 µg/mL 
4Sera of the best responding mouse 
5The albumin of the coating antigen was different from the one in the immunogen. 
 
Three mice were immunized with smt-bgg. The sera of the best responding mouse 
reacted with azocasein, sulfa-bsa, S-ova and TS-ova (Table 8.3), and showed 80% inhibition 
in the presence of 10 µg/mL of a mix of sulfonamides in the ciELISA coated with TS-ova 
(Table 8.2). This means that the antibodies recognized a common structure. Unfortunately, 
this mouse died. The antibody titers of the other mice did not became high enough, even after 
seven immunizations. 
Immunizations with the S-conjugates led to high antibody responses, highly specific 
for the S-conjugates (Table 8.3). However, the free S-molecule was only weakly recognized 
(data not shown) as were the 4 sulfonamides in the competitor mixture (at a concentration of 
10 ppm, less than 20% inhibition was observed, table 8.2). Fusion experiments with the 
splenocytes of mice immunized with these conjugates did not result in any group-specific 
mAb. 
High antibody responses were also obtained after immunizations with the PS- and TS-
klh conjugate. Sera tested in the antigen ciELISA had titers from 100 000 to 300 000 on TS-
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ova coating (Table 8.3). Furthermore, these antibodies could be inhibited in the ELISA with 
different sulfonamides (Table 8.4). Lower titers (20 000 tot 50 000) were obtained on PS-ova 
coating (Table 8.2). No response was measured in the ELISA coated with azocasein, sulfa-bsa 
or S-ova (Table 8.3). 
 
Production of mAb 
Three mice (m90, m98 and m95, table 8.4) differently immunized with TS- and PS- 
conjugates were selected for fusion experiments. In table 8.4 the cross-reactivities are given 
for different sulfonamides detected in the antigen ciELISA with sera of the three mice. The 
three sera had the highest affinity for sulfachloropyridazine and sulfathiazole, a lower affinity 
for sulfadiazine, -dimethoxine and –pyridine, and the lowest affinity for sulfamethazine, -
merazine and sulfisoxazole. The sensitivity of the three sera for sulfonamides was higher in 
the ELISA coated with PS-ova as compared to TS-ova. 
 
Table 8.3: Reactivity of sera on different coating antigens in a screening ELISA. The results of the 
sera obtained from the best responding mouse of each group immunized with different immunogens, 
are presented. 
 Reactivity1 of sera on different coating antigens 
Immunogen Azocasein Sulfa-bsa S-ova TS-ova ova bsa 
Smt-bgg ++ +++ ++ ++++ - - 
Azocaseïn ++++ ++++ - - - - 
Sulfa-bsa +++ ++++ - - - - 
S-bsa + + ++++ - - + 
TS-&PS-klh - - - ++++ - - 
TS-klh - - - ++++ - - 
1Scores are given for the absorbance obtained in the screening ELISA for 1/1000 diluted sera: - = < 0.200; + = 
0.200 – 0.500; ++ = 0.500 – 1.000; +++ = 1.000 – 1.800; ++++ = > 1.800.  
 
The antigen ciELISA 
The cross-reactivities of the mAb for sulfonamides were determined in the antigen 
ciELISA coated with PS-ova (Table 8.5). The antibodies could be divided into three groups. 
The mAb of group I had a very high affinity for sulfathiazole, -methoxazole and –
chloropyridazine, but also recognized sulfadiazine, -dimethoxine and –pyridine at an 
acceptable level. The antibodies were at least ten times less reactive to sulfamethazine and –
merazine. The antibodies of group II had the same reactivities as group I, except that the 
sensitivity for sulfamethazine and –merazine was at least four times higher. The mAb also 
recognized sulfadiazine at least four times better than group I. Group III showed better 
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recognition of sulfamethazine and –merazine as compared to –diazine and -dimethoxine. But 
the recognition of both latter was at least four times lower as for group II. The antibodies 
seemed to recognize sulfamethazine and –merazine in the same way. However, mAb 27G3 
(Group IV, Haasnoot et al., 2000a) obtained after TS-klh immunization, had higher affinity 
for sulfamerazine as compared to –methazine. 
 Cross-reactivities of mAb 3B5B10E3 were determined for structural related molecules 
and drugs currently administered together with sulfonamides: diuretics (Furosemide, 
acetazolamide, hydrochlorothiazide, bumetanide), thiamphenicol, florphenicol, lidocaine and 
para-aminobenzoic acid (PS-ciELISA). The diuretics only have the –SO2NH- group in 
common with sulfonamides. Thiamphenicol and florphenicol have a –SO2- group, lidocaine 
has nothing structural in common with sulfonamides. Para-aminobenzoic acid contains the 
common sulfonamide p-aminobenzoyl ring. The monoclonal recognized all four diuretics 
(IC50 > 10 µg/ml), but none of the other molecules. This indicates that the epitope recognized 
by the monoclonal contains the –SO2NH- group. Substitution of this sulfonamide-group on a 
benzene ring favors the binding of the monoclonal since sulfonamides are recognized with 
higher sensitivity (IC50 < 1 µg/ml; table 8.6). 
 
Table 8.4: Cross-reactivities1 (IC50, ng/mL) for different sulfonamides of three mice sera (m90, m95 
and m98) in the antigen ciELISA (coated with PS-ova)  
Mouse m90 m95 m98 
Immunogen 
TS-klh (2x),  
PS-bsa (2x) 2 
TS-klh (2x),  
PS-klh (1x) 2 
TS-klh (3x) 
Coating  PS-ova TS-ova PS-ova TS-ova PS-ova TS-ova 
Dilution serum 1/5000 1/20000 1/8000 1/20000 1/8000 1/20000 
Sulfonamide (sulfa-) IC50 (ng/mL) 
-chloropyridazine 7 100 30 400 30 600 
-thiazol 7 85 30 150 3 100 
-diazine 70 600 500 800 300 7000 
-dimethoxine 400 3000 500 3000 600 1500 
-pyridine 150 900 800 4000 1000 4000 
-methazine 1000 >10000 10000 >10000 10000 >10000 
-merazine 600 >10000 4000 >10000 10000 >10000 
sulfisoxazole 3000 3000 10000 4000 >10000 >10000 
1the cross-reactivities = concentration of a sulfonamide (ng/mL) required to obtain 50% inhibition (IC50) in the 
antigen ciELISA. 
2alternated injected with TS-klh and PS-bsa or PS-klh 
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Table 8.5: Cross-reactivities1 (IC50, ng/mL) for different sulfonamides of different monoclonal antibodies in the antigen ciELISA (coated with PS-ova)  
GROUP  I II III IV 
Mouse m95 m95 m98 m98 m98 m98 m90 m95 Haasnoot2 
Monoclonal  
antibody 
6
H
1
2
H
3
 
1
8
E
1
D
9
 
1
7
D
1
1
E
6
 
1
1
F
5
D
5
B
1
2
 
1
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1
2
B
1
1
G
5
 
3
A
1
0
E
3
 
3
B
5
B
1
0
E
3
 
1
4
D
6
D
6
 
1
4
D
6
C
9
 
2
7
G
3
A
9
B
1
0
 
sulfathiazole 20 7 5 10 15 < 20 30 350 10 
sulfamethoxazole 20 7 9 10 15 < 20 9 1000 150 
sulfachloropyridazine 30 10 15 40 30 < 20 < 20 600 4 
sulfadiazine 1000 300 250 500 1000 60 30 >10 000 80 
sulfadimethoxine 1000 150 200 500 1000 200 100 >10 000 250 
sulfapyridine 1000 300 300 1000 2000 400 350 3000 30 
sulfamethazine >10 000 4000 8000 >10 000 >10 000 1050 1050 4000 8000 
sulfamerazine >10 000 4000 8000 >10 000 >10 000 700 600 4000 500 
sulfisoxazole >10 000 10 000 6000 >10 000 >10 000 400 350 >10 000 250 
1The cross-reactivities = concentration of a sulfonamide (ng/mL) required to obtain 50% inhibition (IC50) in the antigen ciELISA. 
2Haasnoot et al. (2000a) 
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Table 8.6: Cross-reactivity1 (IC50, ng/mL) and limit of detection2 (LOD, ng/mL) for different 
sulfonamides in buffer solution detected with mAb 3B5B10E3 in the antigen ciELISA (coated with 
PS-ova) and in the antibody ciELISA. 
 Antigen ciELISA Antibody ciELISA 
 LOD (ng/mL) IC50 (ng/mL) LOD (ng/mL) IC50 (ng/mL) 
sulfathiazole 5 30 3 50 
sulfamethoxazole < 1 9 < 1 10 
sulfachloropyridazine < 1 < 20 ND ND 
sulfadiazine 6 30 3 50 
sulfadimethoxine 50 100 30 500 
sulfapyridine 80 350 70 1050 
sulfamethazine 300 1050 400 4000 
sulfamerazine 200 600 ND ND 
sulfisoxazole 80 350 200 2000 
1The cross-reactivities = concentration of a sulfonamide (ng/mL) required to obtain 50% inhibition (IC50) in the 
antigen ciELISA. 
2Limit of detection = concentration read from the calibration curve at a response (absorbance) minus 3 standard 
deviation from the mean (n=12) for the zero standard (buffer sample without sulfonamides) 
 
 
The antibody ciELISA 
Monoclonal antibody 3B5B10E3 of group II was selected to develop an antibody 
ciELISA. Therefore, the mAb was captured on an ELISA-plate precoated with mouse-specific 
polyclonal antibodies. Furthermore, competition of sample sulfonamide for binding to the 
mAb was done using TS-biotin because with PS-biotin, no or very little absorbances were 
obtained. The cross-reactivity values (IC50) and limit of detection (LOD, Babiel et al., 1993) 
were determined for different sulfonamides in buffer solution analyzed in the antigen 
ciELISA and in the antibody ciELISA (Table 8.6). Most of the sulfonamides were recognized 
with the same sensitivity (LOD) in both ELISAs.  
 
Discussion 
 
The aim of this study was the production of mAb specific for all sulfonamides. With 
such antibodies, a sensitive, group-specific immunoassay could be developed for the detection 
of sulfonamides in food products. 
Our first approach was the use of sulfanilamide as hapten since it is the common 
structure of all sulfonamides and it does not have a “disturbing” side group. Antibodies 
against sulfanilamide should be group-specific. Different coupling methods were applied to 
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link sulfanilamide to proteins using glutaraldehyde (sulfa-glut-albumin (1) and (2)) or a 
succinimide (sulfa-MBS-albumin) as cross-linker or by diazotation (sulfa-bsa and azocasein). 
No immune response was obtained after immunization with the sulfa-glut-albumin or sulfa-
MBS-albumin. For the glutaraldehyde coupling with the procedure of Van Regenmortel 
(1988), a sulfa-glut-ova (1) conjugate was developed with a molar incorporation of 165/1 
(Table 8.1). The reaction of glutaradehyde with proteins involves mainly lysine residues, as 
well as the α-amino group and sulfhydryl group of cysteine residues of the protein. 
Ovalbumin has 20 lysine and 4 cysteine residues accessible for glutaraldehyde conjugation 
and therefore the highest molar incorporation possible is 24/1, if a one to one ratio is 
respected. However, glutaraldehyde can form polymers (Van Regenmortel, 1988; Hermanson, 
1996). This property in combination with the high ratio of sulfanilamide / ovalbumin (400/1) 
mixture used for coupling could explain the high coupling ratio of 165/1. The absence of 
immune response using this sulfa-glut-ova (1) conjugate could be due to the high load of 
hapten on the carrier protein. Ideally, a hapten/protein ratio of 5-20 is needed to obtain a good 
immunogen (Van Regenmortel, 1988). Therefore the glutaraldehyde procedure according to 
Märtlbauer (20) was applied (sulfa-glut-albumin (2)). Märtlbauer (1993) reported 
sulfonamide conjugates using this method with a molar incorporation of 7/1 and high 
antibody titers after immunization. However, our conjugates were still not immunogenic. 
Unfortunately, the hapten/protein ratio was not determined. Haasnoot et al. (2000b) also did 
not determine the molar incorporation ratio and obtained only low titers after immunization 
with several sulfonamide-protein conjugates linked by glutaraldehyde. In previous work 
(Cliquet et al., 2001), we immunized mice with ampicillin coupled to albumins using the 
glutaraldehyde procedure according to Märtlbauer (coupling efficiency of 8 to 16) and also 
found the conjugates to be weak immunogens.  
 
The molar incorporation of our sulfa-MBS-albumin conjugates (10/1, table 8.1) was in 
accordance with other studies (Kitagawa et al., 1988; van de Water, 1990; Cliquet et al., 
2001). In previous work we constructed ampicillin-MBS-albumin conjugates with a 
hapten/protein ratio of 8/1 to 13/1 but obtained only a moderate immune response (Cliquet et 
al., 2001).  
High antibody titers were obtained after immunization with the diazotation conjugates 
sulfa-bsa and azocasein. However, these antibodies could only be slightly inhibited in ELISA 
by free sulfonamides or even sulfanilamide. This means that the antibodies were highly 
specific for the bound sulfanilamide molecule. The diazotation reaction was used by others 
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for the development of antibodies specific for sulfamethazine (Fleeker and Lovett, 1985), 
sulfamerazine (Garden and Sporns, 1994) and sulfathiazole (Sheth et al., 1990) leading in all 
cases to antibodies able to recognize the respectively free sulfonamide molecule. 
Sulfanilamide does not have a side chain like sulfamethazine, -merazine and –thiazole and 
this could be the reason why only low amounts of sulfanilamide-specific antibodies were 
obtained. The available epitope in the sulfanilamide conjugates is probably build up by the 
linkage at the aromatic amino group (N4) and the benzene ring (Figure 3.1, chapter 3).  
 
Our second approach was the use of sulfonamide-protein conjugates in which the 
sulfonamide is linked at its side chain, leaving the common group unchanged. In the 
commercially available smt-bgg conjugate sulfamethazine was linked through its pyrimidin 
ring to bovine gamma globulin (bgg). Polyclonal antibodies obtained after immunization with 
this antigen are also commercially available. These antibodies recognized several 
sulfonamides and therefore the antigen was believed to induce group-specific antibodies. 
Especially one of the three mice immunized with this smt-bgg indeed produced sulfonamide-
specific antibodies. Unfortunately, no fusion experiments could be performed with the 
splenocytes of this mouse.  
 
Immunizations with the N-sulfanilyl-4-aminobenzoic acid-protein conjugates (S-
conjugates) led to a large production of antibodies (high absorbances), but all of them were 
highly specific for the conjugates. Fusion experiments with the splenocytes of mice 
immunized with the S-albumin conjugates did not result in any group-specific antibody. 
Muldoon et al. (1999) used the same sulfonamide derivative coupled to klh. Only one of five 
immunized mice produced high titers of antibodies able to recognize other sulfonamides. 
Fusion experiment resulted in only one monoclonal antibody specific for the group of 
sulfonamides.  
 
Using the sulfonamide derivatives of Sheth and Sporns (1991) and Assil et al. (1992) 
was more successful. Haasnoot et al. (2000a; 2000b) also used the same approach and found 
out that immunization of mice with PS-klh led to the recognition of sulfonamides 
(sulfamethazine, -merazine, -diazine, -dimethoxine) that were not well recognized after TS-
klh immunization. Consequently, we tried to guide the immune response in the direction of 
recognition of the common sulfonamide structure by immunizing the animals alternately with 
TS- and PS-protein conjugates. All mice immunized with TS-klh showed high titers in the 
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ELISA with TS-ova coating. As expected from the results of Haasnoot et al. (2000a; 2000b), 
immunization with PS-bsa or PS-klh did not induce a high increase of the titer. However, the 
mouse only immunized with TS-klh had a lower antibody binding to sulfonamides containing 
a pyrimidinyl group (sulfamethazine, -merazine, -diazine) or a pyridinyl group (sulfapyridine) 
than the alternately immunized mice (Table 8.4). The detection of the sulfonamides was 
improved when the ELISA was coated with PS-ova as compared to TS-ova.  
 
In contrast to the group-specific serum antibodies of the mouse immunized with smt-
bgg, serum of the mouse immunized with TS-klh did not bind to coated azocasein, sulfa-bsa 
or S-ova (Table 8.3). Probably, the major epitope recognized by the TS-klh antibodies is more 
positioned toward the side chain of the sulfonamides, and therefore binding of these 
antibodies to the conjugated sulfanilamide or S-molecule could be sterically inhibited by the 
carrier protein. The major epitope recognized by the smt-bgg antibodies is probably more 
located at the side of the common sulfonamide structure and antibody binding is therefore less 
influenced by the side chain. 
 
The mAb obtained after fusion experiments with the splenocytes of mice immunized 
with TS-klh could be divided, based on their cross-reactivities, in three groups, independently 
from which mouse they were deduced. This means that alternately immunization with two 
different immunogens will improve the broad specificity of the polyclonal serum but not of 
the individual mAb. Consequently, to obtain broad specific mAb, it would be sufficient to 
immunize with TS-klh, and to screen the hybridomas in ELISA coated with PS-ova.  
 
Two ELISA-systems, an antigen-coated and an antibody-coated ciELISA, were 
constructed with mAb 3B5B10E3. Almost all tested sulfonamides were detected with the 
same sensitivity in both ELISA. Because the sensitivity of the antigen ciELISA was improved 
when PS-ova was used as coating antigen compared to TS-ova, the sensitivity of the antibody 
ciELISA would probably be improved using the biotinylated PS-sulfonamide PS-bio instead 
of TS-bio. However, very little absorbances were obtained with PS-bio.  
Most sulfonamides, except sulfamethazine and sulfamerazine, can be detected in 
buffer solution at the MRL (100 ppb) in the antigen ciELISA with mAb 3B5B10E3. On the 
other hand, a lot of sulfamethazine-specific immunoassays already exist. Most of the time, 
such assays cross-react with sulfamerazine. Due to the diversity of the sulfonamide side 
chain, a broad specific immunoassay for sulfonamides using one monoclonal antibody is 
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probably not possible. Most likely, two or three immunoassays, each with a different 
monoclonal, have to be used for the screening of food products (Muldoon et al., 2000; 
Haasnoot et al., 2000a; Haasnoot et al., 2000c, Haasnoot et al., 2003). Haasnoot and 
coworkers (2000c) could detect sixteen sulfonamides in the BIAcore 2000 biosensor using a 
mixture of three group-specific monoclonal antibodies. However, a group-specific 
sulfonamide ELISA based on the use of several monoclonals has not been described yet. In 
further work, the detection of sulfonamides in meat samples using the antigen ciELISA with 
mAb 3B5B10E3 will be investigated. 
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Chapter 9 
 
 
Extraction procedure for sulfachloropyridazine in 
porcine tissues and detection in a sulfonamide-
specific ELISA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on: P. Cliquet, E. Cox, W. Haasnoot, E. Schacht and B. M. Goddeeris. Extraction 
procedure for sulfachloropyridazine in porcine tissues and detection in a sulfonamide-specific 
ELISA. Analytica Chimica Acta, 2003, 494, 21-28. 
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Abstract 
 
Sulfonamide-specific polyclonal rabbit antibodies were obtained after immunization 
with a sulfathiazole derivative (N1-[4-(carboxymethyl)-2-thiazolyl]sulfanilamide = TS) 
coupled to keyhole limpet hemocyanin. Using these antibodies, two sulfonamide-specific 
ELISAs were developed differing in coating antigen: TS-ovalbumin (TS-ova) and PS-
ovalbumin (PS-ova, PS = N1-[4-methyl-5-[2-4-carboxyethyl-1-hydroxyphenyl)]-azo-2-
pyridyl]-sulfanilamide). The detection of sulfamethazine, sulfamerazine, sulfadimethoxine, 
sulfadiazine, sulfathiazole, sulfapyridine, sulfachloropyridazine and sulfisoxazole in buffer 
was analysed. Higher antibody titers were obtained in the ELISA coated with TS-ova (TS-
ciELISA) as compared to the ELISA coated with PS-ova (PS-ciELISA), but the detection of 
sulfonamides was more sensitive in the PS-ciELISA, allowing the detection of all tested 
sulfonamides at the MRL-value (100 ng/ml).  
 
In a subsequent step, an extraction procedure was developed for the detection of 
sulfonamides, in muscles, kidney, liver and fat, by both ELISAs using sulfachloropyridazine 
as model. As extraction buffer a carbonate/bicarbonate buffer (pH 10) was chosen in which 
sulfonamides are highly soluble. Differences in homogenizing techniques (high-speed mixer 
(ultraturax) versus vortex) and the effect of kaolin (hydrated aluminum silicate) treatment, to 
diminish the background signal in ELISA, were evaluated. The best extraction procedure was 
the one using a vortex mixer as homogenizer and no kaolin treatment. Sulfachloropyridazine 
was easily detected at the MRL in all tissues.  
 
The decision limit and detection capability for sulfachloropyridazine in porcine 
kidneys were determined (CCα = 9.4 ppb, CCβ = 12.9 ppb). Good correlations were found 
between the PS-ciELISA and LC-MS/MS for the analysis of incurred porcine liver and 
kidney samples (r2 = 0.88 and 0.77, respectively). 
 
Keywords: Sulfonamide – ELISA – extraction procedure - porcine tissues 
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Introduction 
 
Sulfonamides are chemotherapeutics widely used in veterinary medicine for the 
treatment of bacterial infections, and as feed additive (Long et al., 1990). As a result, 
sulfonamides can occur in food products from animal origin (Franco et al., 1990). To protect 
consumers from risks related to drug residues, maximum residue levels (MRL) have been 
established by law. In Europe, Canada and the United States, the MRL for the total amount of 
sulfonamides in edible tissues is 100 µg/kg (Anonymous, 1991; Anonymous, 1999). In Japan, 
this MRL is 20 µg/kg. Detection methods for sulfonamides include bioassays, thin-layer 
chromatography (TLC) and High Performance Liquid Chromatography (HPLC, LC-MS/MS). 
Liquid chromatography is a sensitive and specific assay but is also very laborious and 
expensive. The method is very suitable for confirmation but not for screening of large 
amounts of samples. A rapid, sensitive and specific assay is needed to pick up positive 
samples in routine analyses, which then can be confirmed for the presence of sulfonamides by 
liquid chromatography. Therefore, during the past ten years, a variety of immunoassays were 
developed, each highly specific for an individual sulfonamide (Fleeker and Lovett, 1985; 
Dixon-Holland and Katz, 1988; Sheth and Sporns, 1990; Garden and Sporns, 1994; Muldoon 
et al., 2000a; Lee et al., 2001; Spinks et al., 2001). However, it would be more efficient to 
have one immunoassay able to detect all sulfonamides instead of an immunoassay for each 
individual sulfonamide (Sheth and Sporns, 1991; Assil et al., 1992; Muldoon et al., 1999; 
Spinks et al., 1999; Haasnoot et al., 2000a; Haasnoot et al., 2000b; Li et al., 2000). 
The sulfonamides share a common p-aminobenzoyl ring moiety with an aromatic 
amino group at the N4-position and differ in the substitution at the N1-position. For the 
group-specific detection of sulfonamides, sulfonamide-specific competitive ELISAs were 
developed with polyclonal antibodies against the aromatic amino group. In the present study, 
the detection of different sulfonamides in buffer solution using these ELISAs and the 
development of an appropriate extraction procedure for the detection of sulfachloropyridazine 
in porcine tissues is described. The aim of our study was to develop a simple procedure that 
can be applied in further work for the extraction of all sulfonamides in porcine kidney as well 
as liver, muscle and fat. For homogenizing sample and extraction buffer the use of a rigorous 
method (ultraturax high speed mixer) was compared to a simple shaking method (vortex 
mixer). In previous experiments in which an extraction procedure for the detection of 
penicillins in meat samples was developed, kaolin treatment was found to be very efficient to 
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diminish background signals in ELISA (personal communication). In the present study, it was 
assessed if such a treatment was needed for the analysis in the sulfonamide-specific ELISAs. 
 
Material and methods 
 
Reagents 
Sulfathiazole, sulfadiazine, sulfamethazine, sulfadimethoxine, sulfapyridine, 
sulfamerazine, sulfisoxazole, sulfachloropyridazine, para-aminobenzoic acid, bovine serum 
albumin (bsa), ovalbumin (ova), kaolin (hydrated aluminum silicate) and 3,3’,5,5’-
tetramethylbenzidine (TMB) were purchased from Sigma-Aldrich (Bornem, Belgium). 
Furosemide, acetazolamide, hydrochlorothiazide, bumetanide, thiamphenicol, florphenicol 
and lidocaine were a kindly gift of the Department of Pharmacology, Pharmacy and 
Toxicology, Faculty of Veterinary Medicine, Ghent University. The TMB substrate solution 
was prepared by adding 3.3 mg TMB in 250 µl DMSO to 25 ml phosphate-citrate buffer 
(0.1M citric acid + 0.2M Na2HPO4; pH 4.3) containing 3.25 µl of a 30 % H2O2 solution. 
Dimethylsulfoxide (DMSO) was from VWR (Leuven, Belgium). Complete Freund’s adjuvant 
(CFA) and incomplete Freund’s adjuvant (IFA) were provided by Difco Laboratories, 
Biotrading (Bierbeek, Belgium). Tween®20 (polyoxyethylene sorbitan monolaurate) was 
purchased from Merck-Belgolabo (Overijse, Belgium). Swine anti-rabbit immunoglobulins 
(code n°P0217) conjugated to peroxidase were obtained from DAKO Diagnostica (Prosan, 
Ghent, Belgium). ELISA microtiter plates (maxisorp®) were from NUNC (Life technologies, 
Merelbeke, Belgium). All other chemicals were of reagent grade.  
 
Synthesis of sulfonamide-protein conjugates 
N1-[4-methyl-5-[2-4-carboxyethyl-1-hydroxyphenyl)]-azo-2-pyridyl]-sulfanilamide 
(PS) was synthesized at the State Institute for Quality Control of Agricultural Products 
(RIKILT, Wageningen, Netherlands) and conjugated to ovalbumin (PS-ova) as previously 
described (Assil et al., 1992; Haasnoot et al., 2000a). 
 
The sulfathiazole derivative (N1-[4-(carboxymethyl)-2-thiazolyl]sulfanilamide (TS) 
was synthesized in the Laboratory of Organic Chemistry (Faculty of Sciences, Ghent 
University) as described (Sheth and Sporns, 1991). The TS-molecule was coupled to the 
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proteins keyhole lympet hemocyanin (klh) and ovalbumin (ova) according to Haasnoot et al. 
(2000a), resulting in the conjugates TS-klh and TS-ova. 
 
Production of polyclonal antibodies 
New Zealand white rabbits were immunized subcutaneously with 100 µg of the TS-
klh conjugate. For the first immunization, the conjugate was emulsified in 500 µl sterile saline 
and 500 µl complete Freund’s adjuvant. For all subsequent immunizations, at six weeks 
interval, incomplete Freund’s adjuvant was used. Blood was sampled two weeks after each 
immunization. The serum was collected (3000 g, 20 min) and treated with kaolin (hydrated 
aluminum silicate) (Van den Broeck et al., 1999). Therefore one part of serum was mixed 
with four parts of kaolin and incubated for 30 min at room temperature. The mixture was 
centrifuged (3000 g, 20 min) and the supernatant was stored frozen. The antibodies pAb K3 
were analysed in the competitive inhibition ELISA. 
 
Competitive inhibition ELISA coated with TS-ova (TS-ciELISA) or with PS-ova (PS-
ciELISA) 
 Microtiter plates were coated overnight at 4 °C with PS-ova or TS-ova (1 µg/ml; 100 
µl/well) diluted in coating buffer (bicarbonate buffer, 0.05 M, pH 9.4). Between each 
incubation step, the plates were washed 3 times with phosphate buffered saline (PBS, 0.15 M 
pH 7.4) containing 0.05% Tween® 20. Free binding sites were blocked with 200 µl of 5 % 
glycine in coating buffer for 2 hours at 37 °C. Subsequently, 100 µl of the samples (tissue 
extract or standard dilution of sulfachloropyridazine in PBS) together with 100 µl of an 
appropriate dilution of pAb K3 in PBS containing 3% BSA and 0.05% Tween® 20, were 
added to the wells (specific absorbance). For background measurement, the samples were 
added without pAb K3 (background absorbance). The plates were incubated for 1 hour at 37 
°C. Then, 100 µl of the peroxidase labelled swine anti-rabbit immunoglobulins (diluted in 
PBS containing 0.05% Tween® 20) were added for 1 hour at 37 °C, whereafter 50 µl TMB 
substrate solution was added. Subsequently, the plates were incubated at 37 °C for 30 
minutes. The colour development was measured at 650 nm using an ELISA reader 
(Spectrafluor, TECAN) and presented as absorbance or optical density (OD). 
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Interpretation of the ciELISA results 
 The competition in the ciELISA between a free sulfonamide in the sample and the 
coated sulfonamide was calculated with the formula: competition (%) = (1-(A/Ao))*100 with 
A= absorbance of a tested sample solution and Ao the absorbance of a similar solution without 
sulfonamide. 
 A calibration curve was constructed plotting the concentration (log) of 
sulfachloropyridazine in the standard dilution against the competition values obtained for the 
corresponding dilutions. The concentration of sulfachloropyridazine in the spiked tissues was 
calculated by extrapolation of the competition values, obtained for these tissue samples, in the 
calibration curve.  
 Recoveries (RC, %) were calculated with the formula: (calculated concentration 
sulfachloropyridazine in the tissue sample / spiked concentration sulfachloropyridazine in the 
tissue sample) x 100. The mean tissue sample recovery, the standard deviation (SD) and 
standard error of the mean (SEM) were calculated. The variation coefficient of the mean 
recovery (CV, %) was calculated with the formula: (SD / mean)*100.  
The differences between the mean specific absorbances (with pAb K3) obtained for 
tissue sample and buffer sample without sulfonamides were compared using the Student t-test 
for independent samples. The same was done for the mean background absorbance  (no pAb 
K3). 
 
Development of an extraction procedure 
Porcine tissues spiked with sulfachloropyridazine were used to evaluate five extraction 
procedures differing in homogenizing method, volume of extraction buffer and treatment with 
kaolin (Table 9.1). During each procedure the tissue samples were diluted ten times. 
 
Preparation of spiked tissue samples 
 Negative pork tissues (kidney, liver, fat and muscle) were obtained at slaughter from 
animals reared on an experimental unit, without sulfonamide treatment. The tissues were 
minced with a conventional kitchen mixer (Multi chop, CH100, 250 Watt, Braun) and stored 
at -80°C until use. Prior to analysis, the minced tissues were removed from the freezer. One 
gram of tissue was brought into a 50 ml tube (Cellstar®, Greiner bio-one, Wemmel, Belgium) 
and spiked with 50 µl of an appropriate sulfachloropyridazine solution. For example, to obtain 
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a sample spiked with sulfachloropyridazine at 100 ng/g, 50 µl of a solution of 2 µg/ml of the 
sulfonamide diluted in PBS was added to one gram of minced tissue. 
 
Three tot six samples were prepared per concentration and the extracts were analysed 
in triplicates in the TS-ciELISA or in the PS-ciELISA. In the TS-ciELISA, 
sulfachloropyridazine can be detected in the range of 10 to 1000 ng/ml, and therefore spiked 
kidney tissues of 500, 1000 and 1500 ng/g sulfachloropyridazine were prepared, which 
became diluted ten times during the extraction giving extracts with 50, 100 and 150 ng/ml 
sulfachloropyridazine. For the analysis in the PS-ciELISA (detection range of 0.2 to 20 
ng/ml), spiked samples of 200, 100 and 50 ng/g were prepared. 
  
Choice of an appropriate extraction buffer 
 The solubility of different sulfonamides (sulfanilamide, sulfacetamide, 
sulfachloropyridazine, -pyridine, - thiazole, -diazine, -dimethoxine, -methazine, -
methoxazole, -methizole and sulfisoxazole) in a carbonate-bicarbonate buffer pH 10 (0.2 M 
Na2CO3, 0.2 M NaHCO3, distilled water, 1.22:1:6.62; v/v/v) was analysed. Hereto, the 
amount of buffer required to completely dissolve 1 mg of a given sulfonamide was 
determined.  
 
Homogenization of sample and extraction buffer 
Four (Table 9.1, procedure 1, 4 and 5) or 9 ml (Table 9.1, procedure 2 and 3) 
extraction buffer was added to one gram of spiked samples.  
Two methods for homogenizing of the sample with extraction buffer were compared: a 
rigorous method with an ultraturax high speed mixer (Heidolph DIAX 900, Germany, speed 
2, 1 min) (Table 9.1, procedure 1, 2 and 4) or a milder method by shaking with a vortex 
(Labinco L46, The Netherlands) at full speed for two minutes (Table 9.1, procedure 3 and 5).  
 
Heating of the samples 
Glucuronide metabolites of sulfonamides are formed in incurred tissues during storage 
(Haasnoot et al., 1996; Korsrud et al., 1996; Thomas et al., 1997; Alfredsson and Ohlsson, 
1998; Smit et al., 1999). Since incurred samples cannot always immediately be tested, the 
presence of glucuronide metabolites can cause false-negative results. These metabolites were 
not formed in the spiked samples because the incubation time of the sulfonamides with the 
meat matrix was too short. Glucuronide metabolites can be reconverted into free sulfonamide 
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molecules by heating or under acidic condition (Thomas et al., 1997, Smit et al., 1999) or 
using β-glucuronidase from Helix pomatia (Crabbe, 2002). Therefore, heating of the samples 
in a warm water bath at 90°C for 15 min. (Alfredsson and Ohlsson, 1998) was included in our 
extraction procedures. When analysing spiked samples, no differences were noted between 
the analysis of heat-treated and not treated samples in the ELISA (data not shown), indicating 
that heat treatment had no negative effect. 
 Centrifugation and pH adjustment 
The extracts were collected after centrifugation (10 000 g, 10 min, 4°C) of the 
homogenized tissue sample/buffer mixture and the pH was adjusted to pH 7-7.5 with HCl (1 
M).  
 
Kaolin treatment 
The tissue samples extracted with 4 ml buffer (Table 9.1, procedure 1, 4 and 5), were 
further diluted by adding 500 µl PBS to 500 µl extract or were treated with kaolin. 
Irrespective of the procedure, the final dilution of the tissue samples was ten times. 
Kaolin treatment was tested for two reasons:  
1) Kaolin treatment can remove any remaining fat or other disturbing components, so 
decreasing the background reading in ELISA (Van den Broeck et al., 1999). The kaolin 
treatment was evaluated for the samples extracted with 4 ml buffer (Table 9.1, procedure 1 
and 5). Hereto, 750 µl extract was mixed with 750 µl of a kaolin solution (25 % kaolin in 
PBS) and incubated for 30 min. at room temperature. Next, the kaolin was removed by 
centrifugation (10 000 g, 10 min) and 1 ml of the supernatant was diluted with 200 µl PBS.  
2) When muscle samples were mixed with the extraction buffer using the ultraturax, a 
solid mixture was obtained. No extract could be collected after centrifugation. Mc Cracken 
and coworkers (2000) also noticed that the use of high speed homogenizers can give rise to 
sample/solvent emulsions from which no extract can be collected after centrifugation. To 
circumvent this problem in the present study, the samples were not centrifuged but 
immediately treated with kaolin after ultraturax homogenization and heating (Table 9.1, 
procedure 4). Hereto, 5 ml kaolin solution (25 % kaolin in PBS) was mixed with the 
homogenized sample (tissue/extraction buffer mixture) and incubated for 30 min. at room 
temperature. After centrifugation, 220 µl PBS was added to 780 µl of the supernatant.  
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Origin of the incurred samples 
Four kidneys and 4 livers were obtained at slaughter from pigs treated with 
sulfachloropyridazine on an experimental unit (Department of Pharmacology, Pharmacy and 
Toxicology, Faculty of Veterinary Medicine, Ghent University). The tissues were stored at –
80°C.  
 
Table 9.1: Overview of five procedures for the extraction of sulfonamides in meat products 
 Extraction procedure 
 1 2 3 4 5 
volume  
extraction buffer 
4 ml 9 ml 9 ml 4 ml 4ml 
homogenization 
method 
ultraturax ultraturax vortex ultraturax vortex 
heating yes yes yes yes yes 
centrifugation yes yes yes no yes 
adjust pH yes yes yes yes yes 
kaolin yes or no no no yes yes or no 
 
 
Results and discussion 
 
Detection of sulfonamides in the ciELISA 
 
Specificity and limit of detection of the ELISA 
The polyclonal antibodies pAb K3 were obtained by immunizing rabbits with the TS-
klh conjugate. Therefore higher antibody titers were obtained in the ciELISA coated with TS-
ova (TS-ciELISA) than in the ciELISA coated with PS-ova (PS-ciELISA). However, the PS-
ciELISA was at least 8-times more sensitive as compared to the TS-ciELISA. In Table 9.2 the 
cross-reactivities (IC50 values) and limit of detection (LOD) are given for different 
sulfonamides (sulfadiazine, -thiazole, -chloropyridazine, -methazine, -pyridine, -dimethoxine, 
-merazine and sulfisoxazole) diluted in PBS, and analysed in both ciELISA. In the PS-
ciELISA, all tested sulfonamides were detected at the MRL-value (100 ng/ml). The LOD for 
all sulfonamides, except for sulfisoxazole, was lower than 10 ng/ml. Because the ciELISA is 
designed to detect sulfonamides in meat samples and because samples are diluted ten times 
during the extraction, the detection of sulfonamides in our ciELISA should be at least ten 
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times more sensitive than the MRL. This requirement is fulfilled for all tested sulfonamides, 
except for sulfisoxazole, in the PS-ciELISA but not in the TS-ciELISA. 
 
Table 9.2: The cross-reactivities1 (IC50, ng/ml) and limit of detection2 (LOD, ng/ml) for different 
sulfonamides analysed in the PS-ciELISA or TS-ciELISA 
 PS-ciELISA TS-ciELISA 
 LOD  IC50  LOD  IC50  
Sulfathiazole <1 3 <20 39 
Sulfadiazine 2 53 <200 780 
Sulfamethazine 3 326 <200 3125 
Sulfadimethoxine 5 >1000 <200 4700 
Sulfapyridine <1 9 <200 400 
Sulfamerazine 3 326 400 25000 
Sulfisoxazole 47 >1000 400 25000 
Sulfachloropyridazine <1 9 <200 400 
1The cross-reactivities = concentration of a sulfonamide (ng/ml) required to obtain 50% inhibition (IC50) in the 
ciELISA. 
2Limit of detection = concentration read from the calibration curve at a response (absorbance) minus 3 standard 
deviation from the mean (n=12) for the zero standard (sample without sulfonamides) 
 
Cross-reactivities of pAb K3 were determined for structural related molecules and 
drugs currently administered together with sulfonamides: diuretics (Furosemide, 
acetazolamide, hydrochlorothiazide, bumetanide), thiamphenicol, florphenicol, lidocaine and 
para-aminobenzoic acid (PS-ciELISA). The diuretics only have the –SO2NH- group in 
common with sulfonamides. Thiamphenicol and florphenicol have a –SO2- group, lidocaine 
has nothing structural in common with sulfonamides. Para-aminobenzoic acid contains the 
common sulfonamide p-aminobenzoyl ring. The polyclonals recognized p-aminobenzoic acid 
(IC50 > 10 µg/ml), but none of the other molecules. This indicates that the epitope recognized 
by the polyclonals contains p-aminobenzoyl ring. Substitution of the sulfonamide-group on 
the common p-aminobenzoyl ring favors the binding of the polyclonals since most 
sulfonamides are recognized with higher sensitivity (IC50 < 1 µg/ml; Table 9.2). 
 
Repeatability of the ELISA 
 The repeatability of the PS-ciELISA (within-laboratory) was determined with the 
analysis of sulfachloropyridazine in buffer solution (5 different concentrations) repeated four 
times on the same day on the same assay (intra-assay variation), on six different assays (inter-
assay variation) and on six different days (inter-day variation).  
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The highest variation observed was 24% for the interday variation for a concentration 
of 1.25 ng/ml (Table 9.3). For immunoassays, the coefficient of variation should not exceed 
15 % (Crabbe, 2002). However, the level of interest is 10 ng/ml (ten times lower than the 
MRL). The variation around that level is acceptable. The inter-laboratory variation was not 
assessed. 
 
Table 9.3: Repeatability (Coefficient of variation, %) of the PS-ciELISA with pAb K3. 
 Coefficient of variation (%) for sulfachloropyridazine (ppb) 
 20 10 5 2.5 1.25 
Intra-assay 2-8 2-6 1-3 2-4 4-10 
Inter-assay 0-3 1-8 2-13 4-9 13-17 
Inter day 8 12 12 16 24 
 
Development of an extraction procedure 
The target organs for the detection of sulfonamides in the residue control program are 
the kidney, liver, fat and muscle tissues (Anonymous, 1996). In practice, mostly only the 
kidneys and sometimes also muscles are screened for sulfonamides. Therefore, the 
development of an appropriate extraction procedure was first assessed on spiked kidney 
tissues. The extracts were analysed in the TS-ciELISA. Next, the most suitable method for the 
analysis of kidneys was applied on the other tissues (muscle, liver and fat) and the extracts 
were analysed in the more sensitive PS-ciELISA. 
 
Choice of an appropriate extraction buffer 
Most of the time, organic solvents are chosen as extraction solvent for sulfonamides, 
for example methanol for the extraction of sulfonamides from porcine muscle tissues (Li et 
al., 2000), methanol for sulfachloropyridazine in beef and lamb muscle (Spinks et al., 2001), 
acetonitril for sulfathiazole in porcine liver (Lee et al., 2001). For sulfamethazine, phosphate 
buffered saline (PBS) has often been used (Dixon-Holland and Katz, 1988; Haasnoot et al., 
1996). Crooks and coworkers (Crooks et al., 2000) used a carbonate-bicarbonate buffer pH 10 
for the extraction of sulfamethazine from porcine tissues. A buffer like PBS or other aqueous 
solutions are user-friendlier than organic solvents. Because it is the intention to develop an 
extraction procedure that can be applied for the extraction of all sulfonamides, a buffer in 
which all sulfonamides are soluble should be used. The solubility of sulfonamides is 
increasing with pH and temperature (Budavari et al., 1988). Therefore, the solubility of the 
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sulfonamides mentioned in material and methods was determined in the carbonate-
bicarbonate buffer pH 10 and was at least 1 mg/ml. The MRL-value for sulfonamides is 100 
ng/g (100 ng/ml). Sulfonamides present in meat at the MRL can therefore easily be extracted 
with the carbonate/bicarbonate buffer pH 10. 
 
Comparison of five extraction procedures for the analysis of kidney samples 
Negative kidney samples and kidney tissues spiked with sulfachloropyridazine were 
extracted using the five procedures, differing in homogenization method (ultraturax or 
vortex), in volume of extraction buffer (4 or 9 ml), and in presence or absence of kaolin 
treatment (Table 9.1). Recoveries were determined for each spiked sample and the mean 
recovery (RC % ± SEM) was calculated (Table 9.4). The reproducibility of a procedure was 
defined as the variation of the mean recovery (coefficient of variation, CV %).  
 
Table 9.4: Recovery (RC % ± SEM) and reproducibility (CV %) of the extraction of 
sulfachloropyridazine from spiked porcine kidney tissues using five different extraction methods, and 
analysed in the TS-ciELISA. 
Extraction 
procedure 
Homogenization 
method 
Kaolin 
 treatment 
RC % ± SEM CV % 
1 Turax No 269 ± 43 49 
1 Turax Yes 98 ± 16 49 
2 Turax No 139 ± 24 31 
3 Vortex No 130 ± 8 11 
4 Turax Yes 97 ± 32 57 
5 Vortex No 95 ± 6 10 
5 Vortex Yes 67 ± 7 18 
 
Lower recoveries were obtained when kaolin treatment was included in the extraction 
procedure (procedure 1 and 5). Samples prepared following procedure 1 with kaolin treatment 
resulted in a mean recovery of 98 % as compared to 269 % without kaolin. For procedure 5, 
an RC of 67 % was found after kaolin treatment as compared to 95 % for the extraction 
carried out without kaolin (Table 9.4).  
Using a vortex resulted in a lower variation in the mean recovery (CV % between 10 
and 18 %, procedure 3 and 5) and thus provided a higher reproducibility than the procedures 
using the ultraturax mixer (CV % between 31 and 57 %, procedure 1, 2 and 4) (Table 9.4). 
The large variation with the ultraturax mixer, is most likely due to direct adherence of sample 
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to the mixer resulting in a variable loss when the mixer is removed. Furthermore, this contact 
increases the risk for cross-contamination (McCracken et al., 2000). No loss of sample nor 
cross-contamination occurs during the homogenization with the vortex mixer. Loss of sample 
causes a concentration effect: the analyte is distributed in a smaller volume, increasing the 
concentration and thus leading to recoveries exceeding 100 %. 
In a previous study in which an extraction procedure for the detection of penicillins in 
meat samples was developed, kaolin treatment was found to be very efficient to diminish 
background signals in ELISA (unpublished data). It was assessed if such a treatment was 
required for the analysis of samples in the sulfonamide-specific TS-ciELISA. Hereto negative 
kidney tissues were extracted with the five procedure (Table 9.1) and the extracts were 
analysed in the TS-ciELISA. Background absorbances (without pAb K3) and specific 
absorbances (with pAb K3) obtained for the extracts were compared to the background and 
specific absorbances respectively obtained for PBS. It was found that kaolin treatment did not 
influence the absorbances. For all procedures, irrespective the application of kaolin, no 
significant difference (p > 0.05) was noted between the specific absorbance in extract 
compared to the response in PBS. Furthermore, higher background signals were measured 
when the ultraturax mixer was used (background absorbances > 0.1000, procedure 1 and 4) 
compared to vortex mixing (background absorbances < 0.0800, procedure 5).  
 
As conclusion, procedure 3 and procedure 5 without kaolin treatment were found to be 
the most suitable procedures for the extraction of sulfachloropyridazine from kidneys when 
analysing the extracts in the TS-ciELISA, because vortex homogenization provided a higher 
reproducibility and lower background signals than the procedures using the ultraturax mixer.  
 
Comparison of both extraction procedures with vortex homogenization for the analysis of 
kidney, fat, liver and muscle tissues 
In a second step procedure 3 and 5 were assessed on more tissues. Therefore, extracts 
of porcine muscle, liver, kidney and fat tissues, spiked with sulfachloropyridazine, were 
prepared with both procedures. Procedure 5 was applied with and without kaolin treatment, 
except for the kidney samples, which were only extracted without kaolin treatment. The 
extracts were analysed in the PS-ciELISA. 
The recoveries obtained for procedure 5 varied considerably between the different 
tissues (Table 9.5). Recoveries between 59 % and 184 % were noticed without kaolin 
treatment, and between 59 % and 374 % with kaolin treatment. Furthermore, procedure 5 
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showed a low reproducibility for fat and muscle samples (CV between 37 % and 61 %), 
whereas using procedure 3, the recoveries were comparable for the different tissues (107 % 
for kidney, 109 % for liver, 119 % for fat and 116 %) for muscle tissues, with a higher 
reproducibility for fat (CV = 16 %) and muscle (CV = 23 %) (Table 9.5).  
 
Table 9.5: Recovery (RC % ± SEM) and reproducibility (CV %) of the extraction of 
sulfachloropyridazine from spiked porcine tissues (muscle, fat, liver and kidney) using extraction 
procedure 3 or 5 (with and without kaolin treatment) and analysed in the PS-ciELISA. 
 Procedure 3 
Procedure 5 
without kaolin 
Procedure 5 
with kaolin 
 RC % ± SEM (CV %) 
Kidney 107 ± 14 (22) 98 ± 10 (18) -1 
Liver 109 ± 5 (8) 59 ± 2.5 (14.5) 59 ± 2 (13) 
Fat 119 ± 4.5 (16) 140 ± 20 (61) 374 ± 33 (38) 
Muscle 116 ± 6 (23) 184 ± 20 (45) 116 ± 10 (37) 
1For the kidney tissues, no kaolin was applied for procedure 5. 
 
In contrast to the TS-ciELISA, a significant matrix effect was observed in the PS-
ciELISA for most tissues as evidenced by significant differences between the specific 
absorbances for extracts in comparison with PBS. This was not the case for fat extracts 
prepared using procedure 5 without kaolin (not significant, p = 0.36) and muscle extracts 
prepared with procedure 5 with kaolin treatment (not significant, p = 0.08). This highlights 
the importance of an appropriate matrix control (negative tissue extract) for the calculation of 
competition values of spiked and incurred samples analysed in the ciELISA.  
As for the TS-ciELISA, kaolin treatment did not improve the efficiency of sample 
analysis in the PS-ciELISA. No background differences between tissue extracts and PBS were 
noted for kidney extracts prepared with procedure 3 and 5 (p = 0.45 and p = 0.08, 
respectively), and for liver prepared with procedure 3 and 5 with kaolin treatment (p = 0.71 
and p = 0.10 respectively). In contrast, significantly different background signals were seen 
between tissue extract and PBS for fat and muscle extracts prepared with both procedures. 
However, even when significantly different, the background absorbances never exceeded 
0.0900 for most extracts nor for PBS, with the exception of procedure 5 without kaolin 
applied on fat tissue (absorbance = 0.1222), and procedure 3 for liver (0.0962), and therefore 
it was concluded that kaolin treatment will not improve the efficiency of the sample analysis 
in the PS-ciELISA.  
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Thus, when analysing samples in the PS-ciELISA, procedure 3 was preferred for the 
extraction of sulfachloropyridazine from porcine kidney, liver, fat and muscle tissues. 
 
Care must be taken when comparing recoveries obtained in different studies. The 
recovery is not only dependent on the homogenization method, but also on the extraction 
buffer, the extracted analyte, the concentration of analyte and de detection method.  
Thomas and coworkers (1997) reported different recoveries for sulfathiazole, 
sulfachloropyridazine, sulfamethazine and sulfaquinoxaline extracted with the same 
procedure from spiked porcine liver tissues and analysed in LC-MS/MS (recovery = 27%, 
69%, 84% and 33%, respectively). These differences were subscribed to the fact that the 
efficiency of extracting different sulfonamides is pH dependent. So a procedure using a single 
extraction pH cannot quantitatively recover the full range of sulfonamides with the same 
efficiency. At the moment, there are no data available on the recovery of other sulfonamides 
using procedure 3.  
Spinks and coworkers (2001) analysed porcine liver, muscle and kidney tissues spiked 
with sulfachloropyridazine, and extracted with methanol and/or PBS, in ELISA. 
Unfortunately, they did not mention the recovery data.  
In the present study, the same extraction buffer was used as Crooks and coworkers 
(1996). They extracted sulfamethazine from homogeneous lyophilised pig tissues for the 
detection in HPLC. Recoveries of at least 80% were mentioned. However, the use of the 
extraction buffer is only one step in the sample preparation for the HPLC analysis and 
therefore, comparison with present results is not relevant. There are no data cited in literature 
about the recovery of sulfachloropyridazine from porcine tissues using a 
carbonate/bicarbonate extraction buffer. 
 
Decision limit and detection capability 
In conclusion of preceding paragraph, procedure 3 can be applied for the extraction of 
sulfachloropyridazine in kidney, muscle, liver and fat tissues. In order to use the ELISA for 
screening purposes, the decision limit CCα and detection capability CCβ were determined 
according to the Commission Decision 2002/657/EC (Anonymous, 2002). Twenty negative 
porcine kidneys were fortified with sulfachloropyridazine at the MRL (100 ppb), extracted 
following procedure 3 and analysed in the PS-ciELISA. CCα and CCβ were calculated using 
the average competition (XMRL) and standard deviation (SD) obtained for the spiked samples 
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(CCα = XMRL + 1.64*SD; CCβ = CCα + 1.64*SD). According to the Commission Decision 
2002/657/EC, at least 20 samples spiked at the CCα should be analysed to determine CCβ. 
However, CCβ was determined using the calculated CCα and the SD of XMRL, in the 
supposition that approximately the same SD for the average competition for 20 spiked 
samples at CCα would be obtained as for spiked samples at the MRL. The resulting values 
are therefore an approximately estimation for CCα and CCβ. The corresponding 
concentrations were obtained by plotting the competition values in a calibration curve of 
sulfachloropyridazine: CCα = 94 ppb, CCβ = 129 ppb. 
During screening, a sample should thus be considered non-compliant when the 
concentration is higher than the CCβ , compliant when lower than CCα and suspected when 
between CCα and CCβ. 
 
Analysis of incurred samples 
The extraction procedure for the analysis of porcine tissues in the PS-ciELISA was 
developed using spiked samples. The decision limit and detection capability for porcine 
kidneys were also determined using spiked samples containing penicillin at the MRL, 
according to Commission Decision 2002/657/EC (Anonymous, 2002).  However, attention 
must be taken when validating a method based on fortified samples. An extraction protocol 
optimized using fortified samples will not necessarily be efficient for incurred samples. The 
efficiency of the extraction procedure to extract analytes from the tissue matrix cannot be 
determined using fortified samples because the interaction between analyte and the sample 
matrix is different compared to incurred samples (McCracken et al., 2000). Therefore, 4 
kidneys and 4 livers from pork experimentally treated with sulfachloropyridazine were 
analysed in the PS-ciELISA and compared with the analysis of the same samples using LC-
MS/MS method. The LC-MS/MS analyses were performed at the Department of 
Pharmacology, Pharmacy and Toxicology, Faculty of Veterinary Medicine, Ghent University 
(De Baere et al., 2000). 
The concentrations obtained with the ELISA and the LC-MS/MS method are shown in 
Table 9.6, the correlation between both methods is established in Table 9.7. The concentration 
sulfachloropyridazine in the 4 liver samples was higher in ELISA as compared to the LC-
MS/MS method. However, the correlation between both methods for the liver analyses was 
satisfactory (r2 > 0.85; Table 9.6). Supposing that the LC-MS/MS method gave the correct 
concentration, this means that the ELISA will produce false non-compliant results rather than 
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false-compliant results. The concentrations of the kidneys prepared following extraction 
procedure 5 are much lower as compared to the concentrations obtained with procedure 3 and 
with LC-MS/MS. The correlation between the ELISA and the LC-MS/MS for the kidney 
analyses is higher when using extraction procedure 3 as compared to procedure 5 (r2 = 0.77 en 
0.52, respectively; Table 9.7).  
A possible explanation for the higher concentrations obtained using the ELISA as 
compared to the LC-MS/MS method, could be the use of a different extraction buffer. For the 
ELISA, an aqueous buffer (carbonate/bicarbonate pH 10) is used while organic solvents 
(acetone and ethylacetate) for the LC-MS/MS analysis.  Muldoon and coworkers (2000b) 
compared HPLC with ELISA for the determination of sulfadimethoxine concentration in 
chicken livers. When an organic solvent was used for sample preparation before ELISA 
analysis, high correlations were found between both methods (r2= 0.97). When an aqueous 
extraction method was used, higher concentrations were detected in ELISA as compared to 
HPLC. Moreover, the ELISA results did not correlate well with the HPLC results (r2= 0.61). 
They deduced that the ELISA detected other cross-reactive compounds such as 
sulfadimethoxine-protein conjugates and free metabolites of the sulfonamide present in the 
aqueous extract. They concluded that the amount of sulfadimethoxine detected in incurred 
samples was not only dependent of the detection method but also of the extraction procedure. 
The importance of the extraction procedure in sample analysis is also demonstrated in our 
results. For most of the samples, in particular livers, higher amounts of sulfachloropyridazine 
were detected after extraction using procedure 3 as compared to procedure 5. The recovery 
using procedure 5 is also lower than the recovery obtained with procedure 3 (Table 9.5), 
indicating that there is a loss of analyte during the extraction. 
 
Table 9.6. Concentration sulfachloropyridazine in liver and kidney tissues (in ppb) analysed with the 
LC-MS/MS method and in the PS-ciELISA. 
ELISA 
 Sample LC-MS/MS procedure 3 procedure 5 (without kaolin) 
procedure 5  
(with kaolin) 
1 4.7 28.2 34.0 8.3 
2 50.0 260.5 111.6 64.6 
3 84.0 231.1 126.0 120.1 Liver 
4 150.0 726.7 416.6 641.8 
1 24.0 45.0 4.3  
2 71.0 250.7 22.9  
3 773.0 734.5 50.0  Kidney 
4 5232.0 1140.7 55.9  
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Table 9.7. De correlation (r2) between LC-MS/MS and the PS-ciELISA using pAb 
K3 for the analysis of porcine kidney and liver 
 procedure 3 
procedure 5 
(without kaolin) 
procedure 5 
(with kaolin) 
Liver 0.88 0.89 0.85 
Kidney 0.77 0.52  
   
In conclusion, based on the comparison of different extraction procedures for analysis 
of spiked porcine tissue samples in the PS-ciELISA, based on the correlation between the 
ELISA and LC-MS/MS for the analysis of incurred samples, and because it is more suitable 
to have one extraction procedure for different tissues, extraction procedure 3 is preferred for 
the analysis of porcine kidney and liver tissues in the PS-ciELISA. In further work, the 
detection of other sulfonamides using this sample preparation in combination with the 
analysis of the extract in the PS-ciELISA should be assessed. 
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Chapter 10: General discussion and conclusion 
 
This study started 7 years ago, when the demand for sensitive methods for the 
detection of all kinds of antimicrobials in food products became more and more important. At 
that time, microbiological inhibition assays were mostly applied for the screening of food 
products of animal origin. These tests have a broad-spectrum specificity and are therefore 
useful for screening purposes. Suspected non-compliant samples are further screened using 
other microbiological assays or using immunoassays to identify the inhibitory substance or 
the group to which it belongs. Finally, the analyte is identified and quantified using a 
confirmatory method. The aim of this thesis was to investigate the possibility of developing a 
group-specific screening test using antibodies. The idea was to develop antibodies specific for 
the common structure of a group of antimicrobials, for example the group of penicillins or the 
group of sulfonamides. Such antibodies should allow the development of an immunochemical 
assay, like the enzyme-linked immunosorbent assay (ELISA), which then, in combination 
with an appropriate extraction procedure, could be applied for the detection of penicillins, or 
sulfonamides in meat samples. 
  
10.1. Development of group-specific antibodies 
 
10.1.1. Immunogens and immunization 
 
An important part of this thesis deals with the development of monoclonal and 
polyclonal antibodies specific for the group of penicillins and monoclonals and polyclonals 
specific for the group of the sulfonamides. The aim was to find a suitable strategy for the 
induction of such antibodies.  
First, good immunogens had to be constructed because penicillins and sulfonamides 
are too small to elicit an immune response. Hereto a penicillin and a sulfonamide, 
respectively, were conjugated to a carrier protein. The conjugations were performed in such a 
way that the common structure of penicillins and sulfonamides remained free for binding 
antibodies (Chapter 4 and 8; Cliquet et al., 2001; Cliquet et al., 2003a).  
 
10.1.1.1. Penicillins 
Ampicillin was chosen as the penicillin to be coupled to different carrier-proteins 
(bovine serum albumin, chicken ovalbumin and thyroglobulin), because of the free amino 
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group in its side chain.  Different coupling methods were compared: two methods using a 
cross-linker (glutaraldehyde or a succinimide ester), one carbodiimide-mediated coupling 
method and one method without any cross-linker or mediator molecule (physiological 
binding) (Chapter 4).  
  
 The hapten-carrier conjugates were characterized by determining the number of 
penicillin molecules per carrier molecule and by their capacity to induce polyclonal antibody 
responses in mice (Chapter 4). For the penicillin-carbodiimide mediated conjugates, no 
appropriate method was available for determining the number of ampicillin molecules per 
carrier molecule. For the other conjugates, the number of hapten molecules coupled to one 
protein molecule could be measured. These numbers were similar to or slightly higher than 
those obtained by other investigators (Van Regenmortel, 1988; Katsutani and Shionoya, 1993; 
Märtlbauer, 1993).  
  
 The antibody response against non-physiological conjugates was moderate to low and 
no penicillin-specific monoclonals were obtained (Chapter 4, Cliquet et al., 2001). Usleber 
and coworkers (2000) immunized rabbits and mice with ampicillin or benzylpenicillin 
coupled to albumins using glutaraldehyde, mixed anhydride or an active ester as cross-linker 
and also found the conjugates being non- or weakly immunogenic. Only three out of nine 
rabbits and none of the twelve mice immunized with the glutaraldehyde conjugate produced 
specific antibodies. Similar weak responses were observed coupling ampicillin to keyhole 
limpet hemocyanin (klh) with glutaraldehyde. This conjugate was non-immunogenic in 
rabbits and resulted in an immune response in only two of twelve mice. These data 
demonstrate the importance of immunizing enough animals before making conclusions. In 
addition, results about the conjugate indicate that despite using genetically selected strains 
(Balb C mice) there is still diversity in the immune response between different animals. In our 
work, we assessed the immunogenicity of penicillin conjugates using three to four animals. 
 As expected from literature, a high antibody response was obtained against the 
physiological ampicillin-protein conjugates, (Chapter 4; Dietrich et al, 1998; Cliquet et al., 
2001). Such conjugates are also formed in vivo after intake of penicillin and are responsible 
for the penicillin hypersensitivity reactions (Katsutani and Shionoya, 1993). Fusion 
experiments with the splenocytes of one mouse resulted in four penicillin-specific 
monoclonals. Two of them, mAb 19C9 and mAb 9H3, were selected for further investigation.  
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 10.1.1.2 Sulfonamides  
 In our first approach for the induction of sulfonamide-specific antibodies, 
sulfanilamide was chosen for conjugation because it is the common structure of all 
sulfonamides and it does not have a “disturbing” side group. Sulfanilamide was linked to 
proteins using glutaraldehyde or a succinimide ester as cross-linker or by diazotation. As for 
the penicillins, the sulfonamide-carrier conjugates were characterized by determining, if 
possible, the number of sulfonamide molecules per carrier molecule and by their capacity to 
induce polyclonal antibody responses in mice. While the non-physiological penicillin 
conjugates induced moderate to low antibody responses, no immune response at all was 
obtained using the sulfanilamide-protein conjugates cross-linked with glutaraldehyde or a 
succinimide ester. On the other hand, high antibody titers were obtained after immunization 
with the diazotation conjugates. But these antibodies were highly specific for the bound 
sulfanilamide molecule and did not recognize free sulfanilamide or other sulfonamides. Other 
investigators have also reported the use of the diazotation reaction to construct sulfonamide-
protein conjugates for the induction of antibodies against one particular sulfonamide 
(sulfamethazine, sulfamerazine and sulfathiazole). They also obtained antibodies highly 
specific for the bound sulfonamide molecule, but their antibodies were always able to 
recognize the free molecule (Fleeker and Lovett, 1985; Garden and Sporns, 1994; Sheth et al., 
1990). Sulfanilamide does not have a side chain like sulfamethazine, -merazine and –thiazole 
and this could be the reason why we did not obtain sulfanilamide-specific antibodies. The 
epitope in the sulfanilamide conjugates is probably too close to the linkage side and thus 
sterically inhibited by the carrier protein for the binding of antibodies.  
 Our second approach was the use of sulfonamide-protein conjugates in which the 
sulfonamide is linked at its side chain, leaving the common group unchanged and thus 
available for the immune system. Sulfonamide derivates with a large side chain containing a 
carboxyl group were coupled to carrier proteins by a carbodiimide-mediated reaction. 
Immunizations with the N-sulfanilyl-4-aminobenzoic acid-protein conjugates (S-conjugates) 
led to high antibody production, but all of them were highly specific for the conjugates. The 
use of a sulfathiazole derivative (N1-[4-(carboxymethyl)-2-thiazolyl]-sulfonamide) (TS) 
(Sheth and Sporns, 1991) and another sulfonamide derivative with a larger side chain (N1-[4-
methyl-5-[2-4-carboxyethyl-1-hydroxyphenyl)]-azo-2-pyridyl]-sulfanilamide) (PS) (Assil et 
al., 1992) was more successful. Haasnoot et al. (2000a; 2000b) used the same approach and 
found that immunization of mice with PS-klh led to antibodies that recognized sulfonamides 
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(sulfamethazine, -merazine, -diazine, -dimethoxine) that were not well recognized after TS-
klh immunization. Therefore, we tried to direct the immune response towards recognition of a 
broader range of sulfonamides by immunizing the animals alternately with TS- and PS-
protein conjugates. As expected from the results of Haasnoot et al. (2000a; 2000b), 
immunization with PS-bsa or PS-klh did not induce a high antibody titer. On the other hand, 
the alternate immunization with TS- and PS-conjugates induced antisera with a broader 
specificity than immunization with TS-conjugates only. The mice immunized with TS-klh 
only, had lower antibody binding to sulfonamides containing a pyrimidinyl group 
(sulfamethazine, -merazine, -diazine) or a pyridinyl group (sulfapyridine) as compared to the 
binding of antibodies derived from the alternately immunized mice (Chapter 8, Cliquet et al., 
2003a).  
 
10.1.2. Production of monoclonal and polyclonal antibodies 
 
10.1.2.1. Penicillins 
 For the production of the monoclonals, an intravenous final boost gave antibodies with 
a higher specificity and affinity than an intraperitoneal one (Chapter 4; Cliquet et al., 2001). 
Indeed, the intravenous injection will result in a rapid and strong response of splenic 
lymphocytes that subsequently will be used for fusion, as the antigen will be captured quickly 
in the spleen (Harlow and Lane, 1988). But, in our experience, intravenous injection can 
sometimes fail, probably because it is a delicate manipulation. It is difficult to insert a needle 
in a tail vein. To overcome this risk, a final boost consisting of an intravenous and an 
intraperitoneal injection was performed 4 days before fusions instead of three (for intravenous 
injections) or five (for intraperitoneal injections) days. This procedure was applied to all 
fusion experiments that were done to obtain sulfonamide-specific monoclonal antibodies. In 
our hands, this procedure works excellent.  
 After fusion experiments with splenocytes of a mouse immunized with the 
physiological ampicillin-protein conjugates, two mAbs were selected. These monoclonals 
(mAb 19C9 and 9H3) bind to ampicillin (100%), amoxicillin (964%, 212% respectively), 
benzylpenicillin (43%, 181% respectively), oxacillin (24%, 19 % respectively), dicloxacillin 
(14%, 21% respectively) and cloxacillin (9 %, 17 % respectively) (data obtained in an antigen 
ciELISA). Hydrolysed penicillins (open β-lactam ring) are less well recognized by both 
monoclonals, whereas the structural related cephalosporins (dihydrothiazin instead of 
thiazolidin ring) are not recognized at all. Therefore, it is concluded that the monoclonals are 
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specific for the thiazolidin ring of the penicillin molecule but that both the β-lactam ring and 
the thiazolidin ring are important for the detection of penicillins by the monoclonals (Chapter 
6; Cliquet et al., 2004).  
In literature only two other monoclonal antibodies (mAb 1D1 and mAb 3B5; Usleber 
et al., 2000) are mentioned as being penicillin-specific. These monoclonals show a high 
affinity for ampicillin (100 %) and amoxicillin (187 %, 108 % respectively) and a lower for 
benzylpenicillin (31%, 8.6 % resp.), oxacillin (14 %, 4.5 % respectively), cloxacillin (30 %, 
4.8 % respectively) and dicloxacillin (44 %, 1.7 % respectively) (data obtained in an antigen 
ciELISA). No cross-reactivities with hydrolysed penicillins or cephalosporins were observed. 
These cross-reactivity profiles indicate that the monoclonals are specific for the intact β-
lactam ring and that the amino-group in the side chain is important (Dietrich et al., 1998; 
Usleber et al., 2000). Our mAbs recognize the thiazolidin ring of the penicillin structure. 
However, it is assumed that the β-lactam ring is also important for the binding of these 
monoclonals since hydrolysed penicillins are recognized with lower affinity. Usleber and 
coworkers (2000) obtained their monoclonals after immunization with a weak immunogenic 
glutaraldehyde coupled ampicillin-klh conjugate whereas we used the highly immunogenic 
physiological penicillin-protein conjugates. It can be questioned if such antibodies could have 
been obtained with our immunogen. In the present thesis, hybridomas were selected based on 
the screening of their supernatant in an antigen ciELISA. Only the hybridomas generating a 
high absorbance as well as a high inhibition in the presence of non-hydrolysed ampicillin 
were selected. Doing this, no selection is made between antibodies specific for the open ring 
and the antibodies specific for the intact β-lactam ring. To differentiate between these two 
groups of antibodies, inhibition of the antibodies in the presence of hydrolysed ampicillin 
should also be tested. Antibodies expressing inhibition in presence of the native ampicilline 
but not in presence of the hydrolysed molecule are consequently specific for the intact β-
lactam ring. Similarly, antibodies expressing inhibition in the presence of hydrolysed 
penicillins but not in the presence of the native penicillin are consequently specific for the 
open β-lactam structure. In the present study, we have selected antibodies specific for the 
thiazolidin ring recognizing both intact and hydrolysed penicillins. Moreover, using an 
isoxazolyl penicillin instead of ampicillin would probably allow to select hydridomas 
producing antibodies with higher affinity for these penicillins as compared to hybridomas 
selected using ampicillin. These results demonstrate the importance of well-defined screening 
strategies. 
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The limit of detection (LOD) of amoxicillin, ampicillin, benzylpenicillin and 
cloxacilline in buffer solution analyzed in an antigen ciELISA using mAb 1D1 ranged from 
12 to 130 ng/ml (Dietrich et al., 1998). This ELISA is much more sensitive than our ELISA 
using mAb 19C9 or mAb 9H3 in which the LOD of almost all tested penicillins is higher than 
200 ng/ml, except for amoxicillin using mAb 19C9 (LOD = 18 ng/ml) (Chapter 6, Cliquet et 
al., 2004).   
Based on the results obtained for mice, three rabbits were immunized with the 
physiological penicillin-albumin conjugates in order to obtain polyclonal antibodies. In 
contrast to the mAbs, the pAbs were more specific for the hydrolysed penicillins than for the 
native penicillin (Chapter 5; Cliquet et al., submitted). Cross-reactivities of the rabbit pAb 
with the structural related cephalosporins were only noticed for cefaclor when analysed at 
high concentration (IC50 cefaclor approx. 5000 ng/ml as compared to IC50 < 200 ng/ml for 
all tested penicillins). It is not clear why these pAbs recognize cefaclor but not cephalexin or 
cephadrin. These three cephalosporins mainly differ in the substitution on the dihydrothiazin 
ring (-Cl for cefaclor vs –CH3 for cephalexin and cephadrin) (Budavari, 1988). Probably the 
polyclonals mainly recognize the upper part of the thiazolidin and dihydrothiazin ring, since 
they do not recognize clavulanic acid (oxygen instead of sulphur). Other cephalosporins have 
larger side groups causing sterical hinder to the antibodies for binding to the upper part of the 
dihydrothiazin ring. 
 The detection of penicillins in ELISA was more sensitive using the pAb than the mAb. 
All tested penicillins could be detected at their MRL in the antibody ciELISA using pAb K2 
(Chapter 5; Cliquet et al., submitted). The MRL concentration was not reached for any 
penicillin when mAb 9H3 was used (LOD > 50 ng/ml), however with mAb 19C9, only 
amoxicillin (LOD = 18 ng/ml) could be detected at the MRL. 
Usleber and coworkers (1998) obtained a penicillin-specific rabbit antiserum after 
immunization with a glutaraldehyde coupled ampicillin-albumin conjugate. The ELISA 
developed with these antibodies was not sensitive enough and detected the intact, non-
hydrolysed penicillins. The MRL is set up for this structure. With our antisera, a sensitive 
method is developed that mainly detects the degradation products, which are not taken into 
account in the MRL. However, the detection of the hydrolysed penicillin can be important. 
Although no scientific evidence is provided that people can have adverse reactions after 
intake of penicillin through food products, the risk in case of already sensitised individuals 
may not be underestimated (Dewdney, 1991). Ormerod et al. (1987) reported the induction of 
adverse reaction after intake of milk containing benzylpenicillin (6 ppb) by individuals who 
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were already hypersensitive for penicillins. De Baere and coworkers (2002) detected high 
amounts of metabolites after administration of amoxycillin to pigs, in contrast to what is 
usually assumed. Furthermore, spontaneous hydrolysis of penicillins will occur during sample 
handling and will always give an underestimation of the penicillin concentration in the 
original sample. The MRL for penicillins was one of the first established levels (Anonymous, 
1990). At that time, no attention was paid to the metabolites of the molecule.  Phillips and 
coworkers (2004) remarked that penicillin would nowadays probably not be approved for use 
in human medicine given its neurotoxicity, the high incidence of allergy and the common 
occurrence of resistance. It is about time to review this MRL.  
  
10.1.2.2 Sulfonamides 
The mAbs obtained after fusion experiments with the splenocytes of mice immunized 
with TS- and/or PS-protein conjugates could be divided, based on their cross-reactivities, into 
three groups, independently from which mouse they were deduced (Chapter 8; Cliquet et al., 
2003a). This means that the alternate immunization with two different immunogens with the 
intention to broaden the specificity of the antibodies, indeed improved the broad-specificity of 
a polyclonal serum, but not of individual mAbs. Consequently, to obtain broad-specific mAb, 
it would be sufficient to immunize with TS-klh, and to screen the hybridomas in an ELISA 
coated with PS-ova.  
To induce polyclonal antisera, rabbits were immunized with the most successful 
sulfonamide immunogen. As for penicillins, the detection of sulfonamides was more sensitive 
using the pAb-based ELISA as compared to the mAb-based ELISA. 
Cross-reactivities of mAb 3B5B10E3 and pAb K3 for structural related molecules or 
drugs that are administered together with sulfonamides to animals were determined (PS-
ciELISA) (Chapter 8 and 9). The monoclonal recognized four diuretics (furosemide, 
acetazolamide, hydrochlorothiazide, bumetanide; IC50 >10 µg/ml), but none of the other 
tested molecules (thiamphenicol, florphenicol, lidocaine and p-aminobenzoic acid). The 
diuretics only have the –SO2NH- group in common with sulfonamides. Thiamphenicol and 
florphenicol have a –SO2- group, p-aminobenzoic acid contains the common sulfonamide p-
aminobenzoyl ring and lidocaine has nothing structural in common with sulfonamides. This 
indicates that the epitope recognized by the monoclonal included the –SO2NH- group. 
Substitution of this sulfonamide-group on a benzene ring favors the binding of the 
monoclonal since sulfonamides are recognized with higher sensitivity (IC50 <1 µg/ml). On 
the other hand, the polyclonals recognized p-aminobenzoic acid (IC50 >10 µg/ml), but none 
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of the other molecules. This indicates that the epitope recognized by the polyclonals contains 
the p-aminobenzoyl ring. Substitution of the sulfonamide-group (-SO2NH-) on the common p-
aminobenzoyl ring favors the binding of the polyclonals since most sulfonamides are 
recognized with higher sensitivity as compared to p-aminobenzoic acid (IC50 sulfonamides 
<1 µg/ml). 
Several studies have been published on the development of group-specific 
sulfonamide antibodies. Some studies followed the same strategy as we did (Sheth and 
Sporns, 1991; Assil et al., 1992; Muldoon et al., 1999; Haasnoot et al, 2000a; Haasnoot et al., 
2000b). The most sensitive monoclonal, mAb 27G3, was obtained by Haasnoot and 
coworkers (2000a; 2000b) and showed 50 % inhibition (IC50) with 18 tested sulfonamides at 
values less than 10 µg/ml, and with eight at concentrations below 0.1 µg/ml. Nevertheless, the 
most relevant sulfonamides sulfamethazine, sulfatroxazole and sulfachloropyrazine were not 
detected at the MRL value (100 ppb or 0.1 µg/ml). The improvement of the cross-reactivity 
profile of that monoclonal by genetic engineering has also been published. Korpimäki and 
coworkers (2002, 2003) obtained a mutant M3.4. with higher affinity for the tested 
sulfonamides than the wild-type mAb 27G3. 
 Li and coworkers (2000) used synthetic sulfonamides not described by anyone else to 
produce rabbit polyclonals. They reported IC50 values in the range of 0.2 to 2.2 µg/ml for 
sulfamethazine, sulfadimethoxine, sulfathiazole, sulfadiazine and sulfaquinoxaline in buffer 
solution analyzed in a competitive ELISA using the pAb. Spinks et al. (1999) carried out 
molecular modeling studies on the sulfonamide structure and noticed that the molecule has a 
characteristic bend around the tetrahedral –SO2- group. They deduced that the recognition of 
the common sulfonamide structure would be maximal for these drugs where the bend had the 
greatest angle. Consequently, cross-reactive antibodies could possibly be obtained using a 
sulfonamide as hapten with a more planar structure (sulfacetamide) or a larger bend 
(sulfachloropyridazine). Despite this interesting hypothesis, immunization with such 
conjugates did not lead to antiserum with a broad-specificity for sulfonamides.  
Beside the mutant M3.4, two other interesting monoclonals were reported in literature: 
the sulfonamide-specific rat mAb 21C7 obtained by coincidence during the development of 
sulfamethazine-specific monoclonals  (Kohen et al., 2000) and the monoclonal used in the 
Biacore kit for sulfonamides (Qflex kit) (Mc Grath et al, 2004). The development of the latter 
one has not been published. Bienenmann-Ploum and coworkers (2004) have compared a 
biosensor assay using the mutant M3.4. and the mAb 21C7 with the Qflex kit for the detection 
of 26 different sulfonamides and metabolites in chicken serum. The mutant M3.4 was found 
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to be the most sensitive toward most of the sulfonamides, whereas the Qflex kit detected 5 
sulfonamides registered for application in poultry (sulfamethazine, sulfamethoxazole, 
sulfaquinoxaline, sulfachloropyridazine, sulfadiazine) within the narrowest measurement 
range (LOD between 19 and 62 ng/ml for the Qflex kit versus LOD between 4 and 82 ng/ml 
for mutant M3.4.). For group-specific screening assays it is more interesting to detect the 
analytes in a narrow range because the decision of compliance is made by comparing to a 
reference analyte. A small range will avoid too much false compliant and false non-compliant 
results.  
 Our monoclonal 3B5B10E3 detects most of the tested sulfonamides (sulfathiazole, 
sulfamethoxazole, sulfachloropyridazine, sulfadiazine) in buffer solution in a range of less 
than 1 to 80 ng/ml, and thus below the MRL (100 ng/ml). However, sulfamethazine and 
sulfamerazine cannot be detected at the MRL with this monoclonal (Chapter 8; Cliquet et al, 
2003a). This problem can be solved using polyclonal antisera or a combination of monoclonal 
antibodies, each with different specificities. Haasnoot et al (2000c) could detect sixteen 
sulfonamides in the BIAcore 2000 biosensor using a combination of three group-specific 
monoclonal antibodies.  
 
10.1.3. Conclusions 
 
The main problem for the induction of penicillin-specific antibodies was the development 
of a suitable immunogen. Positive results were obtained with the physiological conjugates. In 
these conjugates, the β-lactam ring of penicillins is opened; as a result, an immune response is 
induced against an epitope different from the closed β-lactam structure of penicillins and 
cephalosporins. A screening of hybridomas to select antibodies recognizing the intact β-
lactam ring has not been performed. Consequently, penicillin-specific, but not β-lactam 
specific antibodies were selected.  
  The main problem for the induction of sulfonamide-specific antibodies was the large 
structural difference between the different molecules due to variations in the side chains. A 
monoclonal able to recognize the sulfonamide core in all the different sulfonamide molecules 
is therefore difficult to find. 
 For both the penicillins and the sulfonamides, the detection of the analytes using the 
polyclonal antibodies was more sensitive than using the monoclonals. Booman (1988) already 
discussed that the affinity of monoclonals is usually far below the avidity of the 
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corresponding polyclonal antisera, since polyclonals contain different antibodies against all 
the haptens. The sensitivity of detection using these polyclonals is related to their avidity.  
 It can be questioned if the production of a group-specific antibody is more a trial and 
error process in combination with the coincidence of the induction of that rare, specific 
antibody. Strong immunogens, like the physiological penicillin-protein conjugates or the 
sulfonamide-protein conjugates (azocasein, TS- and S-conjugates), resulted in high titers of 
penicillin-specific or sulfonamide-specific antisera in all immunized animals, but fusion 
experiments have not necessarily provided group-specific antibodies. On the other hand, weak 
immunogens induced generally low titers. But in some animals moderate to high titers can be 
found and fusion experiments can result in some rare group-specific antibodies. For instance 
the ampicillin-klh glutaraldehyde conjugate used by Usleber and coworkers (2000) only 
induced an immune response in two of the twelve immunized mice. Fusion experiments using 
the splenocytes of these two responding mice resulted in two rare penicillin-specific and 
sensitive monoclonal antibodies. The same is true for the study of Muldoon et al. (1999). 
They immunized 5 mice with a sulfonamide derivative coupled to klh. Only one mouse 
produced high titers of antibodies able to recognize other sulfonamides. The fusion 
experiment resulted in only two wells of the thirty 96-wells microtiter plates containing 
hybridoma colonies that recognized more than one sulfonamide and resulted in one 
monoclonal antibody specific for the group of sulfonamides. Thus, it can be worthwhile to do 
more research on such weak immunogens and their induction of group-specific antibodies, 
instead of looking for strong immune responses. Another interesting study was described by 
Kohen and coworkers (2000). They obtained by chance a sulfonamide cross-reactive 
monoclonal antibody using as immunogen sulfamethazine coupled by diazotation to BSA. 
Such immunogens would normally induce sulfamethazine-specific antibodies, as observed by 
other investigators (Fleeker and Lovett, 1985; Sheth et al., 1990; Garden and Sporns, 1994). 
This mAb was used to develop a biosensor assay (Haasnoot et al, 2003). Eight sulfonamides 
(sulfamethazine, -diazine, -merazine, -chloropyazine, -sulfisoxazole, -sulfachloropyridazine, -
sulfatroxazole, -sulfathiazole) were detected in buffer solution and in diluted chicken serum at 
concentrations between 7 to 20 ng/ml. 
 
Thus, the choice of an appropriate immunogen is critical for the development of 
group-specific antibodies. However, it must be taken into account that the potential of 
inducing a high immune response is not necessarily the most important selection parameter. 
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10.2. Influence of the test system on the sensitivity of detection 
 
The cross-reactivities and sensitivities of antibodies not only depend on the way they 
were induced or selected, but also on the test system they are used in. During our research, 
two immunochemical methods were applied: a competitive inhibition ELISA (ciELISA) and 
the optical biosensor of BIAcore (biosensor).   
 
The penicillin-specific monoclonals mAb 19C9 and mAb 9H3 were analysed using a 
ciELISA coated with antigen (antigen ciELISA) and using the biosensor (Chapter 6; Cliquet 
et al, 2004). Both monoclonals recognize ampicillin, amoxicillin and benzylpenicillin better 
than oxacillin, cloxacillin and dicloxacillin. The latter ones have a larger side chain, possibly 
causing sterical inhibition for the binding of the monoclonals to the common penicillin 
nucleus. No ciELISA coated with antibodies (antibody ciELISA) could be developed using 
the monoclonal antibodies, probably because of changes in their conformation due to the 
immobilization on the plate. With both antibodies, but especially with mAb 9H3, oxacillin, 
cloxacillin and dicloxacillin were better recognized in the biosensor system than in the 
ELISA. In ELISA, it was not possible to detect these penicillins at concentrations below 1 
µg/ml. A possible explanation is that in ELISA the binding of the antibodies to the coated 
molecule is favoured above its binding to the antigens in solution for which it has a lower 
affinity (oxacillin, cloxacillin and dicloxacillin). Indeed, during incubation time dissociation 
of weak antibody-antigen interactions (solution) will occur and not of strong antibody-antigen 
interactions (coated antigen). Free antibodies preferably will adhere to the antigens for which 
they have a higher affinity, resulting in lower cross-reactivities for the lower affinity antigens 
(Tijssen, 1985). In the biosensor the antigen-antibody interaction is measured in real-time and 
therefore higher cross-reactivities can be monitored for low affinity binders.  
The penicillin-specific polyclonal antibodies were applied in an antigen ciELISA and 
in an antibody ciELISA (Chapter 5; Cliquet et al., submitted). For the three antisera, the 
detection of ampicillin, amoxicillin, benzylpenicillin, oxacillin, cloxacillin and dicloxacillin 
was more sensitive in the antibody ciELISA as compared to the antigen ciELISA. The 
difference in sensitivity between both ELISAs could be ascribed to a combination of factors 
such as the use of a different competitor molecule (Choi et al., 2002), the immunogen used to 
produce the antibodies (Kirkley et al., 2001) and the set-up of the test system. Indeed, in the 
antibody ciELISA, the binding of the sample penicillins is favoured above the binding of the 
biotinylated penicillins due to the preincubation of sample and coated antibodies. As a result, 
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higher sensitivities can be measured in the antibody ciELISA as compared to the antigen 
ciELISA. 
 
The sulfonamide-specific monoclonal mAb 3B5B10E3 was also used in an antigen 
ciELISA coated with PS-ova and an antibody ciELISA precoated with mouse 
immunoglobulin-specific antisera (Chapter 8; Cliquet et al., 2003a). Almost all tested 
sulfonamides were detected with the same sensitivity in both ELISA. The sensitivity of the 
antigen ciELISA was improved when PS-ova was used as coating antigen compared to TS-
ova. Muldoon and coworkers (2000) also assessed different cross-reactivity profiles for an 
anti-sulfadimethoxine monoclonal when using different coating antigens. Based on their 
findings, it was assumed that the sensitivity of our antibody ciELISA could be improved by 
using the biotinylated PS-sulfonamide PS-bio instead of TS-bio. However, the absorbances 
obtained with PS-bio were too low to develop an assay. Our results on the penicillin-specific 
ELISA using polyclonals showed that an antibody ciELISA could be more sensitive as 
compared to the antigen ciELISA using the same antibodies. Therefore, it should be 
worthwhile to do some more research on the amplification of the signal or on the use of 
another labelled sulfonamide to develop an antibody ciELISA using our mAb 3B5B10E3. 
Moreover, as for the penicillin-specific mAb, it should be interesting to evaluate this mAb for 
its use in an optical biosensor. 
 
Two Ag ciELISAs were developed using the sulfonamide-specific polyclonal 
antibodies pAb K3 (Chapter 9; Cliquet et al., 2003b). These ciELISAs differed from each 
other in the coated antigen, namely TS-ova or PS-ova. As for the mAb 3B5B10E3, no 
antibody ciELISA could be developed that was more sensitive than the antigen ciELISAs due 
to the lack of an appropriate labelled sulfonamide. The pAb K3 were obtained by immunizing 
rabbits with the TS-klh conjugate. Therefore higher antibody titers were obtained in the 
ciELISA coated with TS-ova (TS-ciELISA) than in the ciELISA coated with PS-ova (PS-
ciELISA). As for the mAb 3B5B10E3, the PS-ciELISA was at least eight times more 
sensitive than compared to the TS-ciELISA. In the PS-ciELISA, all tested sulfonamides 
(sulfadiazine, -thiazole, -chloropyridazine, -methazine, -pyridine, -dimethoxine, -merazine 
and sulfisoxazole), except sulfisoxazole, were detected in buffer solution below 0.01 µg/ml.  
In conclusion, for the mAb as well as for the pAb, our results demonstrated the 
importance of using an appropriate test system (ELISA, biosensor), test set-up (antigen 
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ciELISA, antibody ciELISA) and suitable competitor molecules (different coating antigens, 
labelled antigens). 
 
10.3. Analysis of meat samples 
 
10.3.1 Sample preparation procedures 
 
One of the aims of this thesis was to determine whether it was possible to develop one 
extraction procedure for a group of antimicrobial drugs. During the development of an 
appropriate multi-analyte extraction procedure, it is important to take into account the 
distribution of the analytes in the tissues (tissue fluids, intracellular), the solubility of the 
analytes in the extraction buffer and the compatibility of the extract solvents with the test 
system (anorganic solvents are preferred for immunochemical methods). Furthermore, the 
extraction procedure should be kept as simple as possible to avoid loss or degradation of 
analyte during handling and to reduce the time for sample analysis.  
In literature, no simple procedure was described for the extraction of all penicillins or 
all sulfonamides in meat samples for analysis in an immunochemical assay. Therefore, we 
developed simple sample preparation procedures for meat samples containing penicillins or 
sulfonamides. Recently, simple extraction procedures were reported for the analysis of 
penicillins and sulfonamides containing meat samples using the Parallux™ assay (Okerman et 
al., 2003) and the Biacore® biosensor (McGrath et al., 2004).   
Usually, meat samples are minced using a conventional kitchen mixer before 
homogenization with an appropriate extraction buffer (McCracken et al., 2000). However, 
this way of working produced high background signals in our penicillin-specific ELISAs. 
Therefore, the tissue samples were cut into small pieces with a knife instead of minced with a 
mixer (Chapter 7). Working with minced tissues implied a centrifugation step. The extracts 
were subsequently filtered and adjusted to pH 7. This rather simple extraction procedure still 
took too much time. Therefore, we investigated the possibility of using sample fluids instead 
of tissues. Penicillins are present in the intercellular fluid of tissues (Divers, 1996). The use of 
tissue fluid simplified the sample preparation. Before analysis in ELISA, the fluids were 
treated with kaolin to reduce background signals in ELISA by removing disturbing fat or 
other matrix components (Van den Broeck et al, 1999). For the analysis of kidneys using the 
Parallux™ assay, tissue samples are homogenized with the extraction buffer using a 
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Stomacher, whereafter a centrifugation step has to be performed to obtain the extraction fluid 
(Okerman et al., 2003). Our procedure only required an eppendorf centrifuge.  
Mostly, organic solvents are used for the extraction of sulfonamides (Guggisberg et 
al., 1992). However, these solvents are not very compatible with immunochemical methods. 
Therefore, we preferred to use an anorganic buffer (Chapter 9; Cliquet et al., 2003b). A 
carbonate/bicarbonate buffer (pH 10) was chosen in which sulfonamides are highly soluble 
(Budavari, 1988). Differences in homogenizing techniques (high-speed mixer (ultraturax) 
versus vortex) and the effect of kaolin were evaluated. The best extraction procedure was the 
simplest method, using a vortex mixer as homogenizer and no kaolin treatment. A similar 
procedure is applied when analyzing samples using the Biacore® biosensor Qflex assay 
(McGrath et al., 2004).  
  
10.3.2. Validation of the ELISAs 
 
In order to determine if it was possible to make a screening assay using group-specific 
antibodies, not only antibodies, assays and extraction procedures had to be developed, but 
tests had to be properly evaluated. Indeed, any method or combination of methods may only 
be used for screening or confirmatory purposes if it can be proven that they fulfill the 
requirements established in the Commission Decision 2002/657/EC. For screening purposes, 
only those methods that are validated and have a false-compliant rate lower than 5% at the 
MRL are allowed. Validation of a method means demonstrating that the method complies 
with the criteria applicable for the relevant performance characteristics. For a qualitative 
screening method, the detection capability (CCβ), the selectivity/specificity and the 
applicability/ruggedness/stability must be demonstrated. When a screening assay will be used 
quantitatively, the precision must also be determined (Anonymous, 2002).  
Some of the relevant performance characteristics (the specificity, sensitivity, 
repeatability, decision limit (CCα) en detection capability (CCβ)) were determined for the 
penicillin-specific antibody ciELISA with pAb K2 and for the sulfonamide-specific antigen 
ciELISA with pAb K3 (Chapter 7 and 9). 
The detection capability and decision limit were determined according to the 
Commission Decision 2002/657/EC, for amoxicillin (CCα =9 ppb; CCβ =19 ppb) and 
sulfachloropyridazine (CCα = 9.4 ppb, CCβ = 12.9 ppb) in porcine kidneys. These ELISAs 
are multi-analyte assays for penicillins and sulfonamides, respectively. Their sensitivity is not 
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the same for all analytes. Amoxicillin was chosen as standard analyte in the penicillin ELISA. 
The detection capability and decision limit were established for that standard penicillin. 
However, the identity of a penicillin in a sample is not known during screening. Therefore, 
decision based on CCβ  (non-compliant if the concentration is higher than CCβ) will not 
necessarily give certainty about the false compliant rate of the ELISA. For the sulfonamide-
specific ELISA, CCα and CCβ were determined for sulfachloropyridazine because incurred 
samples were available for that sulfonamide. Sulfachloropyridazine cannot be used as 
reference sulfonamide because the sensitivity of this assay is much higher for that 
sulfonamide than for most of the tested sulfonamides (Chapter 9). The decision limit and 
detection capability for amoxicillin and sulfachloropyridazine are rather giving information 
about the precision of the measurements of the penicillin-specific and sulfonamide-specific 
ELISA, respectively. Since a sample is considered non-compliant when the concentration is 
higher than the CCβ, compliant when lower than CCα and suspect when between CCα and 
CCβ, the range between CCα and CCβ should be as narrow as possible. This is obtained 
when the repeatability of the ELISA is high (small variations between repeated analyses). The 
coefficient of variation should not exceed 15 % (Crabbe, 2002). This requirement was 
fulfilled for both ELISAs (Chapter 7 and 9). Compared to the penicillin-specific ELISA (CCα 
=9 ppb; CCβ =19 ppb), the sulfonamide-specific ELISA is thus more precise (CCα = 9.4 ppb, 
CCβ = 12.9 ppb). 
The ideal group-specific assay would detect all members of the group with the same 
sensitivity (cross-reactivities 100%). At that moment, decision based on CCβ can give a 
correct idea about the compliance of a sample. 
To determine the detection capability of the ELISA in accordance to the Commission 
Decision 2002/657/EC, fortified samples containing penicillin at the MRL were used. 
Fortified samples are more appropriate than samples obtained from in vivo experiments 
because it is difficult to predict the concentration that will be obtained in the tissues after 
administration of the drug to animals. On the other hand, attention must be taken when 
validating a method based on fortified samples. An extraction protocol optimized using 
fortified samples will not necessarily be efficient for incurred samples. The efficiency of the 
extraction procedure to extract analytes from the tissue matrix cannot be determined using 
fortified samples because the interaction between analyte and the sample matrix is different 
than for incurred samples (Mc Cracken et al., 2000). Therefore, the analysis of incurred 
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samples in the ELISAs was compared to the analysis of the same samples using other 
qualitative or quantitative methods.  
Because the antibody ciELISA with pAb K2 is designed as a qualitative screening 
assay, the efficiency of the extraction procedure and analysis of samples was investigated by 
analyzing 15 incurred samples and comparing the results with these obtained using two other 
qualitative screening assays, the New Belgian Kidney Test (NBKT) and the Parallux™ assay. 
Almost 100 % correlation (r2 = 0.94) was found between the Parallux™ and the ELISA. 
Because the incurred samples came from animals with unknown treatment, and because not 
only penicillins but also other substances with antimicrobial activity are detected in the 
NBKT, a positive result in NBKT indicated the presence of one or more antimicrobial 
substances and thus not only penicillins. This could be the reason why two samples were 
tested positive in the NBKT, but negative in the Parallux™ and the ELISA. 
For the development of an appropriate extraction procedure for the sulfonamide-
specific ELISA, fortified porcine tissue samples were used. Two procedures were selected 
based on the recovery and repeatability (procedure 3 and 5). The comparison of the analysis 
of kidneys and livers from pigs experimentally treated with sulfachloropyridazine in the PS-
ciELISA with the analysis of the same samples using LC-MS/MS method, allowed us to 
select one of both extraction procedure. The comparative study demonstrated that extraction 
procedure 3, using a vortex mixer as homogeniser and no kaolin treatment, was more suitable 
than procedure 5, using a vortex mixer and kaolin treatment, for the extraction of 
sulfachloropyridazine from both kidney and liver tissues (Chapter 9). 
 
10.4. Main conclusions and future perspectives 
 
In this study, the development of group-specific screening assays using antibodies was 
investigated. The hope was to find a general strategy for the development of group-specific 
assays based on the results obtained for penicillins and sulfonamides.  
The biggest part of the research was the development of group-specific antibodies. 
Results showed that is difficult to build up a general strategy for making an optimal 
immunogen, because the immunogenicity of an antigen will not necessarily guarantee the 
production of suitable antibodies. The screening procedure for selecting antibodies is as 
important.  
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It was possible to develop antibodies that recognize a broad range of antimicrobials of 
the same group and, although nothing is absolute, following parameters are thought to be 
critical for the development of group-specific antibodies: 
- The development of an appropriate immunogen, taking into account that the potential 
of inducing a high immune response is not necessarily the most important selection 
parameter. 
- The immunization procedure (mice) including a final intravenous and intraperitoneal 
boost injection. 
- The procedure for the screening of sera and hybridomas. 
  
Using the monoclonal and polyclonal penicillin- and sulfonamide-specific antibodies, 
different test systems were developed, namely antigen ciELISAs, antibody ciELISAs and 
biosensor assays. Thus, it was possible to develop group-specific assays using our group-
specific antibodies. The choice of the test system influenced the sensitivity and specificity of 
the antibodies. Therefore, when developing a detection system using antibodies, the screening 
assay should resemble the final test as much as possible. Results showed that the detection of 
analytes using polyclonal antibodies is in general more sensitive than using monoclonals.  
 
For the analysis of samples, appropriate extraction procedures were developed for the 
group of penicillins and for the group of sulfonamides, respectively. Most important factors 
are the extraction buffer and the sample handling, which should be kept as minimal as 
possible. 
A method or combination of methods may only be used for screening if it can be 
proven that they fulfill the relevant requirements established in the Commission Decision 
2002/657/EC. This validation is performed using fortified samples. It is advisable, however, 
to compare the analysis of incurred samples using a reference method. An extraction 
procedure developed using fortified samples will not necessarily be efficient for incurred 
samples because the interaction of the analyte with the sample matrix can be different. The 
comparative studies of the analysis of incurred tissues using our ELISAs and using a 
commercial immunochemical assay (penicillins) or a physico-chemical method 
(sulfonamides) demonstrated the suitability of the ELISAs and the corresponding extraction 
procedure. 
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Summary 
 
Microbiological inhibition assays are mostly applied for the screening of food 
products of animal origin. These tests have a broad-spectrum specificity and are therefore 
useful for screening purposes. A sample with a positive result in the microbiological test must 
be confirmed with a physico-chemical method. Such techniques can be very reliable and 
precise, but they are expensive and labour-intensive. It is therefore advisable to avoid false 
non-compliant results during screening. Moreover, before analysing with a physico-chemical 
method, it would be advisable to determine to which family of antibiotics the unknown 
compound in the presumed non-conform sample belongs, because the broad-spectrum 
microbiological assays do not discriminate between different families of antibiotics. The aim 
of this study was to investigate the possibility of developing such group-specific screening 
tests using antibodies specific for penicillins or sulfonamides. Such group-specific antibodies 
should allow the development of an immunochemical assay, like the enzyme-linked 
immunosorbent assay (ELISA). In combination with an appropriate extraction procedure, the 
ELISAs can then be applied for the detection of penicillins and sulfonamides, respectively, in 
meat samples. 
 
Chapter 1 gives an overview of the principles of immunoassays. Because such assays 
are based on the interaction between antigen and antibody, the physicochemical properties of 
the interaction and the influencing factors are reviewed. The nature of immunogens, antigens 
or haptens, is discussed. The production of antibodies is explained and the properties of 
monoclonal and polyclonal antibodies are compared. An overview is given of immunological 
methods applied in this work, namely ELISA and the optical biosensor, in which detection is 
based on surface plasmon resonance. 
Chapter 2 and 3 review the application of penicillins and sulfonamides, respectively, 
in veterinary medicine. Their physicochemical and biological properties, and their 
metabolisation are discussed. Furthermore, the consequences of the abuse of penicillins and 
sulfonamides in veterinary husbandry are mentioned. In addition, an overview is given on the 
current state on detection methods, microbiological inhibition assays, receptor assays and 
immunoassays. 
Chapters 4 to 9 present the experimental work of this research. The aim of the study 
was to answer to following questions: 
1. Is it possible to develop antibodies recognizing a group of antimicrobials? 
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2. Can a screening assay be developed using group-specific antibodies? 
3. Is it possible to develop one extraction procedure for a group of antimicrobials? 
 
The development of penicillin-specific monoclonal antibodies (mAb) is discussed in 
chapter 4. Several procedures were evaluated to obtain monoclonal antibodies specific for the 
common structure of penicillins. Ampicillin was coupled to different carrier-proteins (bovine 
serum albumin, chicken ovalbumin and thyroglobulin) to render it immunogenic. Hereto, 
different coupling methods were compared, namely two methods using a cross-linker 
(glutaraldehyde or a succinimide ester), one carbodiimide-mediated coupling method and one 
method without a cross-linker or mediator molecule (physiological binding). Mice were 
immunised with the conjugates intraperitoneally, intravenously or in the footpad. A 
screening-ELISA was developed to detect anti-ampicillin antibodies in sera. Specificity and 
affinity of the antibodies were demonstrated by inhibiting their binding to coated ampicillin-
protein conjugate with a 10 mM solution of ampicillin. No difference in the obtained 
hybridoma could be observed using electrofusion or PEG-mediated fusion. For the production 
of the monoclonals, an intraveneous final boost gave antibodies with better specificity and 
affinity than an intraperitoneal final booster injection. Two anti-ampicillin monoclonals (mAb 
19C9 and mAb 9H3) were selected that cross-reacts with penicillin G, oxacillin, cloxacillin, 
dicloxacillin and carbenicillin, and not with cephalosporins (cephadrin, cephalexin, cefaclor), 
clavulanic acid, sulfanilamide, chloramphenicol, neomycin and streptomycin, and were 
therefore interesting for trying to develop a penicillin-specific ELISA. 
The production of penicillin-specific polyclonal rabbit antibodies (pAb) and the 
application of these antibodies in an ELISA are described in chapter 5. The polyclonals were 
obtained after immunization of three rabbits (K2, K6 and K8) with physiological ampicillin- 
and benzylpenicillin-protein conjugates (pAb K2) or with physiological ampicillin-, 
benzylpenicillin-, oxacillin and dicloxacillin-protein conjugates (pAb K6 and pAb K8). The 
broad-specificity of the antisera induced by physiologic penicillin-protein conjugates was 
improved by alternately immunizing the animals with conjugates containing different 
penicillins as hapten. With each of the polyclonals, an antigen and an antibody competitive 
inhibition (ci) ELISA was developed. For the three antisera, the detection of ampicillin, 
amoxicillin, benzylpenicillin, oxacillin, cloxacillin and dicloxacillin was more sensitive in the 
antibody ciELISA as compared to the antigen ciELISA. However, the detection of all 
penicillins in buffer solutions below the MRL in the antibody ciELISA was only achieved 
                                                                                                                                                                    Summary                             
 192
when the penicillins were hydrolysed with Penicillinase I. No cross-reactions were observed 
for cephadrin, cefalexin, cefazolin, clavulanic acid, sulfanilamide or chloramphenicol. 
In chapter 6, the monoclonals 19C9 and 9H3 and polyclonals K2 are compared for 
their use in ELISA and in the BIAcore™ optical biosensor. In the ELISA, an ampicillin-
protein conjugate was used as coating molecule whereas for the biosensor assay, ampicillin 
was directly immobilized on a CM5 chip. With both monoclonal antibodies and in both 
testsystems, ampicillin, amoxicillin and benzylpenicillin were better recognized than 
oxacillin, cloxacillin and dicloxacillin. Because the reproducibility was better in the biosensor 
(CV = 1.6 %) than in the ELISA (CV = 8.9 %), the limit of detection for ampicillin in a buffer 
solution using mAb 19C9 was lower in the biosensor (46 ng/ml) than in the ELISA (356 
ng/ml). Ampicillin could thus be detected below the MRL (50 ng/ml) in the biosensor assay 
but not in the ELISA.  
Both the ELISA and biosensor assay using pAb K2 were more sensitive as compared 
to the assays with the monoclonals. Indeed, the ELISA using pAb K2 allowed the detection of 
all tested penicillins below the MRL, whereas in the biosensor assay, ampicillin was detected 
with an IC50 of 10 ng/ml which is lower as using mAb 19C9 (IC50 = 524 ng/ml). In contrast 
to the binding of the monoclonals, no spontaneous dissociation was observed after injection of 
the polyclonal antibodies in the biosensor. Whereas the monoclonals were completely 
removed from the sensor surface using ampicillin in buffer solution (500 µg/ml) as 
regeneration solution, stronger conditions (0.1 M NaOH containing 20% acetonitril) were 
necessary for removing the pAb. Probably the detection of ampicillin in the biosensor assay 
using pAb K2 can still be improved by hydrolysis of the ampicillin using Penicillinase I 
before analysis.  
With the monoclonals (mAb 19C9 and mAb 9H3) as well as with the polyclonal 
antibodies (pAb K2, pAb K6 and pAb K8), an antigen ciELISA was developed for the 
detection of ampicillin, amoxicillin, benzylpenicillin, oxacillin, cloxacillin and dicloxacillin 
in buffer solutions (Chapter 6). However, the antigen ciELISAs were not able to detect all 
tested penicillins below the MRL (50 µg/kg). Ampicillin was only detected sensitive enough 
in the antigen ciELISA with the polyclonals (LOD = 6 ng/ml with pAb K2; LOD = 20 ng/ml 
with pAb K6 and pAb K8) and amoxicillin in the antigen ciELISA with mAb 19C9 (LOD = 
18 ng/ml). With the polyclonals, but not with the monoclonals, an antibody ciELISA could be 
developed that was ten times more sensitive than the antigen ciELISA. Therefore only the 
ELISAs using pAb K2 were chosen to assess the possibility of analysing porcine tissues 
according to the European requirements for screening tests used for the inspection of food 
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derived from treated animals (Chapter 7). Some of the relevant performance characteristics 
(specificity, sensitivity, repeatability, decision limit (CCα) and detection capability (CCβ)) 
for the validation are discussed. Results demonstrated that the precision of the antibody 
ciELISA is higher than this of the antigen ciELISA: the range between CCα and CCβ is 
smaller for the analysis of kidney samples in the antibody ciELISA (9-19 ng/ml) as compared 
to the antigen ciELISA (21-69 ng/ml). Since a sample is considered non-compliant when the 
concentration is higher than the CCβ, compliant when lower than CCα and suspected when 
between CCα and CCβ, the range between CCα and CCβ should be as narrow as possible. 
The suitability of the antibody ciELISA and of the used extraction procedure for screening 
purposes was demonstrated by comparing the analysis of the ELISA results for incurred 
samples with these of a commercial immunochemical method, the Parallux™ assay. Almost 
100 % correlation (r2 = 0.94) was found.  
Chapter 8 reports the different attempts to obtain monoclonal antibodies specific for 
the common structure of sulfonamides. In a first approach, sulfanilamide was linked to 
albumins using glutaraldehyde or a succinimide ester as cross-linker. No or a weak immune 
response was induced after immunization of mice with these conjugates. High antibody titers 
were obtained with conjugates of sulfanilamide linked to albumins or casein with a 
diazotation reaction. However, the antibodies were only highly specific for the bound 
sulfanilamide molecule. In a second approach, sulfonamide-protein conjugates were used in 
which the sulfonamide molecule was linked at its side chain, leaving the common structure of 
sulfonamides unchanged. Hereto, three sulfonamide derivatives (N-sulfanyl-4-aminobenzoic 
acid (S), N1-[4-methyl-5-[2-4-carboxyethyl-1-hydroxyphenyl)]-azo-2-pyridyl]-sulfanilamide 
(PS) and N1-[4-(carboxymethyl)-2-thiazolyl]sulfanilamide (TS)), previously described in 
literature, containing a carboxyl group in their side chain were synthesized and subsequently 
linked to proteins using a carbodiimide-mediated reaction. Immunization with the S-
conjugates led to high antibody titers, but the antibodies were only highly specific for the 
bound S-molecule. Group-specific antibodies were obtained after immunization with the PS- 
and TS-conjugates. It had been described that immunization with PS-conjugates led to the 
recognition of other sulfonamides (sulfamethazine, -merazine, -diazine and –dimethoxine) 
that are not well recognized by antibodies induced after immunization with TS-conjugates. 
Therefore, we tried to guide the immune response in the direction of recognition of the 
common structure of sulfonamides by immunizing the animals alternately with PS- and TS-
conjugates. The polyclonal antibodies of the mice had indeed a broader specificity, but the 
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specificity of the monoclonals obtained after fusion experiments was not influenced. 
Immunization with TS-conjugates seemed sufficient to obtain sulfonamide-specific 
monoclonal antibodies. With the best monoclonal (mAb 3B5B10E3) two competitive 
inhibition (ci) ELISAs were developed: one coated with antigen and the other coated with the 
monoclonal antibody. Sulfadiazine, –dimethoxine, -thiazole, -pyridine and -methoxazole were 
detected in both ELISAs at their MRL-value (100 ng/ml) in buffer solution. Sulfadiazine, 
sulfathiazole and sulfamethoxazole could even be detected at 10 ng/ml. Cross-reactivities 
were noticed for diuretics (furosemide, acetazolamide, hydrochlorothiazide, bumetanide; IC50 
>10 µg/ml), but not for thiamphenicol, florphenicol, lidocaine and p-aminobenzoic acid. 
Since the diuretics only have the –SO2NH- group in common with sulfonamides, this 
indicates that the epitope recognized by the monoclonal contains the –SO2NH- group.  
 
In chapter 9, the development of an ELISA using sulfonamide-specific polyclonal 
rabbit antibodies (pAb K3) is described. The antibodies were obtained after immunization 
with the TS- keyhole limpet hemocyanin (TS-klh) immunogen. Using these antibodies, two 
sulfonamide-specific ELISAs were developed differing in coating antigen: TS-ovalbumin 
(TS-ova) and PS-ovalbumin (PS-ova). The detection of sulfamethazine, sulfamerazine, 
sulfadimethoxine, sulfadiazine, sulfathiazole, sulfapyridine, sulfachloropyridazine and 
sulfisoxazole in buffer was analysed. Higher antibody titers were obtained in the ciELISA 
coated with TS-ova (TS-ciELISA) than in the ciELISA coated with PS-ova (PS-ciELISA), 
but the detection of sulfonamides was more sensitive in the PS-ciELISA, allowing the 
detection of all tested sulfonamides at the MRL-value (100 ng/ml). Cross-reactivities of pAb 
K3 were noticed for para-aminobenzoic acid (IC50 >10 µg/ml), but not for diuretics 
(furosemide, acetazolamide, hydrochlorothiazide, bumetanide), thiamphenicol, florphenicol 
and lidocaine. Para-aminobenzoic acid contains the common sulfonamide p-aminobenzoyl 
ring. This indicates that the epitope recognized by the polyclonals contains p-aminobenzoyl 
ring. Substitution of the sulfonamide-group on the common p-aminobenzoyl ring favors the 
binding of the polyclonals since most sulfonamides are recognized with higher sensitivity 
(IC50 <1 µg/ml) than p-aminobenzoic acid (IC50 >10 µg/ml). 
In a subsequent step, an extraction procedure was developed for the detection of 
sulfonamides, in muscles, kidney, liver and fat, by both ELISAs using sulfachloropyridazine 
as model. As extraction buffer a carbonate/bicarbonate buffer (pH 10) was chosen in which 
sulfonamides are highly soluble. Differences in homogenizing techniques (high-speed mixer 
(ultraturax) versus vortex) and the effect of kaolin (hydrated aluminum silicate) treatment, to 
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diminish the background signal in ELISA, were evaluated. The best extraction procedure was 
the one using a vortex mixer as homogenizer and no kaolin treatment. Sulfachloropyridazine 
was easily detected at the MRL in all tissues. The decision limit and detection capability for 
sulfachloropyridazine in porcine kidneys were determined (CCα = 9.4 ng/ml, CCβ = 12.9 
ng/ml). Acceptable correlations were found between the PS-ciELISA and LC-MS/MS for the 
analysis of incurred porcine liver and kidney samples (r2 = 0.88 and 0.77 resp.). 
 
A general discussion and conclusions are given in Part V of this thesis. The results of 
this thesis show that it is possible to develop antibodies recognizing a group of antimicrobials. 
To obtain such antibodies, an appropriate immunogen for induction of group-specific 
antibodies is very important. Other conclusions that can be drawn are that alternately 
injecting different immunogens enhances the polyclonal response and that a final intravenous 
booster immunization enhances hybridoma production. However, neither the immunogen nor 
the immunization procedure can guarantee the production of suitable antibodies. The test for 
selecting the antibodies is as important and should resemble as close as possible the test that 
will be developed for detecting the analytes in food of animal origin.  
Using the monoclonal and polyclonal penicillin- and sulfonamide-specific antibodies, 
different test systems were developed, namely antigen ciELISAs, antibody ciELISAs and 
biosensor assays. Thus, it is possible to develop group-specific assays using our group-
specific antibodies. It was demonstrated that the choice of the test system influenced the 
sensitivity and specificity of the antibodies. In our research the detection of analytes using 
polyclonal antibodies was more sensitive than using monoclonals.  
For analysing tissue samples, an appropriate simple extraction procedure had to be 
developed. This was achieved for penicillins as well as for sulfonamides. It is thus possible to 
develop one extraction procedure for a group of antimicrobials. Very important factors are the 
extraction buffer and the sample handling, which should be kept as minimal as possible. 
Any method or combination of methods may only be used for screening or 
confirmatory purposes if it can be proven that they fulfill the relevant requirements 
established in the Commission Decision 2002/657/EC. For a qualitative screening method, the 
detection capability (CCβ), the selectivity/specificity and the 
applicability/ruggedness/stability must be demonstrated. When a screening assay will be used 
quantitatively, the precision must also be determined. The validation is performed using 
fortified samples. It is advisable, however, to compare the analysis of incurred samples with 
the analysis using a reference method. An extraction procedure developed using fortified 
                                                                                                                                                                    Summary                             
 196
samples will not necessarily be efficient for incurred samples because the interaction of the 
analyte with the sample matrix can be different in fortified samples as compared to incurred 
samples. The comparative studies of the analysis of incurred tissues using our ELISAs and 
using a commercial immunochemical assay, in case of penicillins, or a physico-chemical 
method, in case of sulfonamides, demonstrated the suitability of our ELISAs and of the 
corresponding extraction procedures. 
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Samenvatting 
 
Microbiologische inhibitietesten worden meestal gebruikt voor het screenen van 
voedingswaren van dierlijke oorsprong. Deze testen hebben een brede spectrumspecificiteit 
en zijn daarom nuttig voor screening. Wanneer een staal positief (niet-conform) bevonden 
wordt met een microbiologische test, dan moet dit resultaat bevestigd worden met chemische 
analysemethoden. Deze methoden kunnen heel betrouwbaar en nauwkeurig zijn, maar 
anderzijds zijn ze arbeidsintensief en duur. Het is daarom aangeraden om tijdens de screening 
foutieve niet-conforme resultaten te vermijden. Bovendien moet men eerst bepalen tot welke 
groep antibiotica het onbekende residu in het niet-conforme staal behoort, zodat de meest 
geschikte confirmatiemethode kan gekozen worden. Breed-spectrum microbiologische testen 
maken geen onderscheid tussen de verschillende antibioticafamilies. Het doel van deze studie 
was om na te gaan of groepsspecifieke antistoffen kunnen worden ontwikkeld voor 
penicillines en voor sulfonamiden. Met zulke groepsspecifieke antistoffen zou het vervolgens 
mogelijk moeten zijn om een immunochemische test te ontwikkelen, zoals de enzyme-linked 
immunosorbent assay (ELISA). Zo’n test kan dan gebruikt worden voor de 
groepsidentificatie van een vermoedelijk niet-conform staal. In combinatie met een geschikte 
extractieprocedure zouden deze ELISA’s dan kunnen gebruikt worden voor de detectie van 
penicillines en sulfonamiden in vlees. 
 
In hoofdstuk 1 wordt een overzicht gegeven van de principes van immunochemische 
testen. Omdat deze testen gebaseerd zijn op de interactie tussen antistof en antigeen, worden 
de fysicochemische eigenschappen van de interactie en de beïnvloedende factoren besproken. 
De productie van antistoffen wordt behandeld waarbij een vergelijking gemaakt wordt tussen 
monoklonalen en polyklonalen. Vervolgens wordt ook een overzicht gegeven van de 
immunologische testen gebruikt in deze thesis, nl de ELISA en de optische biosensor op basis 
van oppervlakte plasmonresonantie.  
In hoofdstuk 2 en 3 wordt het gebruik van penicillines en sulfonamiden in de 
diergeneeskunde besproken. Hun fysicochemische en biologische eigenschappen, alsook hun 
metabolisatie worden behandeld. Verder worden de gevolgen van het overmatige gebruik van 
penicillines en sulfonamiden toegelicht. Tenslotte wordt een overzicht gegeven van de 
huidige stand van zaken betreffende de beschikbare microbiologische inhibitietesten, 
receptortesten en immunochemische testen.  
                                                                                                                                                               Samenvatting                            
 199
In hoofdstuk 4 tot en met 9 wordt het experimentele werk van dit onderzoek 
weergegeven. Deze thesis had tot doel volgende vragen te beantwoorden: 
1. Is het mogelijk om antistoffen te ontwikkelen specifiek voor een groep 
antimicrobiële stoffen? 
2. Kan een screeningstest ontwikkeld worden met zulke groepsspecifieke 
antistoffen? 
3. Is het mogelijk om een extractieprocedure te ontwikkelen voor een groep 
antimicrobiële stoffen? 
 
De ontwikkeling van penicilline-specifieke monoklonale antistoffen wordt besproken 
in hoofdstuk 4. Verschillende procedures werden geëvalueerd teneinde monoklonalen te 
bekomen die specifiek zijn voor de gemeenschappelijke structuur van penicillines. Hiertoe 
moesten penicillines immunogeen gemaakt worden. Teneinde ampicilline immunogeen te 
maken, werd het gekoppeld aan verschillende drager-eiwitten (bovien albumine, 
kippenalbumine and thyroglobuline). Hierbij werden verschillende koppelingsmethoden 
vergeleken: twee methoden gebruikmakend van een crosslinkermolecule (glutaaraldehyde of 
een succinimide ester), een carbodiimide-gemediëerde koppeling en een methode zonder 
crosslinkermolecule of mediator (fysiologische binding). Muizen werden intraperitoneaal, 
intraveneus of in de voetzool geïmmunizeerd. Een screenings-ELISA werd ontwikkeld voor 
de detectie van de anti-ampicilline antistoffen in sera. De specificiteit en affiniteit van de 
antistoffen werd getest door de inhibitie van hun binding aan de gecoate ampicilline-
eiwitconjugaten na te gaan in aanwezigheid van ampicilline (10 mM in bufferoplossing). 
Voor de productie van monoklonalen werd geen verschil waargenomen in het aantal 
hybridomen bekomen na elektrofusies en PEG-gemediëerde fusies. Antistoffen met een 
hogere specificiteit en affiniteit werden bekomen na een intraveneuze finale injectie in 
vergelijking met een intraperitoneale injectie. Twee anti-ampicilline monoklonalen (mAb 
19C9 en mAb 9H3) werden geselecteerd die kruisreageren met benzylpenicilline, oxacilline, 
cloxacilline, dicloxacilline en carbenicillin, en niet met cefalosporinen (cefadrine, cefalexine, 
cefaclor), clavulaanzuur, sulfanilamide, chloramphenicol, neomycin en streptomycin. 
Bijgevolg werden deze monoklonalen interessant bevonden voor de ontwikkeling van een 
penicilline-specifieke ELISA.  
De productie van penicilline-specifieke polyklonale konijnenantistoffen (pAb) en het 
gebruik van deze antistoffen in een ELISA wordt beschreven in hoofdstuk 5. De polyklonalen 
werden bekomen na immunizatie van 3 konijnen (K2, K6 en K8) met fysiologische 
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ampicilline- en benzylpenicilline-eiwitconjugaten (pAb K2) of met fysiologische ampicilline-, 
benzylpenicilline-, oxacilline and dicloxacilline-eiwitconjugaten (pAb K6 en pAb K8). De 
groepsspecificiteit van de antisera geïnduceerd met fysiologische penicilline-eiwitconjugaten 
kon worden verbeterd door de dieren afwisselend te immunizeren met conjugaten die een 
verschillend hapteen bevatten. Met elk polyklonaal werden zowel een met antigeen gecoate 
competitieve inhibitie ELISA (antigeen ciELISA) als een met antistof gecoate competitieve 
inhibitie ELISA (antistof ciELISA) ontwikkeld. Voor alle drie de antisera was de detectie van 
ampicilline, amoxicilline, benzylpenicilline, oxacilline, cloxacilline and dicloxacilline 
gevoeliger in de antistof ciELISA dan in de antigeen ciELISA, doch de detectie van alle 
penicillines in bufferoplossing onder de MRL was enkel mogelijk in de antistof ciELISA als 
de penicillines voorafgaandelijk gehydrolyseerd werden met Penicillinase I. Er werden geen 
kruisreacties waargenomen voor cefadrine, cefalexine, cefazoline, clavulaanzuur, 
sulfanilamide en chloramphenicol. 
In hoofdstuk 6 wordt het gebruik vergeleken van de monoklonalen 19C9 en 9H3, en 
de polyclonaal K2 in ELISA en in de BIAcore™ optische biosensor. In de ELISA werd een 
ampicilline-eiwitconjugaat gebruikt als coatingsmolecule terwijl in de biosensortest 
ampicilline rechtstreeks geïmmobiliseerd werd op een CM5 chip. Met beide monoklonale 
antistoffen en in beide testsystemen, werden ampicilline, amoxicilline en benzylpenicilline 
beter herkend dan oxacilline, cloxacilline en dicloxacilline. Omdat bij gebruik van mAb 
19C9, de herhaalbaarheid hoger was in de biosensortest (CV = 1.6 %) dan in de ELISA (CV 
= 8.9 %), was de detectielimiet voor ampicilline in bufferoplossing lager in de biosensor (46 
ng/ml) dan in de ELISA (356 ng/ml). Ampicilline kon bijgevolg gedetecteerd worden aan de 
MRL (50 ng/ml) in de biosensortest maar niet in de ELISA.  
Zowel de ELISA als de biosensortest gebruikmakend van de polyklonale antistoffen 
was gevoeliger dan de testen gebruikmakend van de monoklonalen. Met de polyklonalen 
kunnen alle geteste penicillines in de ELISA en ampicilline in de biosensortest tot onder de 
MRL gedetecteerd worden. In de biosensortest werd, in tegenstelling tot de binding van de 
monoklonalen, geen spontane dissociatie waargenomen na injectie van de polyklonale 
antistoffen in de biosensor. De monoklonalen konden gemakkelijk van het sensoroppervlak 
verwijderd worden met een overmaat ampicilline (500 µg/ml) als regeneratievloeistof. Voor 
de polyklonalen waren echter strengere regeneratiecondities nodig (0.1 M NaOH + 20% 
acetonitril). De detectie van ampicilline in de biosensortest gebruikmakend van de pAb K2 
kan waarschijnlijk nog verbeterd worden door de stalen vooraf te behandelen met 
Penicillinase I.  
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Zowel met de monoklonalen (mAb 19C9 en mAb 9H3) als met de polyklonale 
antistoffen (pAb K2, pAb K6 en pAb K8) werd een antigeen ciELISA ontwikkeld voor de 
detectie van ampicilline, amoxicilline, benzylpenicilline, oxacilline, cloxacilline en 
dicloxacilline in bufferoplossing (Hoofdstuk 5 en 6). De antigeen ciELISA’s waren echter 
niet in staat om alle geteste penicillines te detecteren tot onder de MRL (50 µg/kg). 
Ampicilline werd enkel gevoelig genoeg gedetecteerd in de antigeen ciELISA met de 
polyklonalen (LOD = 6 ng/ml met pAb K2; LOD = 20 ng/ml met pAb K6 en pAb K8) en 
amoxicilline in de antigeen ciELISA met mAb 19C9 (LOD = 18 ng/ml). Met de 
polyklonalen, maar niet met de monoklonalen, werd een antistof ciELISA ontwikkeld die 
tienmaal gevoeliger was dan de antigeen ciELISA. Daarom werden enkel de ELISA’s 
gebruikmakend van pAb K2 gekozen om na te gaan of varkensweefsels geanalyseerd kunnen 
worden overeenkomstig de Europese richtlijn voor het gebruik van screeningstesten voor de 
inspectie van voedingswaren van dierlijke oorsprong (Hoofdstuk 7). Een aantal relevante 
karakteristieken (specificiteit, gevoeligheid, herhaalbaarheid, beslissingsgrens (CCα) en 
detectievermogen (CCβ)) voor de validatie worden besproken. De resultaten tonen aan dat de 
nauwkeurigheid van de antistof ciELISA hoger is dan deze van de antigeen ciELISA: de 
spreiding tussen CCα en CCβ is kleiner voor de analyse van nierweefsels in de antistof 
ciELISA (9-19 ng/ml) dan in de antigeen ciELISA (21-69 ng/ml). Immers, een staal is niet-
conform wanneer de concentratie hoger is dan CCβ, conform wanneer deze lager is dan CCα 
en verdacht wanneer de concentratie tussen CCα en CCβ ligt. Dit betekent dat de spreiding 
tussen CCα en CCβ liefst zo klein mogelijk moet zijn. Bovendien werd de geschiktheid van 
de antistof ciELISA en de gebruikte extractieprocedure voor het screenen van 
varkensweefsels aangetoond door de ELISA resultaten bekomen voor praktijkstalen te 
vergelijken met de resultaten van de analyse van dezelfde stalen met een commerciële 
immunochemische methode, de Parallux™ test. Er werd bijna 100 % overeenkomst 
waargenomen tussen de resultaten van de ELISA en deze van de Parallux™ test (r2 = 0.94).  
In hoofdstuk 8 worden de verschillende strategieën beschreven om monoklonale 
antistoffen te bekomen specifiek voor de gemeenschappelijke sulfonamidenstructuur. Een 
eerste strategie bestond erin sulfanilamide te koppelen aan albumines met behulp van 
glutaaraldehyde of een succinimide ester als crosslinkermolecule. Immunizatie van muizen 
met deze conjugaten induceerde geen of zwakke immuunresponsen. Hoge antistoffentiters 
werden bekomen na immunizatie met sulfanilamide gekoppeld aan albumines of caseïne via 
de diazotatiereactie. Deze antistoffen waren echter enkel heel specifiek voor de gebonden 
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sulfanilamide molecule. In een tweede strategie werden sulfonamideneiwitconjugaten 
gebruikt waarin de sulfonamidenmolecule via zijn zijketen gekoppeld was zodat de 
gemeenschappelijke sulfonamidenstructuur ongewijzigd bleef. Hiervoor werden drie 
sulfonamidenderivaten (N-sulfanyl-4-aminobenzoic acid (S), N1-[4-methyl-5-[2-4-
carboxyethyl-1-hydroxyphenyl)]-azo-2-pyridyl]-sulfanilamide (PS) en N1-[4-
(carboxymethyl)-2-thiazolyl]sulfanilamide (TS)), gesynthetiseerd. Deze derivaten bevatten 
een carboxylgroup in hun zijketen waarmee ze aan eiwitten kunnen worden gebonden via een 
carbodiimide-gemediëerde reactie. Immunizatie met de S-eiwitconjugaten resulteerde in hoge 
antistoffentiters. De antistoffen waren echter zeer specifiek voor de gebonden S-molecule.  
Groepsspecifieke antistoffen werden wel bekomen na immunizatie met de PS- en TS-
eiwitconjugaten. Het was reeds beschreven in de literatuur dat immunizatie met PS-
eiwitconjugaten leidde tot de herkenning van andere sulfonamiden (sulfamethazine, -
merazine, -diazine en –dimethoxine) die niet goed herkend werden door antistoffen 
geïnduceerd na immunizatie met TS-eiwitconjugaten. Bijgevolg werd  geprobeerd de 
immuunrespons te richten naar herkenning van de gemeenschappelijke sulfonamidenstructuur 
door de dieren afwisselend te immunizeren met PS- en TS-eiwitconjugaten. De polyklonale 
antistoffen van de muizen hadden inderdaad een bredere specificiteit, maar de monoklonalen 
bekomen na fusie werden hierdoor niet beïnvloed. Immunizatie met TS-eiwitconjugaten bleek 
voldoende om sulfonamidenspecifieke monoklonale antistoffen te bekomen. Met het beste 
monoklonaal (mAb 3B5B10E3) werden twee competitieve inhibitie (ci) ELISA’s ontwikkeld: 
één gecoat met antigeen en de andere gecoat met de monoklonale antistof. Sulfadiazine, –
dimethoxine, -thiazole, -pyridine en -methoxazole werden in beide ELISA’s in 
bufferoplossingen gedetecteerd aan de MRL (100 ng/ml). Sulfadiazine, sulfathiazole en 
sulfamethoxazole konden zelfs tot 10 ng/ml gedetecteerd worden. Kruisreacties werden enkel 
waargenomen voor diuretica (furosemide, acetazolamide, hydrochlorothiazide, bumetanide; 
IC50 > 10 µg/ml), maar niet voor thiamfenicol, florfenicol, lidocaine en p-aminobenzoëzuur. 
Daar de diuretica enkel de –SO2NH- groep gemeenschappelijk hebben met de sulfonamiden, 
betekent dit dat het epitoop dat door het monoklonaal herkend wordt de –SO2NH- groep 
bevat.  
 
In hoofdstuk 9 wordt de ontwikkeling van een ELISA gebruikmakend van de 
sulfonamidenspecifieke polyklonale konijnenantistoffen (pAb K3) beschreven. De antistoffen 
werden bekomen na immunizatie met het TS-Keyhole limpet hemocyanine (TS-klh) 
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immunogeen. Met deze antistoffen werden twee sulfonamidenspecifieke ELISA’s ontwikkeld 
die van elkaar verschillen in de coatingsmolecule, namelijk TS-ovalbumine (TS-ova) in de 
ene en PS-ovalbumine (PS-ova) in de andere test. De detectie van sulfamethazine, 
sulfamerazine, sulfadimethoxine, sulfadiazine, sulfathiazole, sulfapyridine, 
sulfachloropyridazine en sulfisoxazole in bufferoplossing werden getest. Hogere 
antistoffentiters werden bekomen in de ELISA gecoat met TS-ova (TS-ciELISA) in 
vergelijking met de ELISA gecoat met PS-ova (PS-ciELISA). Anderzijds was de detectie van 
sulfonamiden gevoeliger in de PS-ciELISA omdat alle geteste sulfonamiden gedetecteerd 
werden tot de MRL (100 ng/ml). Kruisreacties werden waargenomen voor p-
aminobenzoëzuur (IC50 >10 µg/ml), maar niet voor diuretica (furosemide, acetazolamide, 
hydrochlorothiazide, bumetanide), thiamfenicol, florfenicol en lidocaine. Para-
aminobenzoëzuur bevat de gemeenschappelijke sulfonamide p-aminobenzoylring. Dit wijst er 
bijgevolg op dat het epitoop dat herkend wordt door de polyklonalen deze p-
aminobenzoylring bevat. Substitutie van de sulfonamide-groep op de gemeenschappelijke p-
aminobenzoylring bevordert de binding van de polyklonalen vermits de meeste sulfonamiden 
beter herkend werden (IC50 <1 µg/ml) dan para-aminobenzoëzuur (IC50 >10 µg/ml). 
In een volgende fase werd een extractieprocedure ontwikkeld voor de detectie van 
sulfonamiden in spier-, nier-, vet en leverweefsels, in beide ELISA’s. Sulfachloropyridazine 
werd als model gebruikt. Een carbonate/bicarbonate buffer (pH 10) werd gekozen als 
extractiebuffer daar de meeste sulfonamiden zeer goed oplossen in deze buffer. Verschillende 
homogenisatiemethoden (high-speed mixer (ultraturax) versus vortex) werden vergeleken en 
het effect van kaolin (gehydrateerde aluminium silicaat) werd nagegaan om de 
achtergrondsignalen in de ELISA’s te verminderen. De beste extractieprocedure was deze 
waarbij gebruikgemaakt werd van een vortex en zonder kaolinbehandeling. 
Sulfachloropyridazine werd gemakkelijk gedetecteerd aan de MRL in alle weefsels. De 
beslissingsgrens en het detectievermogen werden bepaald voor sulfachloropyridazine in 
varkensnieren (CCα = 9.4 ng/ml, CCβ = 12.9 ng/ml). Aanvaardbare correlaties werden 
waargenomen tussen de PS-ciELISA en LC-MS/MS voor de analyse van lever en –
nierweefsels afkomstig van met sulfachloropyridazine behandelde varkens (r2 = 0.88 en 0.77 
resp.). 
 
Een algemene discussie en conclusies zijn terug te vinden in deel V van deze thesis. 
De resultaten tonen aan dat het weldegelijk mogelijk is om antistoffen te ontwikkelen 
specifiek voor een groep antimicrobiële stoffen. Hierbij is het heel belangrijk om een geschikt 
                                                                                                                                                               Samenvatting                            
 204
immunogeen te vinden voor de inductie van groepsspecifieke antistoffen. Bovendien kunnen 
enkele richtlijnen neergeschreven worden voor de immunizatie, zoals het afwisselend 
toedienen van verschillende immunogenen voor het verhogen van de polyklonale 
antistoffenrespons, en het toedienen van een finale intraveneuze immunizatie ipv 
intraperitoneaal voor het verhogen van de productie van de hybridomen. Echter, noch het 
immunogeen noch de immunizatieprocedure kan de productie van geschikte antistoffen 
garanderen.  
Zeer belangrijk bij de selectie van geschikte antistoffen is de test die gebruikt wordt bij 
deze selectie. De test moet zo goed mogelijk lijken op de screeningstest die men later wil 
gebruiken. Zowel met de mAb als met de pAb werden voor de penicillines maar ook voor de 
sulfonamiden, groepsspecifieke testen ontwikkeld. Het is dus mogelijk om een screeningstest 
te ontwikkelen met  groepsspecifieke antistoffen. Hierbij beïnvloedt het testsysteem de 
gevoeligheid en specificiteit van de antistoffen. In deze thesis bleek de detectie van analyten 
gebruikmakend van polyklonale antistoffen gevoeliger dan wanneer monoklonalen gebruikt 
werden.  
Teneinde weefsels te kunnen analyseren, moet een geschikte extractieprocedure 
worden ontwikkeld. Dit werd uitgevoerd voor zowel de penicillines als de sulfonamiden. Het 
is dus mogelijk om een extractieprocedure te ontwikkelen voor een groep antimicrobiële 
stoffen. Hierbij zijn de extractiebuffer en de manipulaties van het staal heel belangrijk. Deze 
laatste moeten bovendien liefst zo eenvoudig mogelijk gehouden worden.  
Een methode mag enkel gebruikt worden voor screening indien men kan bewijzen dat 
de methode voldoet aan de eisen neergeschreven in de Europese richtlijn 2002/657/EC. Voor 
een kwalitatieve screeningstest wordt gevraagd om het detectievermogen (CCβ), de 
selectiviteit/specificiteit en de toepasbaarheid, ruwheid en stabiliteit aan te tonen. Wanneer het 
de bedoeling is om een screeningstest kwantitatief te gebruiken, dan moet de nauwkeurigheid 
ook bepaald worden. De validatie wordt uitgevoerd met behulp van aangerijkte stalen.  Het is 
echter aangewezen om ook de analyse van praktijkstalen met de screeningstest te vergelijken 
met de analyse door middel van een referentiemethode. Immers, een methode ontwikkeld met 
behulp van aangerijkte stalen zal niet noodzakelijk geschikt zijn voor stalen afkomstig van 
behandelde dieren (praktijkstalen) omdat de interactie tussen het analyt en de weefselmatrix 
verschillend kan zijn voor aangerijkte stalen in vergelijking met stalen van behandelde dieren. 
Vergelijkende studies tussen onze ELISA’s en een commerciële immunochemische test in 
geval van penicillines of een gevalideerde chemische analysemethode in geval van 
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sulfonamiden hebben de geschiktheid aangetoond van onze methoden voor de detectie van 
deze antimicrobiële stoffen in varkensweefsels.  
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